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Abstract 
Does Fasciola hepatica infection increase the susceptibility of cattle to 
infection with other pathogens normally controlled by a Th1 or pro-
inflammatory response? 
Jennifer Anne Claridge 
Fasciola hepatica is a trematode parasite with wide geographical and host ranges, primarily affecting 
ruminants in the United Kingdom. Infection of host animals leads to significant economic losses in 
production, with reduced weight gains and milk quality and quantity. Clinical disease, known as 
fasciolosis, is expensive to treat and causes significant morbidity and mortality. More than three 
quarters of dairy herds surveyed in England and Wales have been exposed to this parasite, and the 
number of diagnoses of fasciolosis, made by the Animal Health Veterinary Laboratories Agency, has 
increased dramatically in the last fifteen years. 
Experimental studies have demonstrated failure to diagnose bovine tuberculosis (BTB) when co-
infection with F. hepatica is present. In Chapter 2, we demonstrate a novel method for estimating 
the prevalence of BTB in England and Wales and show that, in light of the imperfect diagnostic test 
for BTB, the prevalence may be significantly higher than currently reported. 
In Chapter 3, a logistic regression model for the presence or absence of BTB on farms in England and 
Wales is designed, based upon those previously published. The addition of a variable to describe the 
burden of F. hepatica found in the locality of each farm significantly increases the predictive power 
of the model and may help to explain the under-diagnosis of BTB suggested in Chapter 2. A 
significant, negative association is demonstrated between F. hepatica exposure and the BTB status 
of the farm. The difference between the model predictions for BTB status made with F. hepatica 
exposure as tested and the predictions made assuming F. hepatica exposure is negative is then 
calculated to provide an estimate of the missing BTB diagnoses due to co-infection. We show this 
under-ascertainment to be over one third of cases. 
The significant, negative association between F. hepatica exposure and BTB diagnosis described at 
the herd level in Chapter 3, is then tested on an animal level. In Chapter 4, milk samples from 
individual animals testing negative and inconclusive, or negative and positive to the BTB test are 
assessed using the anti-F. hepatica antibody ELISA and an exposure value obtained. Significantly 
higher exposure to F. hepatica was not found in either pairing of BTB outcome-cattle and potential 
reasons for this are discussed. 
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Chapter 5 investigates the association between F. hepatica exposure and other infectious diseases 
such as Bovine Viral Diarrhoea virus (BVDv), Leptospira spp, Infectious Bovine Rhinotracheitis, Johnes 
Disease and Neospora caninum. A random effects model is constructed using information collected 
about animal and farm parameters, to predict F. hepatica exposure. Vaccination against BVDv and 
Leptospira spp are shown to be significantly associated, the former being positively and the latter 
being negatively correlated. Johnes Disease prevalence is negatively associated with F. hepatica 
exposure and Salmonella Dublin prevalence is positively associated. Farm management and 
husbandry variables were also found to be significantly associated with F. hepatica exposure. 
In total, this thesis adds to the growing realisation that co-infection with this pathogen can have 
significant repercussions on the diagnostic ability of the BTB test and on the health and welfare of 
the national herd.  
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Chapter 1 
Introduction and Literature Review 
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Most pathogens are normally studied in isolation. However, a single host may become naturally 
infected with a number of pathogens at any one time, in the field. Cell culture and single infection 
work in a range of host species are important for understanding the true biology of a pathogen, but 
once that knowledge has been gained, the control and elimination of infectious diseases in a natural 
population becomes the next challenge carrying major animal health and welfare, farm production 
and financial implications.  
Human co-infections have been most widely studied and in particular, the role of parasite infections 
on host susceptibility and clinical disease severity.  The pro-inflammatory immune responses 
required to control human tuberculosis (hTB) in its latent state are down-regulated in individuals co-
infected with filarial nematodes (Babu et al., 2009). It has been demonstrated that mothers carrying 
the filarial nematode, Mansonella perstans, gave birth to children that generated lower protective 
responses to hTB when given Bacille Calmette-Guérin (BCG) vaccines, thus the strongly anti-
inflammatory immune environment established upon such helminth exposure can have detrimental 
effects on control of hTB in Africa (Elliott et al., 2010). However, intestinal nematodes were not 
found to alter tuberculin skin test reactions in humans (Zevallos et al., 2010).  
Advances in knowledge of pathogen-mediated immunomodulation and immune evasion have 
highlighted the potential for pathogens not just to co-exist in a host, but to interact with the immune 
system, exerting an impact on the susceptibility of the host animal to other infectious agents, 
leading to slower clearance, persistent shedding and increased severity of disease when co-
infections are present (Aitken et al., 1978, Aitken et al., 1981, Hall et al., 1981, Brady et al., 1999, 
Flynn et al., 2007b, Flynn et al., 2009, Kao et al., 2007, Charleston et al., 2001, Castrucci et al., 1992). 
Such co-infections are described more fully in the following sections. 
Recently, experimental studies in cattle have shown that co-infection of cattle with Mycobacterium 
bovis, either as the live attenuated BCG strain or as a live virulent strain, and the trematode parasite, 
Fasciola hepatica, can down-regulate the response to purified protein derivatives, necessary to 
diagnose BTB (Flynn et al., 2007b, Flynn et al., 2009).  
This thesis examines the epidemiological association between BTB and F. hepatica in England and 
Wales, as measured in the field. We provide a novel method of prevalence estimation for BTB-
infected herds and hence show the magnitude of disease control required. We offer an additional 
variable to aid prediction of BTB on dairy farms in England and Wales, and estimate the number of 
herds with BTB wrongly classified as non-infected, due to the presence of co-infection with fluke. We 
then looked for associations between F. hepatica exposure and BTB in individual animals, and finish 
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by defining associations between F. hepatica exposure and other common endemic infectious 
diseases in dairy cattle. 
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1.1 Fasciola hepatica 
Fasciola hepatica is a trematode parasite, commonly known as the liver fluke, affecting 
predominantly cattle and sheep in the UK. It is classified as a member of the digenea, and requires 
an intermediate host to complete its life cycle. 
The prevalence of the liver fluke disease, fasciolosis, in livestock in England and Wales is rising 
(Daniel and Mitchell, 2002). This is probably because of increased movement of livestock around the 
country and climatic changes favouring the life cycle (Carrique-Mas et al., 2008, Poulin, 2006).  
Fasciolosis has historically been more common in the wetter western areas of the UK (Froyd, 1975). 
However, an upsurge in clinical bovine fasciolosis reported in East Anglia, an area not usually 
associated with the disease, has been reported (Pritchard et al., 2005). The demonstration that an 
increase in temperature of 10°C has been shown to increase cercarial output up to 8-fold (Poulin, 
2006), provides additional evidence for recent climate change altering fasciolosis distribution in the 
UK, although the impact will be less in the field due to less extreme temperature increases.  
Fasciolosis is a zoonotic disease and can establish in humans. Although very rare in the UK,  human 
fasciolosis is endemic in some countries and the prevalence of clinical disease can be up to 47.7% 
(Gonzalez et al., 2011).   
1.1.1 Financial Implications of F. hepatica infection 
Fasciola hepatica infection, whether symptomatic or not, is responsible for major economic losses to 
the cattle industry. Infected cattle show a reduction in weight gain (Hope-Cawdery et al., 1977).  
When a 50% rise in anti-F. hepatica antibody titre occurs there is a reduction in average milk yield of 
0.7kg/cow/day, average milk fat of 0.06% and an increase in calving interval of 4.7 days for dairy 
cows (Charlier et al., 2007). Another study also reported an average milk drop of 1.5kg milk/cow/day 
in highly exposed herds compared with negative herds determined using the MM3-sero ELISA, 
designed for serum samples, was modified and applied to bulk tank milk samples (Mezo et al., 2011).  
Although estimating economic losses due to sub-clinical F. hepatica infections in cattle and sheep is 
difficult, such losses are predicted to be substantial.  In Switzerland, the cost per clinical case with 
fasciolosis was estimated at 299 euros, with major financial losses in reduced milk yield and 
fecundity, and smaller losses attributed to reduced growth rates and condemnation of infected livers 
(Schweizer et al., 2005).  
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1.1.2 Epidemiology of F. hepatica 
Infection rates of cattle in England and Wales are high, with herd prevalence of infection in dairy 
herds estimated at 76% (McCann et al., 2010b). F. hepatica exposure, with or without clinical 
fasciolosis, has been considered a valuable tool in the management of livestock, for decades 
(Gettinby et al., 1974). More recently, models have been developed to predict F. hepatica exposure 
in livestock in numerous countries, using detailed information gathered from satellites and mapping 
software (Yilma and Malone, 1998, Malone et al., 1998, Fuentes et al., 2005, Dutra et al., 2010). 
Models generally use information with a resolution of about 5x5km (McCann et al., 2010b), but 
recent models have been developed using farm-specific data (Charlier et al., 2011). Although the 
predictive ability of these farm-level models is high (R2 = 0.85), the practicality of using such a system 
country-wide at the moment is debatable as data collection would initially be expensive. A system 
like that of McCann et al., (2010b) would be more financially viable as appropriate variables are 
already being captured and are downloadable from, for example, the Met Office and Countryside 
Information System websites. 
Forecasts of likely F. hepatica burden, made using climatic information have been in operation in the 
UK for decades (Gettinby et al., 1974, Ollerenshaw and Smith, 1969) and use environmental 
variables such as the number of rainy days each month, precipitation and evapotranspiration, to 
predict the monthly risk of F. hepatica infection. More recent models show temperature and rainfall 
to be important factors for occurrence of disease (McCann et al., 2010a). Such findings are expected 
given the lifecycle of F. hepatica. Risk maps for F. hepatica exposure in UK dairy cows show 
substantial risk throughout England and Wales, with particularly high risks in the main dairy regions 
of the west (McCann et al., 2010b). 
1.1.3 Structure of F. hepatica  
Adult F. hepatica grow up to 3.5cm long, are grey-brown and found in the bile ducts of hosts. They 
have an anterior cone containing an oral sucker and below which is a ventral sucker for attachment. 
The muscles lie directly beneath the tegument, which is covered with spines. There is no body cavity, 
with organs packed into parenchyma. From the oral sucker is an opening leading directly into a 
pharynx, oesophagus and paired, blind-ending caeca (Urquhart et al., 1996). 
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Figure 1.1: The structure of adult Fasciola hepatica  
 
 
 
 
 
Flukes are hermaphrodite, so cross- and self-fertilisation occurs. Sperm produced in paired testes 
enter the vas deferens, joining a cirrus sac containing a seminal vesicle and a primitive penis at the 
common genital opening. The single ovary leads into an oviduct. From here the ootype gains a yolk 
from the vitelline glands and a shell that toughens as it moves towards the common genital opening.  
The juveniles are 1.0-2.0mm long and lancet-like at the time of entry into the liver (reviewed 
Urquhart et al., 1996). See Figure 1.1.  
  
Please see the diagram of F. hepatica structure as shown in Veterinary 
Helminthology, page 102, Veterinary Parasitology, Second Edition, 
Blackwell Publishing, by GM Urquhart, J Armour, JL Duncan, AM Dunn 
and FW Jennings. Express permission from the authors was not obtained 
for reproduction of this diagram. 
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1.1.4 Life Cycle 
The life cycle of F. hepatica consists of six major phases, shown in Figure 1.2. 
 
Figure 1.2: The Life Cycle of Fasciola hepatica  
1.1.4.1 Passage of eggs from the host digestive tract onto pasture and their embryonation 
Adult F. hepatica shed eggs into the common bile duct and the duodenum. Eggs pass out of the 
intestine of definitive hosts in faeces in an undeveloped state (Figure 1.2, number 1; Urquhart et al., 
1996).  The embryonation and development of eggs only occur upon release of eggs from faeces. 
Such liberation is facilitated by heavy rain dissolving the faeces, and the spreading of faeces by 
animals or machine (Andrews, 1999). The suppression of complete embryonation by the presence of 
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faeces is likely due to relatively low oxygen tension and the presence of toxins. Temperature, 
moisture, oxygen tension and pH are important for egg development (Rowcliffe and Ollerenshaw, 
1960, Vasileva, 1960, Andrews, 1999, Ollerenshaw, 1959, Ollerenshaw, 1971, Al-habbib, 1974). 
 
1.1.4.2 Hatching of miracidia and the location and penetration of an intermediate host 
The chance of an infective miracidium reaching its snail host is increased by eggs hatching in 
response to favourable environmental conditions, such as light and temperature (Andrews, 1999). In 
addition, hatching of egg cohorts will not occur simultaneously, leading to long-term contamination 
of pastures with embryonated eggs (Figure 1.2, number 2). The wavelength of light has been shown 
to be important, with shorter wavelengths being essential for hatching (Roberts, 1950, Andrews, 
1999).  Once free from the egg, the miracidium is very active, travelling at around 1 mms-1 (Wilson 
and Denison, 1970). Miracidia have approximately 24 hours to infect a host, during which they do 
not feed but instead rely on finite glycogen energy stores (Anderson et al., 1982). They are very 
positively phototropic, an adaptation for finding intermediate snail hosts within their ‘water’s edge’ 
habitats  (reviewed, Graczyk and Fried, 1999). Positive chemotaxis by the miracidium occurs from a 
distance of 15cm from the snail intermediate host (Neuhaus, 1953).   
Miracidial penetration of the intermediate snail host is a complex process involving mechanical 
boring by the miracidial anterior papilla and the secretion of proteolytic enzymes (Smyth and Halton, 
1983).  
1.1.4.3 The Intermediate Host 
Galba truncatula, an amphibious snail with worldwide distribution, is the predominant intermediate 
host in the UK (Figure 1.2, number 3). In other countries, other snails act as intermediates: G. 
tomentosa in Australia and New Zealand, G. columella in North America, Australia and New Zealand, 
G. bulimoides in Southern USA and the Caribbean, G. humilis in North America and G. viator and G. 
diaphena in South America (Urquhart et al., 1996).  
Obviously, in the absence of a suitable intermediate species, the lifecycle of F. hepatica cannot be 
completed and hence fasciolosis will not be seen in livestock. The snail is dependent on moisture 
levels, soil conditions, temperature and solar radiation for its occurrence and survival (Graczyk and 
Fried, 1999). G. truncatula survive and reproduce at a temperature range from 10 to 25°C (Kendall 
and McCullough, 1951). Optimal growth conditions for the snail occur between 22 to 25°C. This 
temperature range coincides with optimal F. hepatica egg, miracidial, sporocyst and redia 
development. 
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Snails such as Radix peregra and a Succinea species have been identified as less common 
intermediate species in Ireland, inhabiting regions with suboptimal environmental conditions for 
Galba species such as those with a low pH soil (Relf et al., 2009).  
Rainfall has a positive effect upon all free-living stages of the F. hepatica and G. truncatula. This risk 
to livestock increases to a maximum risk at approximately 90mm rain per month. Beyond this level, 
excessive rainfall may prevent snail infection, separating the parasite from its intermediate host. 
Hence rainfall greater than 210mm per month is considered to decrease snail infection rate (Rapsch 
et al., 2008). 
In Switzerland, a predictive model has been proposed to determine areas where G. truncatula 
persistence can sustain F. hepatica infection (Rapsch et al., 2008). In the UK, no such data has been 
analysed.  
1.1.4.4 Development and replication of F. hepatica within the snail intermediate host 
Once inside the snail, the miracidium loses its cilia and becomes a young sporocyst (Figure 1.2, 
number 4). The sporocyst migrates to the snail digestive gland and grows. The next larval stages are 
called rediae. Once the sporocyst is full of rediae it will rupture, allowing the escape of rediae into 
the snail digestive gland. From each redia, cercariae are produced that escape via a lateral birth pore 
(reviewed, Graczyk and Fried, 1999). The number of cercariae shed increases with increasing 
temperature of the snail environment, over the range 6-20°C and only occurs in snails subjected to 
diurnally fluctuating photoperiods (Abrous et al., 1999, Abrous et al., 2000, Gomot, 1990). 
1.1.4.5 The emergence of the cercariae from the snails and their encystment in the environment 
Cercariae emerge from the snail 4-7 weeks after initial infection and are very active, swimming 
rapidly for up to 2 hours (Figure 1.2, number 5). Encystment occurs when the cercariae are settled. 
Cercarial contraction releases an outer cyst wall of tanned protein and mucoprotein and the tail is 
shed. The cyst is infective straight away and matures from a white colour to yellow-brown over the 
next few days (Wright, 1927). 
1.1.4.6 Ingestion of the encysted infective metacercariae by the definitive host and development 
to adulthood 
 
Metacercariae remain viable for over 1 year, but infectivity decreases at a rapid rate inversely 
proportional to available moisture and temperature (Figure 1.2, number 6; Soulsby, 1965, Taylor, 
1949). Following ingestion, infective metacercariae excyst in the small intestine, activated by high 
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pCO2, a temperature of 39°C and reducing conditions in the stomach.  Emergence may be stimulated 
by the presence of bile, of which aromatic cholic acid-like salts and glycine-conjugated salts are most 
effective (Sukhdeo and Mettrick, 1986, Dixon, 1966).  
Juvenile flukes rapidly penetrate the intestinal mucosa, to enter the peritoneal cavity. Two to six 
days after infection, the liver capsule is breached, and young flukes burrow through the parenchyma 
for 6-8 weeks. Adult flukes reach the bile ducts, mature and excrete eggs into the bile and 
subsequently the faeces. A single fluke may produce up to 20,000 eggs per day (Fairweather, 2009). 
Aberrant fluke migrations to other organs are more common in cattle and include infection of 
pancreas, lungs and thymus. 
1.1.5 Disease 
F. hepatica infection can be split into three stages described below.  
i) Prehepatic Stages 
Juvenile fluke excyst and penetrate the duodenal wall to enter the abdominal cavity 
within 72 hours (Kendall and Parfitt, 1959). They migrate to the liver and penetrate the 
liver capsule. Although not associated with clinical signs, the ventral or left lobes of the 
liver are usually most heavily parasitized, and may adhere to the peritoneum following 
infection with heavy fluke burdens. 
ii) Juvenile Stage 
Following penetration of the liver capsule, migrating larval flukes destroy hepatocytes 
and leave tracts filled with blood, fibrin and debris. Grossly, these tracts begin as raised 
white lines that become yellow, then haemorrhagic. Eosinophils, neutrophils and 
lymphocytes invade. Macrophages, epithelioid cells and multinucleated giant cells 
become increasingly numerous in older lesions. Lesions begin to heal via ingrowth of 
granulation tissue, leading to random scarring (Jones et al., 1997). The clinical signs of 
acute and chronic F. hepatica infection are described in Table 1.2 and the parasite 
burden known to cause each syndrome are described in Table 1.1. 
iii) Mature Fluke in Bile Ducts 
The presence of adult flukes in the bile ducts leads to a cholangiohepatitis. The biliary 
epithelium is stimulated into hyperplasia or eroded completely. Duct walls become 
infiltrated with leukocytes, and later fibrocytes, leading to a ‘pipe-stem’ liver appearance 
grossly. Extensive calcification of bile ducts occurs most frequently in cattle (Jones et al., 
1997). 
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Fibrosis, as a repair strategy by the liver, begins whilst some fluke are still migrating, 
leading to a mixture of acute and chronic pathologies being present simultaneously. 
Throughout the migration and once the adults reach the bile ducts, the blood-feeding 
habits of the flukes, plus the presence of other gastrointestinal nematodes, may lead to 
anaemia. Depending on the parasite burden carried, the repairing parenchyma may 
become fibrotic and cirrhotic (Ross et al., 1967, Sinclair, 1967, Dow et al., 1968, Boray, 
1969).   
 
Table 1.1: Types of fasciolosis in sheep and cattle (from Urquhart et al., 1996) 
Disease Type of disease Comments 
Ovine 
fasciolosis 
Acute Disease         
    
Subacute Disease     
 
Chronic Disease        
 
Disease 2-6 weeks post ingestion of 2000+ 
metacercariae 
Disease 6-10 weeks post ingestion of 500-1500 
metacercariae 
Disease 4-5 months post ingestion of 200-500 
metacercariae, most common 
Bovine 
fasciolosis 
Acute or Subacute Disease 
 
Chronic Disease         
Rare generally, occurs with heavy challenge in young 
calves 
Most common 
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Table 1.2: Clinical signs of F. hepatica infection seen in sheep and cattle (from Urquhart et al., 1996) 
Ovine Acute Ovine Subacute Ovine Chronic Bovine Acute Bovine Chronic 
Sudden death 
Anaemia 
Lethargy 
Inappetance 
Hepatomegaly 
Abdominal pain 
Ascites 
Dyspnoea 
Clinical signs for 1-2 
weeks before death 
including: 
Loss of condition 
Anaemia 
Hepatomegaly  
Cholangitis 
Submandibular 
oedema 
Ascites 
Anaemia 
Hypoalbuminaemia 
Hepatic fibrosis 
Hyperplastic 
cholangitis 
Loss of condition 
Submandibular 
oedema 
Ascites 
Production deficits 
Light infections may 
be largely 
asymptomatic. 
As for ovine 
disease but 
occurs far less 
frequently. 
As for ovine chronic 
disease, but also: 
Calcification of bile 
ducts and  
gallbladder 
enlargement 
 
Aberrant migration 
of flukes is more 
common. 
  
1.1.6 Diagnostic tests 
Ante mortem tests have been designed to detect F. hepatica eggs, antibodies or antigens using 
serum, milk and faeces. This aids diagnosis and treatment of infected individuals, and can be used 
for screening herds and flocks for monitoring purposes and informed flukicidal treatment regimens.  
1.1.6.1 Diagnosis of Disease 
Clinical signs of affected individuals can be used alongside season, meteorological patterns, previous 
history of fasciolosis on the premises and the proximity of snail habitats, to indicate cases where 
further tests are required (Urquhart et al., 1996). 
Post mortem examinations (PME) can be done when a cadaver is available, and liver pathology can 
be assessed. Serum biochemistry is not specific to fluke infection and hence is used only as an 
adjunct to other tests. 
In an emergency, supportive treatment will be given without the confirmation of F. hepatica 
infection, based upon the clinical signs described in Table 1.2. If PME is not indicated, samples may 
be taken to confirm the exposure to, or presence of F. hepatica in a clinical case parallel to 
supportive treatment, as described in 1.1.6.2. 
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1.1.6.2 Diagnostic tests available 
Faecal Egg Counts (FEC) 
Urquhart et al. (1996) details the procedures for direct flotation, sedimentation and McMasters 
methods of flotation that can be done in veterinary practice. The sedimentation technique was 
recently tested for accuracy of diagnosis using faecal samples from cattle in Belgium and had a 
sensitivity of 0.42-0.45 and a specificity of 1.00 (Charlier et al., 2008). 
Sensitivity of FEC is low, hence the number of animals with false negative results will be high. Also, in 
acute infections flukes will not be producing eggs yet, hence FEC will be negative but disease may be 
present. 
Serological anti-F. hepatica antibody detection Enzyme-Linked ImmunoSorbant Assays (ELISA) 
ELISAs performed using sera from animals are a common and accurate way to diagnose exposure to 
F. hepatica (Hillyer and Santiago de Weil, 1979, Zimmerman et al., 1982, Zimmerman et al., 1985, 
Salimi-Bejestani et al., 2005b). Two such tests for bovine sera were included in the comparative 
study conducted by Charlier et al. (2008) which indicate a good sensitivity (0.82-0.95) and specificity 
(0.80-0.88). 
Salimi-Bejestani et al. (2005b) designed an anti-F. hepatica antibody ELISA to detect antibodies to 
Excretory-Secretory antigens in bovine serum. Results of this ELISA were compared to those 
generated by a commercially available ELISA and showed good agreement. Mulcahy et al. (1998) and 
Bossaert et al. (2000) both found a positive correlation between Immunoglobulin G1 (IgG1) antibody 
titre and fluke burden, suggesting that estimation of the intensity of infection from an ELISA is 
possible. Salimi-Bejestani et al. (2008) showed that their ELISA could be used to indicate intensity of 
F. hepatica burden and the degree of liver pathology seen at PME. 
As ELISAs are laboratory tests requiring time to produce a result, their main use is for herd/flock 
screening for F. hepatica exposure. ELISAs do not present a practical emergency diagnostic facility in 
the acute animal presentation as treatment must be given immediately to prevent death. 
Milk anti-F. hepatica antibody detection ELISA 
The modification of a serum ELISA for use with milk has been successfully done (Salimi-Bejestani et 
al., 2007). Milk is considered a non-invasive and more readily obtainable sample medium than blood 
and antibody titres within milk are considered to correlate well with their counterparts in serum  
(Pritchard et al., 2002). Although not considered in the study by Charlier et al. (2008), this ELISA has 
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provided an excellent means for screening large numbers of cows prior to anthelmintic use and can 
be used on bulk milk tank samples to gain a snap shot of the milking herd of a dairy farm. 
Copro-antigen ELISA 
An ELISA designed to detect ES-antigen of F. hepatica in host faeces (Bio-X Diagnostics, Belgium) was 
considered the most sensitive test studied overall (Charlier et al., 2008). This ELISA detects F. 
hepatica antigen prior to infection reaching patency, hence providing an accurate early screening 
tool.  
1.1.7 Control of F. hepatica 
The only specific treatment for clinical fascioliosis is anthelmintic therapy. Triclabendazole, a 
member of the benzimidazole group, is the only drug to kill F. hepatica after 1 day post infection 
enabling parasite killing in the prehepatic disease stages described in 1.1.5 Disease, above (Boray et 
al., 1983, Turner et al., 1984). Other anthelmintics kill late immature and adult F. hepatica 4 weeks 
post ingestion of metacercariae.  
Other methods of F. hepatica control include draining land to reduce G. truncatula habitats and 
limiting livestock grazing of such habitats by fencing.  Zero-grazing systems employed by some 
farmers lead to only rare appearance of fasciolosis in animals managed this way because the fluke 
life cycle is not completed. 
Use of molluscicides is a contentious issue due to the potentially far-reaching effects application has 
on wildlife ecology.  Molluscicides such as N-trityl morpholine and copper sulphate are efficient but 
not available in the UK (Urquhart et al., 1996). 
1.1.8 Triclabendazole Resistance 
The first report of triclabendazole-resistant F. hepatica was in Australia (Overend and Bowen, 1995). 
Subsequently, resistant fluke have been found in Ireland (Lane, 1998), Scotland (Mitchell et al., 
1998), Wales (Thomas et al., 2000) and the Netherlands (Moll et al., 2000). The lack of reversion to 
triclabendazole susceptibility in resistant flukes (Borgsteede et al., 2005) has focused research on 
alternative treatments for fasciolosis, better land management strategies and vaccines against fluke.   
1.1.9 Immunology of F. hepatica 
The fact that adult cattle in endemic areas of the UK carry a significant burden of fluke (McCann et 
al., 2010b) and require regular flukicidal treatment, suggests that adult cattle do not develop 
resistance to infection in the field (Clery et al., 1996, Ortiz et al., 2000). F. hepatica is a highly evolved 
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pathogen, capable of immunomodulation of the host immune system providing a long-term safe 
environment.  
However, resistance to F. hepatica infection has been reported in recipient rats given passive serum 
transfer from previously inoculated rats and in recipient rats given lymphoid cells at the same time 
as a viable challenge of metacercariae (Corba et al., 1971, Goose, 1978). Giving irradiated 
metacercariae to rats as an immunising infection elicited the strongest protection to subsequent 
infection, in recipient rats, characterised by cellular attachment to the surface tegument of F. 
hepatica. Resistance to re-infection with F. hepatica in rats was apparent within 2 weeks of initial 
infection and was maximal when the immunising infection was allowed to develop for 8 weeks, but 
reduced with chronicity (Goose, 1978). Addition of Excretory Secretory Proteins (ESP) to flukes and 
immune serum in vitro caused a dramatic reduction in cellular adhesion. This suggested that the 
success of early cell-mediated fluke-killing was inhibited/antagonised by ESP (Goose, 1978).  
Metacercarial excystment in the abomasum of the definitive host leads to newly excysted juvenile 
(NEJ) F. hepatica migrating through the intestinal wall and into the peritoneal cavity. Piedrafita et al. 
(2000) demonstrated that reactive nitrogen intermediates (RNI) and reactive oxygen intermediates 
(ROI) can kill over 80% of schistosomula (S. mansoni), but only high levels of ROI were able to kill 
substantial (61%) numbers of NEJ. NEJ could be resistant to cytotoxicity by ROI by their secretion of 
high levels of protective enzymes. Such enzymes can be inhibited artificially to cause 45-75% NEJ 
killing. McGonigle et al. (2008) suggested that F. hepatic ESP contained a peroxiredoxin-like enzyme 
which may protect flukes against hydrogen peroxide and other ROI. 
Within forty-eight hours of penetrating the duodenal wall, NEJ modulate the immune system in their 
favour, with production of ESP that can polarise the immune response towards an anti-inflammatory 
(Th2) type response (Cancela et al., 2008). In mice, alternatively-activated macrophages (AAM) 
develop in response to  interleukin-4 (IL-4) and IL-13 (Donnelly et al., 2005) and show preferential 
expression of Arginase-1, Fizz1 and Ym1, with the ability to induce naive T cells down the Th2 
phenotype directly (Donnelly et al., 2008). AAM may also further inhibit Th1 immune responses via 
Transforming Growth Factor beta (TGF-  and IL-10 release in long-standing infections. Upon 
infection of mice with F. hepatica metacercariae, AAM are recruited to the peritoneal cavity within 
24 hrs, but have reduced microbicidal properties that could result in poor innate defence against 
bacterial infection (Gordon, 2003).  
In vitro incubation of murine macrophages with Liver Fluke Homogenate (LFH) stimulated low 
arginase-1 activity levels whereas the ESP component, peroxiredoxin (Prx), generated the most Ym1. 
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The ability of Prx to activate macrophages has been demonstrated to be independent of peroxidase 
activity. AAM produce less fluke-harming hydrogen peroxide (H2O2) and Prx alone can denature H2O2 
(Varin and Gordon, 2009, Donnelly et al., 2008, Sekiya et al., 2006). AAM can be induced by Prx, in 
the absence of IL-4 and IL-13, but once activated AAMs promote a Th2 response (Donnelly et al., 
2008). Arginase-1 production, was shown to be up-regulated even in the presence of exogenous LPS, 
indicating alternative activation of naive macrophages, despite the presence of a strong Th1 stimulus 
in an in vitro system (Phelps et al., Flynn and Mulcahy, 2008b). AAM biomarker Ym-1 has also been 
suggested to enhance IL-4, IL-5 and IL-13 production from naive CD4+ T cells, suggesting that Prx 
promotes a Th2 environment secondarily to AAM bias (Donnelly et al., 2008). 
The ESP enzyme, Cathepsin L proteinase (FheCL1), has been shown to down-regulate Th1 immune 
responses in an IL-4-dependent manner (O'Neill et al., 2001). Further to this, a single dose of FheCL1, 
given to mice 2 hours before E. coli lipopolysaccharide (LPS) administration, led to a 30% drop in 
mortality, compared with intraperitoneal LPS administration alone (Donnelly et al., 2010a). This 
study also demonstrated significantly reduced levels of proinflammatory mediators (IL-6, IL-12, 
Tumour Necrosis Factor alpha (TNF  and interferon gamma (IFN )) in sera and peritoneal lavage 
fluid of FheCL1-treated mice. Macrophages are the main source of pro-inflammatory mediators in 
the septic shock model and those removed from the peritoneal cavity of mice 2hrs after FheCL1 
treatment and stimulated ex vivo with LPS for 12 hrs showed significantly reduced levels of 
proinflammatory mediators, indicating a down-regulation of the Th1 response normally elicited by 
LPS alone. Inhibitors of FheCL1 and replacement of active site amino acid, cysteine, with glycine, 
negated the effects. In this case, a Th2 bias in mice is protective against the lethal effects of LPS 
administration but in many other instances, co-infection with F. hepatica and a pathogen requiring a 
Th1 response for its elimination may lead to prolonged disease with more severe pathology (see 
section 1.3 Co-infections). 
Toll-like Receptors (TLR) are a family of Pattern Recognition Receptors (PRRs) fundamental to the 
innate immune response. They detect foreign microbial components, termed Pathogen-Associated 
Molecular Patterms (PAMPs) such as lipopolysaccharide from gram negative bacteria. As well as 
buying time until the adaptive immune response matures, the innate immune system acts as a 
stimulator for the adaptive system, secreting cytokines to activate an appropriate immune response 
(Playfair and Chain, 2009). 
 
The TRIF-dependent pathway of TLR3 and TLR4 primarily activates the interferon regulatory 
transcription factor 3 (IRF3), inducing transcription of IFN , leading to STAT1 activation and 
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induction of STAT1-dependent genes such as inducible Nitric Oxide Synthase (iNOS) and interferon-
inducible protein 10. The TRIF-dependent pathway also regulates IL-12 mRNA expression. Donnelly 
et al. (2010b) demonstrated that FheCL1 specifically blocks this pathway by degrading TLR3 within 
the macrophage endosome, diminishing macrophage activation by both TLR3 and TLR4, and hence 
reducing expression of genes such as iNOS, typical of a Th1 response. The TLR3 ligand is double-
stranded RNA, usually present in dsRNA viruses and the TLR4 ligand is LPS. Stimulation of TLR3 or 
TLR4, or both, would normally result in a Th1, proinflammatory immune response. In the absence of 
this, regulatory T cell and Th2 anti-inflammatory immune responses predominate. 
Dendritic cells (DC) stimulated with either recombinant FheCL1 or recombinant F. hepatica 
Glutathione S-Transferase (FheGST-sigma) do not induce differentiation of Th2 cells, rather they 
attenuated the development of a Th17 immune response. Th17 cells are associated with severe 
immunopathology in helminth-infected mice, thus regulation of Th17 cells and IL-17 is crucial to the 
control of inflammatory pathology associated with helminth infection.  Results suggested that Th17 
suppression occurs independently of Th2 cells, by alteration of murine DC function. This makes Th2 
polarisation leading to an inhibitory environment for Th1/Th17 cell development, less likely (Dowling 
et al., 2010). In addition, FheCL1 and FheGST-sigma can partially activate DCs via TLR-4, leading to 
suppression of Th17 cells. Consistent with this theory, F. hepatica-activated DCs secrete reduced 
levels of IL-23, important for expansion and survival of Th17 cells.  Th2 polarisation is not affected by 
the absence or down-regulation of TLRs, however TLR ligation by helminth-derived antigens is 
recognized as a mechanism to limit the development of Th1 cytokine-mediated inflammation 
(Goodridge et al., 2005). 
Fluke tegumental antigens from the surface of developing F. hepatica, have also been found to 
suppress expression of dendritic cell activation markers, reduce the phagocytic ability of these cells 
and diminish the secretion of Th1 cytokines, IL-6 and TNF-  (Hamilton et al., 2009).  
The extreme polarisation of Th1 or Th2 responses seen in inbred strains of mice, is less marked in 
cattle.  Bovine Th0 cells have been described that can express both IFN  and IL-4 (Brown et al., 
1994a).  Studies have shown the mixed expression of Th1 and Th2 cytokines from cells, and that 
these combinations of cytokines do not demonstrate the same inhibitory, in the case of IL-4 and IL-
10, or stimulatory, in the case of IL-12, effects on Th1 responses in cattle, as are seen in mice. T cell 
lines from cattle chronically infected with F. hepatica and re-stimulated in vitro with F. hepatica egg 
antigen were, however, found to express largely Th2 cytokines, predominantly IL-4, with reduced 
Th1 cytokine expression (Brown et al., 1994b). 
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Studies in cattle suggest down-regulation of Th1 responses (IFN  and lymphocyte responsiveness) by 
week 4 post infection with F. hepatica metacercariae (Clery et al., 1996, Clery and Mulcahy, 1998). 
Bovine AAM secrete high levels of IL-10, dampening immune responses in chronically infected 
animals, and presumably limiting host immunopathology (Flynn and Mulcahy, 2008b). A reduction in 
lymphocyte responsiveness occurs after 4 weeks post infection in calves, suggesting an overall 
immune regulation within this time (Oldham and Williams, 1985).  
In cattle, a switching from TGF-  production in early infection to a dominant IL-10 response was 
associated with chronicity, suggesting that early IL-4 and IFN  production is down-regulated by TGF-
 and after 12 weeks post infection, IL-4 levels are low but not suppressed by either IL-10 or TGF- . 
IL-10 does appear to suppress IFN  production in chronic infection, however (Flynn and Mulcahy, 
2008b). Infection of mice with F. hepatica was associated with expansion or recruitment of Foxp3+ 
regulatory T cells (Treg) and induction of adaptive antigen-specific Treg cells, which suppressed the 
host immune response to the parasite and to unrelated antigens (Walsh et al., 2009).  Infection with 
F. hepatica induces IL-10 production by dendritic cells, inhibiting their subsequent maturation and 
indicating induction of Tr1 cells. Such Tr1 cells are a subset of suppressor T cells inducible in vitro, 
whereas Treg cells are naturally occurring regulatory cells demonstrable in vivo.  F. hepatica-specific 
IFN , IL-4 and IL-5 production was enhanced in IL-10-/- mice, suggesting that both Th1 and Th2 
responses during the helminth infection are constrained by parasite-induced IL-10. 
Hacariz et al., (2009) studied gene expression levels of cytokines in ovine hepatic lymph nodes at 23 
weeks post infection with F. hepatica. These authors found that IL-4 was up-regulated regardless of 
F. hepatica burden, IFN  was down-regulated regardless of fluke burden, and that IL-10 and TGF- 1 
were significantly up-regulated in light infections, but down-regulated in heavy burdens. 
IL-10 and TGF- 1 are regulatory cytokines important in minimising the immunopathology of an 
infection and may play a central role in enhancing tissue repair during helminth infections (Belkaid et 
al., 2006). Fibrosis of the liver limits its invasion by migrating flukes and can encapsulate (and thus 
wall-off) flukes themselves. Both of these actions functionally increase host resistance to fluke, 
although this is not necessarily associated with a protective immune response. Lack of TGF- 1 in 
heavy burdens may lead to reduced encapsulation and liver repair, which will enhance liver 
pathology and disease (Hacariz et al., 2009). AAM markers Fizz-1 and Arginase-1, have been linked to 
fibroblast differentiation and cell proliferation, and collagen synthesis respectively, indicating a role 
for AAM in hepatic fibrosis in cattle (Lopez-Navarrete et al., 2011, Liu et al., 2004). FheCL1 from ESP 
has been suggested to act upon hepatic stellate cells, to increase fibrosis-related gene expression 
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and this theory is strengthened by the correlation between intensity and chronicity of infection with 
the degree of fibrosis (Marcos et al., 2007, Marcos et al., 2011). 
Induction of marked IgG1 levels with time also suggests a Th2 or Th0 immune response post 
infection with F. hepatica. The role of antibodies in protection against F. hepatica is unknown as IgG1 
levels did not correlate with F. hepatica burden.  It remains unclear whether IgG1 participates in a 
non-protective Th2 response (Clery et al., 1996) or whether the parasite evades the immune 
response by stimulating a Th2 response and subsequent ineffectual antibody production (Estes et 
al., 1995). As previously stated, passive antibody could confer resistance to subsequent F. hepatica 
infection in experimental rats (Goose, 1978). 
A marked eosinophilia has been recorded following stimulation of bone marrow cells with F. 
hepatica ESP. The cytokine IL-5 is necessary for eosinophil expansion and it is possible that an IL-5-
like protein exists in ESP to mirror this (Milbourne and Howell, 1990). NEJ are not irreversibly 
damaged upon incubation with eosinophils and granulocytes (Doy et al., 1980, Doy and Hughes, 
1982) and NEJs recovered from rat peritoneal cavities have eosinophils attached to them at points of 
surface damage, suggesting a role for eosinophils in mediating resistance to F. hepatica in rats 
(Davies and Goose, 1981). Rapid turnover and excretion of the outer glycocalyx of juvenile flukes 
when complexed with antibodies, prevents the intimate attachment and thus damage, mediated by 
eosinophils (Duffus and Franks, 1981). The role of eosinophils in protection against F. hepatica 
infection in either rodents or cattle remains unclear. 
 
1.2 Bovine tuberculosis 
1.2.1 Mycobacterium tuberculosis Complex 
BTB is a bacterial disease caused by Mycobacterium bovis. M. bovis is a member of the 
Mycobacterium tuberculosis complex (MTB) also comprising M. tuberculosis of humans and M. bovis 
BCG, a strain of M. bovis attenuated for laboratory and vaccination use in humans. The family, 
Mycobacteriaceae, comprises a large number of bacterial species, including many saprophytic 
species. M. bovis primarily causes tuberculosis in cattle but has the broadest host species range of all 
the Mycobacteria, including buffalo, sheep, goats, deer, badgers and humans (Pollock and Neill, 
2002). 
The bacteria are acid-fast bacilli, presumptively diagnosed upon staining with classic Ziehl-Nielsen 
staining. Culture is the gold-standard for diagnosis, with samples grown on media such as 
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Lowenstein–Jensen, Coletsos base or Stonebrinks for 12 weeks. Positive cultures usually become 
apparent within 3-6 weeks but more time is required for a sample to be declared negative. Other 
tests for detection include ELISAs and PCR (OIE, 2002). 
1.2.2 Significance 
1.2.2.1 Human tuberculosis 
Worldwide, hTB is an extremely important health concern (Brewer and Heymann, 2004). 
Approximately one-third of the human population is infected with tuberculosis in a latent or active 
form (Collins and Grange, 1983, Mugerwa, 1998). Many countries do not speciate cultured 
Mycobacteria, hence the incidence of M. bovis in people may be much higher than is known.  
Eight million new cases of active hTB occur annually in Africa, with 2.9 million deaths each year. Of 
the 42 million people currently infected with Human Immunodeficiency Virus (HIV) over 25% are co-
infected with tuberculosis (Bock and Reichman, 2004).  Acquired Immune Deficiency Syndrome 
(AIDS) is a highly immunosuppressive disease of humans caused by HIV. The current pandemic of 
HIV/AIDS mirrors and slightly precedes the rise in hTB cases. Immunosuppression, caused by 
HIV/AIDS, allows a much faster progression to active hTB in co-infected individuals (Sharma et al., 
2005). 
Schistosoma mansoni, a trematode parasite of humans from the family Schistosomatidae, has a wide 
dispersal throughout Africa and South America (Urquhart et al., 1996). Human co-infection with HIV 
and S. mansoni has been shown to accelerate hTB pathology (Brown et al., 2006). A cohort study in 
humans found a significant correlation between S. mansoni eosinophilia and accelerated hTB 
progression in humans (Elliott et al., 2003). Furthermore, low doses of S. mansoni appear to increase 
the susceptibility of mice to BCG infection (Elias et al., 2005), and S. mansoni reduces the efficacy of 
BCG vaccination in mice. 
In 2006, European Union (EU) countries reported 81 600 new hTB cases. In the same year, 8497 new 
cases of hTB arose in the UK (Anon, 2012f). 40% of these cases were in London, where antibiotic 
resistant bacteria have been isolated from people either not completing the full course of treatment 
or using illegal drugs.   
1.2.2.2 Bovine tuberculosis 
BTB worldwide remains a major disease of livestock, particularly cattle, goats and pigs (Radostits et 
al., 2007). In many countries BTB is endemic, being found in livestock, wildlife and zoo collections.  
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Within the EU, cattle consigned from one to another EU Member State must originate from an 
‘Officially Tuberculosis Free’ (OTF) herd and have been pre-movement tested for BTB (OIE, 2002) as 
described below.  
In all EU Member States except England, Wales and Northern Ireland, the statistics for BTB incidence 
in cattle suggest infection is declining. However, the percentage of restricted UK herds from 2003 to 
2004 only reduced by 0.8%. The herd prevalence in England and Wales has been measured at 34% 
per year in recent years (Chapter 2) assuming optimum performance of diagnostic tests for BTB, with 
the number of new herd breakdowns increasing at a rate of 18% annually in recent years (DEFRA, 
2005a). 
In the UK, the Foot and Mouth Disease (FMD) epidemic of 2001 led to the depopulation of many 
farms and their subsequent re-stocking from the dairy-prominent South West of the UK, where BTB 
is also highly prevalent. The movement of cattle country-wide could have contributed to dispersal of 
BTB, and movement of cattle from high frequency testing farms was found to carry a significant risk 
of BTB breakdown on the new farm. Equally, restocking premises that had previous BTB was also 
considered a risk, indicating BTB survival despite no livestock on the farm (Carrique-Mas et al., 
2008). In a study conducted in Brazil, a number of genetically diverse strains of BTB were isolated 
from animals in one herd, indicating the importance of bought-in animals as a source of BTB 
(Figueiredo et al., 2011). The risk of BTB breakdown has also been shown to increase with increased 
movements of cattle onto and off farms (Karolemeas et al., 2011). 
1.2.3 Pathology 
Mycobacteria are phagocytosed into macrophage intracellular phagosomes where they multiply and 
survive due to prevention of phagosome-lysosome fusion. Coalescence of infected macrophages, 
termed epithelioid cells, leads to Langhan’s giant cell formation. These epithelioid cells become 
surrounded by a rim of fibrocytes with occasional lymphocytes, creating a structure called a 
tubercle. As the tubercle grows in size, the centre will often undergo caseous necrosis and become 
calcified. The reason for calcification is currently not understood (Cassidy et al., 2001).  
As the lesion ages, surrounding collagenous connective tissue develops and matures. If bacteria are 
eliminated by the immune response, a small fibrous mass is left. If bacteria are not eliminated, 
tubercles continue to grow and develop large cavity-filled centres (Jones et al., 1997).  
Primary tubercles in cattle are rarely contained by the immune response long-term (Ayele et al., 
2004), leading to active BTB in these animals and dissemination to other organs. If a tubercle breaks 
into a blood vessel, the seeding of bacilli leads to numerous small tubercles being generated in 
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parenchymatous organs, of approximately the same size and age – miliary tuberculosis (Jones et al., 
1997). Other modes of spread are via airways, or via lymphatics (reviewed by Ayele et al., 2004). 
M. bovis is found in respiratory aerosols, saliva, milk, urine and faeces of infected animals, according 
to the pattern of infection in the infected individual, and the host species affected (Hutchings and 
Harris, 1999, Pollock and Neill, 2002). Aerosol spread requires close contact between infected and 
susceptible hosts, with 94% of exhaled M. bovis surviving airborne for 10 minutes (Gannon et al., 
2007). 
1.2.4 Tests for BTB diagnosis in UK Cattle 
Compulsory skin testing for BTB in UK cattle, described below, was introduced in 1950, with 
voluntary testing from 1935. By 1980, the incidence of BTB in the UK was very low. Since then, 
however, the number of cases has been increasing again (Ely and Upton, 2010). The skin test (Single 
Intra-dermal Comparative Cervical Tuberculin, SICCT) is the BTB test described for screening and 
testing animals across the EU and, in the UK.  Testing is conducted every 1-4 years according to the 
proportion of herds in the parish with confirmed BTB breakdown. The protocol for SICCT testing is 
outlined in the box below. 
  
The SICCT relies on a delayed type hypersensitivity immune response to produce an area of localised 
swelling in the dermis, measureable with callipers (Thye et al., 2009) after 72 hours.  The reaction 
relies on the existence of antigen-specific CD4+ Th1 cells in previously exposed or infected 
Single Intra-dermal Comparative Cervical Tuberculin (SICCT) Protocol 
 Identify animal by ear tag and identification record 
 Identify two injection sites in the middle third of the neck, one above the other, 130mm 
apart (do one injection on either side in very small animals). 
 Clip hair from both sites 
 Measure the skin-fold thickness at each site and record 
 Inject avian tuberculin (PPD-A) into the skin of the upper clip-site, and bovine tuberculin 
(PPD-B) into lower clip-site. 
 After 72 hours, the test is read. Each animal is identified by its ear tags again, the same 
skin folds are measured and recorded.  
 A reaction to the bovine tuberculin of 1-3mm greater than the avian reaction is considered 
an ‘inconclusive’ reactor (IR) and will be retested in 60 days. A reactor is an animal that has 
a PPD-B skin thickness of 4mm or greater than the PPD-A injection after 72 hours. Reactor 
animals are isolated, valued and slaughtered. 
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individuals, that amplify in number upon re-stimulation to injected tuberculins, releasing cytokines 
such as monocyte chemotactic protein 1 (MCP-1) and IFN  to activate and attract 
monocytes/macrophages, IL-2 to activate cytotoxic T cells and dendritic cells to present antigen to T 
cells.   
If a reactor animal is found the herd loses its Officially Tuberculosis-Free status and herd movement 
restrictions are applied (DEFRA, 2011c). Two consecutive clear skin tests are required, 60 days apart 
(or one negative test when PME and culture are negative) before restrictions are lifted. 
If the PME and/or laboratory cultures of tissues reveal BTB lesions or bacterial growth, a severe 
interpretation of the SICCT is applied to the next herd test. This lowers the cut-off for skin thickness 
difference to 3mm, with inconclusive reactors being designated reactors, to improve the sensitivity 
of the test.  
1.2.5 IFN  assay 
The IFN  assay also relies on a cell-mediated response in vitro as lymphocytes from bovine whole 
blood samples are incubated with purified protein derivative (PPD) avian or bovine tuberculin for 16-
24 hours, before detection of IFN  by sandwich ELISA (OIE, 2002). IFN  production comes from 
antigen specific T cells, indicating infection.  
The IFN  assay is used to increase sensitivity of diagnosis in confirmed BTB outbreaks in 3 or 4 yearly 
testing herds, in confirmed new outbreaks that have failed to resolve through repeated skin testing 
in annual or 2-yearly tested herds, and at the first inconclusive reactor retest in unresolved cases in 
annual and 2-yearly testing herds (DEFRA, 2011c). 
The test is also used to enhance diagnostic specificity in non-specific reactor cases and in suspected 
fraudulent cases (DEFRA, 2011c). Animal-level sensitivity and specificity of both tests are shown 
below. 
Table 1.3: Animal-level sensitivity and specificity of SICCT and IFN-  assays used in cattle 
Test SICCT (%) IFN-  (%) Both tests in parallel (%) 
Sensitivity 75.0 88.2-89.7 88.0-97.0 
Specificity 96.3-96.7 95.8-97.0 98.9-99.2 
From: (de la Rua-Domenech et al., 2006) 
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1.2.6 Pre- and post-movement testing  
Pre-movement testing reduces the risk of spreading BTB through cattle movements, helping to 
ensure that only SICCT test negative animals are moved. In England and Wales, it is compulsory for 
all cattle over 42 days old moving from a 1 or 2 yearly tested herd to have tested negative to a SICCT 
within 60 days before movement unless the herd or movement meets an exemption  (DEFRA, 
2011c).  In Scotland, a further post-movement test must be done 60-120 days after cattle arrive on 
the holding. 
1.2.7 Immunology of tuberculosis 
Inhalation by cattle, of M. bovis from infected aerosols, leads to deposition of the bacteria in the 
distal airways. From here, alveolar macrophages phagocytose the bacilli via complement receptor 3 
(CR3) and mannose receptors binding mannosylated molecules on the surface of M. bovis 
(Schlesinger, 1993, Zimmerli et al., 1996). Triggering CR3 prevents release of cytotoxic ROI, thus 
helping the bacteria to survive (Le Cabec et al., 2000). 
The phagosome containing M. bovis should, upon uptake into the cell, fuse with a lysosome 
containing hydrolytic enzymes for intracellular digestion. Pathogenic species of Mycobacteria 
however, survive the acid environment of the phagosome. The retention of early endosomal 
markers on mycobacteria-containing phagosomes and the finding that tryptophan-aspartate 
containing coat protein (TACO) is found in higher concentrations in infected phagosomes, suggests 
that Mycobacteria delay phagosomal maturation and prevent phago-lysosome fusion (de Chastellier, 
2009, Pieters, 2001).  
Human macrophages in vitro secreted pro-inflammatory cytokines such as IL-1, IL-6 and TNF  when 
infected with M. tuberculosis (Giacomini et al., 2001, Hickman et al., 2002). However, secretion of 
chemokines such as MCP-1, RANTES and IL-8 by the same cells attracted lymphocytes to the source 
of infection and promoted granuloma formation, hence promoting an immunotolerant environment 
which walls-off rather than eliminates the bacteria. Secretion of IL-10 by these cells suppressed the 
Th1 response further by preventing Major Histocompatability Complex (MHC) class II expression on 
the macrophage cell surface. Toll-Like Receptor 2 (TLR2) stimulation by mycobacterial lipopeptides 
also suppressed MHC class II expression.  With the resulting antigens from digestion not becoming 
available for presentation on the macrophage surface via MHC class II, hence T cell activation is 
suppressed. 
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Dendritic cells are the most potent form of antigen presenting cell and enable vital mediation 
between the innate and adaptive immune responses, enabling polarisation of the immune response 
by secretion of appropriate cytokines (Banchereau and Steinman, 1998, Steinman, 1991). C-type 
Lectin DC-SIGN is a cell surface receptor with high mannose-binding affinity, present on dendritic 
cells. The preferential binding of this surface receptor, by Mycobacteria, helps these bacteria to 
avoid the dendritic cell activation that would occur with MHC class II binding (Tailleux et al., 2003b). 
Bovine dendritic cells infected with M. bovis migrate to lymph nodes and secrete TNF  and IL-12, to 
up-regulate the Th1 response raised against infecting virulent Mycobacteria (Hope et al., 2004, Hope 
and Villarreal-Ramos, 2008). Toll-like receptor recognition of mycobacteria has been more 
thoroughly studied recently. TLR activation leads to MyD88 adaptor protein (MyD88 is an adapter 
protein used by all TLR bar TLR3 to activate the transcription factor NF- B) signalling in cells, leading 
to TNF , IL-10 and IL-1  production (Sohal et al., 2008). IL-10 secretion regulates TNF  expression 
and pathogenic strains of M. tuberculosis have been shown to induce IL-10 secretion to further 
reduce macrophage activation (Balcewicz-Sablinska et al., 1998). 
Established infection of the host depends on a period of bacterial intracellular growth within 
macrophages and dendritic cells. Depletion of such macrophages from mice reduced the 
susceptibility of these animals to M. tuberculosis infection (Leemans et al., 2001). Stimulation of 
macrophages with IFN  or TNF  can lead to successful elimination of most of the Mycobacteria 
within a phagosome, however, the same stimulation does not have the same effect in dendritic cells, 
where elimination does not occur (Bodnar et al., 2001, Mohagheghpour et al., 2000, Tailleux et al., 
2003a). This may give an indication as to why some mycobacterial infections become persistent and 
others are eliminated. 
After reaching an optimal intracellular bacillary load, M. tuberculosis exits the infected macrophage 
to infect other macrophages and to adopt the extracellular existence that helps infectious aerosol 
production. Inducing non-classical apoptosis when bacilliary load exceeds 20 bacteria is how low 
infectious burdens are managed by hosts (Lee et al., 2009). High burdens of M. tuberculosis 
stimulate more rapid cell death, with destruction and phagocytosis of infected cells within 18 hours.  
Another study showed that M. tuberculosis-infected macrophages express less Fas ligand, a 
homotrimeric type II transmembrane protein that, upon binding to a Fas Ligand-Receptor, may 
induce apoptosis. This makes this classical form of cytotoxic T lymphocyte-mediated apoptosis less 
likely (Oddo et al., 1998). Hence M. tuberculosis infection stimulates apoptosis avoidance. 
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Macrophage necrosis promotes infection of  naive macrophages, as well as potentially promoting a 
favourable cholesterol-rich extracellular environment for bacilli survival (Pandey and Sassetti, 2008). 
However, immature dendritic cells fed BCG-infected apoptotic bodies have been shown to activate 
antigen-specific T cells such as CD8+ T cells (Schaible et al., 2003). This suggests that macrophage 
apoptosis primes the adaptive immune system, as well as promoting M. bovis spread. 
 T cells and Natural Killer (NK) cells are innate immune cell types capable of killing foreign cells and 
endogenous cells stressed by infection, and increasing production of cytokines necessary for 
adaptive immune responses (Trinchieri, 1989, Moretta et al., 1994). The greatly enhanced protection 
afforded by BCG-vaccinating neonatal animals with naturally high circulating levels of NK cells 
compared with adults and the production of abundant IFN  from such cells, suggests that this cell 
type is important for mycobacterial immunity (Hope and Villarreal-Ramos, 2008). 
Peripheral blood mononuclear CD4+ T cells and to a lesser extent CD8+ T cells secrete IFN  after 
stimulation with mycobacterial antigen in vitro (Walravens et al., 2002), further enhancing the anti-
mycobacterial immune response to infection. CD8+ T cells, however, have also been implicated in 
immunopathology  (Villarreal-Ramos et al., 2003). From the literature, it is clear that a cell-mediated 
Th1 response is necessary for resistance and immunity to BTB and that a humoral, Th2 response will 
not be appropriate for bacterial elimination.  
1.2.8 Vaccination 
1.2.8.1 Humans 
The human BCG vaccine has been available in various forms since 1921 (McShane, 2009). In 
countries like the UK, where the incidence of hTB is low, the vaccine is efficacious and frequently 
given to children (Black et al., 2002). However, in countries with endemic hTB, such as Malawi, the 
efficacy of the BCG vaccine decreases to zero.  One hypothesis for this lack of efficacy is thought to 
be due to increased infant exposure to saprophytic Mycobacteria species in certain countries prior 
to vaccination age, preventing BCG vaccination working (Palmer and Long, 1966, Black et al., 2002). 
1.2.8.2 Cattle 
Vaccination of animals against BTB is not yet a commercial option. DEFRA (2007) have discussed 
options for vaccine application, should one become available for use in UK cattle. Four possible 
scenarios are suggested. 
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Table 1.4: Possible future scenarios for BTB control in the UK 
Scenario criteria Comments 
Scenario 1 – Compulsory vaccination of all 
cattle  
Gains greatest disease control. 
Greatest costs 
Not targeted nor risk based. 
Scenario 2 – Compulsory vaccination of high risk 
herds 
Risk-based approach to reduce BTB transmission 
within herds in endemic areas.  
1 and 2 yearly testing farms targeted. 
Scenario 3 – Compulsory vaccination of high risk 
herds with the option of voluntary vaccination 
In addition to scenario 2, voluntary vaccination 
of other herds would be allowed. 
Farms would decide based on their own cost-
benefit analysis 
Scenario 4 – Voluntary vaccination The Government would encourage high risk 
premises, but all farms could ultimately decide 
based upon their cost-benefit circumstances. 
 
As future vaccine efficacy will not be 100% and formation of sterile immunity will not occur, 
vaccination alone will not be sufficient to become disease free.  A Differentiating Infected from 
Vaccinated Animals (DIVA) test must be done alongside vaccination. Acceptable sensitivity and 
specificity of a DIVA test and vaccine must coincide to allow use without trade restrictions. Both 
tests and vaccines must be World Organisation for Animal Health (OIE)-accredited to be accepted by 
the EU. In the absence of an EU-accepted DIVA test, BCG-based cattle vaccines are not currently 
deemed appropriate. 
Currently trial vaccines are thought to reduce the numbers of reactor cattle in each breakdown and 
the duration each farm will spend under movement restriction. Reduced transmission of BTB is 
another consideration and the risk of spreading infection to other herd members and wildlife should 
be less. 
Within 5 years, it was thought that a BCG vaccine for cattle that confers full protection to 50% of 
animals vaccinated, with at least partial protection for more than 50% of the vaccinated cattle 
population, will be available. In 5-10 years, a vaccine that confers more than 80% protection against 
BTB will be developed (DEFRA, 2007). 
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Even if a vaccine were available commercially, the EU currently insists that eradication of BTB is 
achieved without use of cattle vaccines.  After the EU legislation has been made more amenable, we 
need either an amendment to the Tuberculosis Order 2007 or new regulations made under section 
2(2) of the European Communities Act 1972 or, a bill amending the Animal Health Act 1981 to 
provide for wider vaccination powers. 
1.3 Co-infections  
Co-infections between F. hepatica and other bacteria have been studied in a range of hosts. 
1.3.1 Salmonella Dublin 
It was concluded from an in vivo study in cattle that prior F. hepatica infection resulted in increased 
susceptibility to Salmonella Dublin infection with all co-infected animals becoming persistent faecal 
carriers of S. Dublin (Aitken et al., 1979). Prior F. hepatica infection did not affect the survival of 
cattle given a sublethal dose of S. Dublin, but did extend persistence of the bacteria in faeces for 
longer (Aitken et al., 1981). F. hepatica infection did not predispose to a more severe bacteraemia in 
orally infected cattle given sublethal doses of S. Dublin (Hall et al., 1981). 
Taylor and Kilpatrick (1975) found that although the peaks of both F. hepatica and S. Dublin infection 
occurred in autumn, the diagnostic samples they studied for both parasitic and bacterial infections 
suggested that these diseases were independent of each other in the UK. However, a subsequent 
case-control study found that S. Dublin infection was highly associated with F. hepatica infection in 
dairy cattle in the Netherlands (Vaessen et al., 1998). Together with the in vivo studies described 
above, this suggests that fluke infection may play a role in the susceptibility of cattle to S. Dublin or 
the time taken to eliminate such an infection. 
1.3.2 Bordetella pertussis 
Brady et al. (1999) clearly demonstrated a Th1 response to Bordetella pertussis vaccine in mice 
characterised by the production of IFN . Subsequent infection of these vaccinated mice with 
metacercariae or treatment with Liver Fluke Homogenate (LFH) abrogated the Th1 response in 
favour of a Th2 response, characterised by IL-4 production. This paper also showed that F. hepatica 
infection given before Bordetella pertussis, polarised the immune system to a Th2 response with 
high IL-4 and undetectable IFN  produced by spleen cells in response to LFH. Co-incident with Th1 
suppression in co-infected animals, bacterial clearance from the lungs was also delayed. In fact, even 
when B. pertussis infection was long-standing, F. hepatica infection inhibited most Th1 activity upon 
re-stimulation with B. pertussis vaccine administration. Th2 cytokines, IL-4 and IL-5, were unaffected 
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by prior B. pertussis vaccination. Bacterial loads in lungs of mice were 40-fold higher in those 
subsequently infected with F. hepatica, indicating that bacterial clearance is negatively affected by 
polarisation of the immune system towards a Th2 response. 
IL-4 knock out (K.O.) and wild-type mice were immunised against B. pertussis at 0 and 4 weeks, then 
given 10 F. hepatica metacercariae by mouth. Wild-type mice just vaccinated against B. pertussis, 
demonstrated a Th1 response with high IFN production. IL-4 K.O. B. pertussis vaccinated mice 
demonstrated slightly reduced IFN  but still a Th1 dominant response. Wild-type and K.O. B. 
pertussis vaccinated, F. hepatica co-infected animals showed abrogation of Th1 in favour of Th2 
dominance with IL-4 production, indicating that F. hepatica can abrogate an existing Th1 response in 
immunocompetent and K.O. mice (Brady et al., 1999).  
Cytokines produced by cells from five mouse-strains after infection with 5 metacercariae each, were 
biased strongly towards a Th2 response in all strains but IL-4 K.O. strain tested (O'Neill et al., 2000). 
Infection with 15 metacercariae, led to extreme Th2 responses being seen. IL-4 K.O. mice produced 
significantly less IL-5 and no IL-4 (both Th2 cytokines), yet produced neither IFN  nor IL-2 (both Th1 
cytokines), suggesting that a Th1 response is not stimulated even when a Th2 response is not 
possible. This study also showed that immune polarisation was dependent on F. hepatica burden 
and the presence of IL-4. IgG1 antibodies were produced in all but IL-4 K.O. strains of mice. IgG2a 
antibodies were not detected. 
IL-4 is associated with IgG1 and IgE secretion. IFN  is associated with IgG2a production. F. hepatica is 
capable of suppressing all cytokines, but most obviously Th1 types. Suppression may be via F. 
hepatica secreted molecules or antigen-stimulated T cells. 
1.3.3 M. bovis and BCG 
Experimental infection of cattle with attenuated M. bovis BCG and F. hepatica showed that seven 
out of nine co-infected cattle tested negative on the SICCT test and eight out of nine co-infected 
cattle tested negative on the IFN  assay (Flynn et al., 2007b), suggesting reduced immune reaction to 
M. bovis if co-infection with F. hepatica exists in cattle. 
The effect of F. hepatica co-infection on the detection of virulent M. bovis in cattle, showed that co-
infected animals had lower IFN  responses and fewer visual lesions on PME, with a lower overall 
group severity score, suggesting down-regulation of the Th1 immune response in these animals 
(Flynn et al., 2009, DEFRA 2005, Claridge et al., 2012). Blood samples were taken 14 weeks post 
infection for IFN  assay, anti-M. bovis antibody ELISA, and TGF-  and IL-4 ELISAs. The SICCT test was 
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performed on each animal, then all cattle were slaughtered and a PME performed. IFN  assays 
revealed elevation of IFN  in all treatment groups but production was significantly greater from M. 
bovis only infected animals compared with co-infected individuals. TGF-  release in response to PPD-
B was significantly greater in the co-infected group compared to the M. bovis-only group, suggesting 
a regulatory immune response dampening the Th1 response.  Five out of six animals given M. bovis 
only had visual BTB lesions on PME compared with three out of six animals given a co-infection 
suggesting regulation of immunopathology with co-infection.   
As an interesting addition to the TLR discussion in section 1.2.7,  a study by Chambers et al. (2010) 
demonstrated that human pro-monocytic leukaemia cells stimulated with the M. tuberculosis and 
M. bovis  cell-associated lipoglycoprotein, MPB83, led to matrix-metalloproteinase 9 enzyme 
induction via interaction with TLR1 and TLR2, but not with TLR4. TLR2 in particular, is considered to 
mediate a pro-inflammatory immune response that helps clear infections stimulated via lipoprotein 
and lipoarabinomannan such as those from mycobacteria. Production of the M. tuberculosis enzyme, 
cell envelope-associated serine hydrolase (Hip1) has been demonstrated to reduce interaction of 
mycobacterial PAMPs with TLR2 in mice, leading to reduced MyD88-signalling and down-regulation 
of the pro-inflammatory, Th1 response in early infection (Madan-Lala et al., 2011).  MyD88 is the 
central adaptor protein for most TLR (reviewed, Diaz and Allen, 2007). In its absence, responses shift 
to a Th2 type immune response.  
The TRIF-dependent pathway of TLR3 and TLR4 stimulation primarily activates the transcription 
factor IRF3, inducing transcription of IFN , leading to STAT1 activation and induction of STAT1-
dependent genes such as iNOS and interferon-inducible protein 10, producing a Th1 
proinflammatory environment. Donnelly et al. (2010b) demonstrated that Cathepsin-L1 (FheCL1) 
from F. hepatica specifically blocks TLR3 by degrading this protein, diminishing macrophage 
activation by both TLR3 and TLR4, and hence reducing expression of genes such as iNOS. This 
pathway block is due to degradation of TLR3 within the macrophage endosome by parasite-derived 
FheCL1. The TLR3 ligand is double-stranded RNA, usually present in dsRNA viruses, and stimulation 
of TLR3 or TLR4 (the ligand of which is LPS) or both would mediate a Th1, proinflammatory immune 
response. In the absence of this, a Treg and Th2 anti-inflammatory immune response predominates. 
Is it possible that the strong Th2 response stimulated by F. hepatica-infection on macrophages via 
their effect on TLR3 and TLR4 sets up an environment whereby subsequent stimulation of TLR1 and 
TLR2 by M. bovis has negligible effect, leading to increased susceptibility of co-infected animals to 
BTB infection. 
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1.4 Other On-farm Pathogens in the UK 
Although many co-infections are dealt with by the immune system without problems, 
immunomodulatory pathogens such as Fasciola hepatica, may polarise the immune response, 
leaving that individual host more susceptible to infections that would normally require the 
suppressed immune response for clearance. It should be made clear here that this 
immunomodulation will not necessarily increase the likelihood of the host being infected, but may 
mean that, once infected, the host cannot eliminate the disease as effectively (Aitken et al., 1979, 
Aitken et al., 1981, Brady et al., 1999). In the case of bovine tuberculosis, this leads to greater risk of 
transmission and persistence of the pathogen on farms before infected individuals are identified and 
culled. 
As discussed in section 1.1.9, F. hepatica is a strong immunomodulatory pathogen of cattle, its 
prevalence in the UK is increasing (Daniel and Mitchell, 2002) and co-infection of hosts with bacteria, 
viruses or protozoa and this parasite have been shown to lead to increased severity of clinical 
disease and bacterial persistence (sections 1.3 and 1.4). It is thus important to determine if this 
abundant parasite is having an effect on the distribution and prevalence of other bovine diseases in 
the UK. 
Five major pathogens were deemed to be of great significance to UK cattle, and are discussed below. 
1.4.1 Bovine Viral Diarrhoea Virus 
BVDv is a pestivirus of the flaviviridae; a group of small, enveloped viruses with a single-stranded, 
positive sense RNA genome (Brackenbury et al., 2003). The two biotypes of the virus, cytopathic (cp) 
and non-cytopathic (ncp), are identifiable based upon their lytic action in in vitro cultures (Meyers 
and Thiel, 1996). Infection of the host is via the oronasal route and initial viral replicate occurs in the 
oronasal cavity, before causing a viraemia that spreads the virus to internal organs. The virus is shed 
essentially in all secretions and excretions (Peterhans and Schweizer, 2010) from the infected animal 
and the type of disease seen depends upon the age of the animal at the time of infection, as shown 
in Table 1.5. 
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Table 1.5: Types of Infection caused by BVDv 
Age of Animal Disease form Reference 
<40 days gestation Acute infection (Brownlie et al., 1989) 
40-120 days gestation Immunotolerance (McClurkin et al., 1984) 
120-140 days gestation CNS-pathology (McClurkin et al., 1984) 
140 days to term leading to 
birth of immunocompetent 
animals 
Acute with virus persistence in 
immunoprivileged sites such as 
testes 
(Brownlie et al., 1980) 
(Kommisrud et al., 1996) 
Adult cattle Acute infection with 
subsequent  virus persistence in 
immunoprivileged sites such as 
testes 
(Brownlie et al., 1980) 
(Kommisrud et al., 1996) 
Persistently infected animals 
as a result of immunotolerance 
Homologous cpBVDv infection 
leads to Mucosal Disease and 
death 
(Brownlie, 1990) 
(Bruschke et al., 1998) 
 
The bovine foetus becomes immunotolerant of ncp BVDv, if infection occurs between 40-120 days of 
gestation. Immunotolerance is the acceptance by the host immune system of antigens as ‘self’ at the 
time of immune system development. In the case of BVDv, this infection window results in a live calf 
that is persistently infected (PI) and continuously sheds infective virus. This produces a ‘PI’ animal 
that serves as a source of infective virus for other animals in the herd. Many PI animals have reduced 
growth rates and are highly susceptible to other pathogens, frequently not surviving to first service 
(Radostits et al., 2007). 
ncp BVDv does not trigger interferon alpha/beta  (IFN / ) production thus this may allow it to infect 
and persist in the foetus, in which an innate IFN /  response is possible very early after conception. 
cp BVDv induces a large IFN /  response from the host innate immune system, hence cp BVDv 
cannot become a persistent infection. It is also hypothesised that infection of the foetus at <40 days 
gestation may stimulate the high concentrations of IFN-  produced by the bovine trophoblast during 
this time. IFN-  is thought to maintain gestation by preventing luteolysis in the bovine ovary but also 
has antiviral activity similar to IFN /  (Short et al., 1991, Cooke et al., 2009). 
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In the acutely infected immunocompetent animal, infection with ncp BVDv leads to an 
asymptomatic or mild disease of 12-14 days duration. During this time, a period of 
immunosuppression is noted. 
In vitro, ncp BVDv inhibits IFN  induction after viral uptake into antigen presenting cells. Schweizer 
and Peterhans (2001) demonstrate that 12 hours is required after host cell invasion to allow the 
virus to induce viral protein production or influence host cell proteins, that enable the host cell to 
resist apoptosis.  In vivo, ncp BVDv has been shown to induce elevated IFN  concentrations in 
foetal serum, but that IFN /  was undetectable from the amniotic fluid of foetuses infected with 
ncp BVDv. This failure to induce IFN /  in the amnion may enable the virus to establish persistent 
infection in the early foetus. 
dsRNA is a pathogen-associated molecular pattern (PAMP) produced during viral replication 
intracellularly. Toll-like receptor (TLR) 3 or protein kinase R stimulation by dsRNA should lead to NF-
B transcription factor-activation of IFN /  genes (Jacobs and Langland, 1996). However, an in vitro 
study showed TLR3 expression was demonstrated to decline rapidly from 1 hour post infection to 24 
hours post infection, and the expression of IL-12, a cytokine involved in the differentiation of naive T 
cells to Th1 cells, crucial for adaptive immune development, mirrored this (Lee et al., 2008), 
indicating down-regulation of the immune response soon after infection.   
Due to the lack of activation of the innate immune system by ncp BVDv, intranasal dendritic cells do 
not become activated to produce IFN /  and viral growth is not restricted. When free virus enters a 
lymph node, interaction between the virus and plasmacytoid dendritic cells (DC) produces a huge 
upsurge in IFN /  production. This IFN /  production influences the development and sensitivity of 
a number of other DC subpopulations and mediates an appropriate adaptive immune response. 
A predisposition for co-infection has been noted in both acutely and persistently BVDv infected 
animals. BVDv infection has been associated with more severe respiratory tract disease caused by 
bovine parainfluenza-3 virus, bovine respiratory syncytial virus, and Mannheimia haemolytica 
infection (Fulton et al., 2000). BVDv reactivation was shown to occur in calves given a subsequent 
bovine herpesvirus 1 (Infectious bovine rhinotracheitis virus; IBR) challenge, and the clinical 
condition of such co-infected animals was significantly worse than the condition seen with a single 
viral infection (Castrucci et al., 1992). 
In addition, delayed-type hypersensitivity responses to Mycobacterium avium subsp 
paratuberculosis (causative bacterium of Johnes disease) purified protein derivative (PPD) were 
demonstrated to be decreased in cows experimentally exposed to this bacterium one week after 
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exposure to a modified-live BVDv vaccine (Thoen and Waite, 1990). This poses concerns for 
countries use the PPD test for Johnes disease diagnosis. 
Salmonella typhimurium DT104 infection was found to be more severe in a group of imported 
pregnant heifers co-infected with BVDv virus (Penny et al., 1996). Another study also showed that 
calves given BVDv and S. typhimurium showed more severe clinical signs and excreted the bacteria 
for longer than calves that were infected with S. typhimurium alone (Wray and Roeder, 1987) . 
Perhaps most worryingly is the demonstration that BVDv infection in calves can render common 
tests used for M. bovis detection – lymphocyte proliferation in response to PPD-A and PPD-B and the 
IFN  assay – less sensitive due to the immunosuppression caused by acute ncp BVDv infection 
(Charleston et al., 2001). Acute BVDv infections have an immunosuppressive effect on lymphocyte 
proliferation and IFN  release that could last over 3 weeks, meaning that herds with such co-
infection may remain undetected and hence spread M. bovis within and between herds. 
Furthermore, it has been shown in experimentally infected calves that BVDv infection leads to 
enhanced M. bovis shedding in nasal secretions for 4 weeks, increasing silent transmission of the 
bacterium (Kao et al., 2007).  
1.4.2 Leptospirosis 
Leptospirosis is a clinical disease of cattle, man and other animals, caused by the spirochaete, 
Leptospira interrogans serovar hardjo and other serovars (Ellis et al., 1985). In cattle, the disease 
manifests as lowered fertility, abortion, mastitis and/or renal failure (Ellis et al., 1985, Higgins et al., 
1980). The organism is carried by a number of mammals such as rodents, but cattle-to-cattle 
transmission via urine has been shown to be most important in Northern Ireland (Ellis et al., 1981). It 
is also transmitted via semen (Heinemann et al., 1999). Leptospirosis is highly prevalent in non-
vaccinated herds, with 76% of such dairy farms in south Wales demonstrating antibodies in bulk milk 
tank samples (Bishop et al., 2010). 
Leptospirosis was thought to cost the UK dairy farming industry £22.3 million in 1996 (Bennett et al., 
1999), with substantial reproductive costs in cattle reported (Grooms, 2006). Further to this cost is 
the possibility of co-infections occurring in cattle, complicating demands upon the immune system 
and reducing production potential further. For example, in a 183-cow dairy herd with a serious 
outbreak of pyrexia, diarrhoea, agalactia, metritis and severe weight loss, BVDv was considered the 
primary cause with increased clinical severity due to the concurrent introduction of L hardjo and 
Coxiella burnetii into an immunologically naive herd during the main calving period (Pritchard et al., 
1989).  
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Risk factors for bulk milk tank levels of antibodies to L. hardjo, BVDv and IBR were recently described 
(Bishop et al., 2010) as large herd size, open farm policy with cattle being bought-in, and hiring bulls. 
On farms where antibody to one of the three diseases listed above was high, the chances of 
antibody against another of those pathogens, was also increased. 
The immune responses of cattle to Leptospira interrogans serovar Hardjo infection have not been 
studied in detail. Several studies have been done to investigate the type of vaccine-induced response 
necessary for protective immunity in cattle. Protective immunity has historically been considered to 
be entirely humoral against L. hardjo due to the highly serovar-specific antibody response elicited 
upon vaccination (Brown et al., 2003). Despite good antibody production in vivo to pentavalent 
vaccines (incorporating antigens from serovars Hardjo, Canicola, Pomona, Grippotyphosa and 
Icterohaemorrhagiae) the presence of antibody against L. hardjo does not protect cattle from 
urinary shedding or abortion post challenge with this serovar. Monovalent vaccines against L. hardjo 
have been shown to induce a strong cell-mediated (pro-inflammatory) immune response, producing 
high quantities of IFN (Naiman et al., 2001). It is postulated that serovar hardjo is most resilient to 
immune-mediated killing thus requiring a different mechanism of immune system control, compared 
to that of the other serovars listed above (Brown et al., 2003). In conclusion, a Th1 or pro-
inflammatory immune response is necessary for effective immunity against L. hardjo. 
Leptospirosis vaccination prevalence was significantly higher in cattle testing negative to the SICCT 
test  compared with those testing positive to the SICCT test, but when anti-Leptospira antibodies 
were assayed, no difference was demonstrable between reactor cattle and negative in-contact 
animals (DEFRA, 2005b), indicating that the relationship between these two infections and 
immunomodulation is not clear cut.  
1.4.3 Infectious Bovine Rhinotracheitis 
Infectious bovine rhinotracheitis (IBR) is a viral disease caused by Bovine Herpesvirus 1 (BHV-1), a 
large dsDNA virus of the -herpesvirinae. It is commonly seen as a bovine respiratory pathogen but 
can cause abortion. The main sources of infection are the nasal exudates and the respiratory 
droplets, genital secretions, semen (Deka et al., 2005), foetal fluids and tissues. The BHV-1 virus can 
become latent following a primary infection with a field isolate or vaccination with an attenuated 
strain. Viral genomic DNA has been demonstrated in the sensory ganglia of the trigeminal nerve in 
infectious bovine rhinotracheitis (IBR) and in sacro-spinal ganglia in pustular vulvovaginitis and 
balanoposthitis cases (Nandi et al., 2009). From here, the virus undergoes recrudescence from a 
36 
 
latent infection state (no circulating virus in system to reactivation of infection by new replication of 
virus previously harboured in neuronal cells).  
In the UK, 83.2% of unvaccinated herds in one study showed evidence of at least one seropositive 
animal on the farm (Woodbine et al., 2009). This study also showed that exposure to BHV-1 
increased with age in larger herds. 
One thing common to the herpesvirinae, and important for successful viral infection in the case of 
herpesviruses, is the latency-reactivation cycle. Acute BHV-1 infection occurs on mucosal surfaces 
and leads to high amounts of host cell apoptosis (Winkler et al., 1999). Viral gene expression is 
temporally regulated in 3 phases: immediate early (IE), early (E) and late (L), each stage being 
activated by products from the stage before. BHV-1 enters the peripheral nervous system by cell-to-
cell spread and lies dormant between periods of recrudescence in the sensory neurons of the 
trigeminal ganglia. Periods of elevated corticosteroids in the circulation and/or immunosuppression 
can initiate recrudescence from the latent viral state (reviewed by Jones and Chowdhury, 2007). 
Latent virus expresses an abundance of the latency related (LR) gene but switches off expression of 
IE and E genes (Jones et al., 2006).  
BHV-1 encodes at least three proteins that can inhibit specific arms of the immune system.  
(a) bICP0 is a transcriptional regulatory protein that activates expression of all viral promoters 
(Everett, 2000). In the absence of viral genes, bICP0 inhibits IFNα/β signalling by infected 
host cells (Henderson et al., 2005) by reducing IRF3 protein levels in human and bovine cells, 
leading to reduced IFN-  promoter activity (Saira et al., 2007).  IRF3 activation is an 
immediate early regulator of the IFN response in infected host cells. It has been shown that 
BHV-1 does not replicate in murine neuronal cells with functional IFNα/β receptors, thus the 
ability of this virus to inhibit IFNα/β production is crucial for its pathogenesis (Abril et al., 
2004).   
(b) UL41.5 protein (or glycoprotein N) is a non-glycosylated type I membrane protein (Liang et 
al., 1993, Liang et al., 1996). Glycoprotein N homologues have been shown to inhibit 
transporter-associated antigen processing-mediated transport of cytosolic peptides into the 
endoplasmic reticulum, hence blocking formation of MHC-I complexes destined for antigen 
presentation on the cell surface (Koppers-Lalic et al., 2005, Lipinska et al., 2006).  This in turn 
inhibits CD8+ T-cell recognition of infected cells  (Nataraj et al., 1997). 
(c) Viral Glycoproteins are virally encoded proteins required for viral particles to bind and 
penetrate host cells and for viral shedding, cell fusion and cell-to-cell spread to disseminate 
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virus after replication (reviewed by Jones and Chowdhury, 2007). Glycoprotein G is a 
chemokine-binding protein that prevents movement of lymphocytes to sites of infection. 
Following acute infection of calves, BHV-1 can also infect and induce high levels of apoptosis 
of CD4+ T-cells (reviewed by Jones and Chowdhury, 2007). Deletion of the BHV-1 
glycoprotein G gene leads to a more attenuated viral phenotype in experimentally infected 
calves (Bryant et al., 2003). 
Previous discussions of co-infections with BVDv and respiratory viruses in cattle have shown that 
clinical disease is more severe when co-infection is present (Castrucci et al., 1992). Parturition also 
leads to immunomodulation (Karcher et al., 2008b) in cows and may affect BHV-1 recrudescence in 
some cases. Following BHV-1 infection, IFN /  are detectable in nasal secretions from 5 hours post 
infection to up to 8 days post infection (Straub and Ahl, 1976). These IFNs promote leukocyte 
infiltration, macrophage activation and increase Natural Killer cell activity (Babiuk et al., 1985, 
Lawman et al., 1987, Jensen and Schultz, 1990). Humoral responses lead to anti-envelope 
glycoprotein neutralizing antibody production that binds virus particles and inhibits further host cell 
infection. Non-neutralising antibody can also lead to antibody-dependent cell cytotoxicity (van 
Drunen Littel-van den Hurk et al., 1993). Humoral responses are generally detectable after 8-12 days 
post infection (reviewed by Jones and Chowdhury, 2007). 
CD8+ cytotoxic T lymphocytes play an important role in protection during the cell-to-cell spread of 
the virus during early infection of the respiratory epithelium (van Drunen Littel-van den Hurk, 2007). 
CD8+ CTLs that produce IFN  are believed to play an important role in preventing reactivation from 
latently infected ganglian neurons (Liu et al., 2000).  
1.4.4 Mycobacterium avium subsp. paratuberculosis 
Johnes Disease, caused by the bacterium Mycobacterium avium subsp. paratuberculosis, is a 
common mycobacterial disease of ruminants worldwide. The clinical condition manifests as extreme 
weight loss and terminal, chronic, profuse diarrhoea in cattle (Begg et al., 2011) with reductions in 
milk yield, milk quality and fertility seen in subclinical and clinical conditions (Beaudeau et al., 2007, 
Smith et al., 2010). The disease costs the US dairy industry over $200 million each year (Ott et al., 
1999). 
The bacterium is extremely difficult to eradicate from a premises with bioaerosol production 
remaining infectious after decontamination of surfaces post depopulation (Eisenberg et al., 2011). 
Coupled with the long incubation time (time between infection and start of clinical signs; often more 
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than 2 years) of this bacterial infection, this disease is very difficult to detect clinically and may 
spread silently through a herd before clinical signs show (Chiodini et al., 1984, Gonzalez et al., 2005).   
Antibiotic treatment is protracted and expensive, and has not been demonstrated to produce a cure 
in infected cattle, hence culling is the only true option for management of this disease on-farm (Lu et 
al., 2008). There is little evidence to suggest that in utero infection of calves occurs despite the dam 
being seropositive/faecal culture positive (Pithua et al., 2010), so snatch-calving is the only way to 
ensure transmission from dam to calf via colostrums or via the faeco-oral route does not occur 
(Dieguez et al., 2008, Antognoli et al., 2007).  Commercial diagnostic tests available in the UK include 
an anti- M. avium subsp. paratuberculosis antibody ELISA and bacterial culture and identification 
(VLA Test List, 2011). 
IFN  is important for initiating the innate immune response to intracellular bacteria and is one of the 
first cytokines to be activated in subclinical M. avium subsp. paratuberculosis-infected dairy cows 
(Sweeney et al., 1998). Together with TNF , IFN  promotes the protective formation of granulomas 
(Roach et al., 2002) necessary for control of M. avium subsp. paratuberculosis infection.  
Post surgical inoculation into the ileum of young calves, it takes M. avium subsp. paratuberculosis 
one hour to translocate to the mesenteric lymph nodes, indicating rapid, efficient and possibly 
strain-dependent spread of the bacterium (Wu et al., 2007). There was a lack of antibody response 
seen during the 9 month study, but a shift towards Th2 (humoral) immunity was associated with 
advancement to clinical disease (Wu et al., 2007). A Th1 immune response was predominant 
throughout the 9 month study, shown by flow cytometry and reverse transcription polymerase chain 
reaction (RT-PCR).  
Investigations in cattle show that adult, naturally infected cows tended to have a Th2 dominant 
immune system phenotype characterised by increased IL-5, GATA 3 and IL-4 mRNA production 
(Coussens et al., 2005). Phagocytosis of M. avium subsp. paratuberculosis by dendritic cells and 
macrophages and these cells’ subsequent migration to local lymph nodes allows Mycobacterium 
avium subsp paratuberculosis (MAP) antigen presentation to T and B cells (Coussens, 2004). T cell 
activation appears to be restricted, with only macrophages that successfully destroy M. avium subsp. 
paratuberculosis infections able to express MAP antigens on MHC class II leading to a Th1 response 
being stimulated. A Th2 response, characterised by antibody production was shown to depend on 
route of entry and dose of the bacteria (Waters et al., 2003). High initial doses lead to more rapid 
antibody production. 
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Experimental infection of sheep has shown variation in the initial immune responses mounted 
against M. avium subsp. paratuberculosis (Begg et al., 2011). Here, the authors show that despite 
there being a predominant classical Th1-Th2 switch in immune response shown by 50% of 
experimentally infected animals, there were actually 3 distinct patterns produced: Th1 – Th2 switch, 
IFN -antibody combination, and IFN  only. It is not stated whether these animals were tested for co-
infections before experimental inoculation, which may help to explain the variation in immune 
responses seen. The fact that outbred animals were used may also explain the variation in immune 
responses seen. Pathological severity and extent of M. avium subsp. paratuberculosis dissemination 
was not correlated at all with clinical signs of the disease (Brady et al., 2008). 
Several authors have hypothesised that a Th1 immune response is more likely to control or eradicate 
M. avium subsp. paratuberculosis in ruminants (Begg et al., 2011, Mikkelsen et al., 2009).  Anecdotal 
evidence suggested that as cattle infected with M. avium subsp. paratuberculosis approach 
parturition, IFN  and TNF-  expression by peripheral blood mononuclear cells (PBMC) reduced, 
leading to a reduction in Th1 activity at parturition (Karcher et al., 2008a).  Studies concentrating on 
the periparturient period of cattle show that clinical cases tended to have a more Th2 response than 
subclinically infected cows or control cows (Karcher et al., 2008b), with a greater CD4:CD8 ratio. The 
relative percentages of lymphocyte subsets were also found to be modulated in cows with clinical 
infection, despite some modulation being attributable to parturition. Overall cytokine gene 
expression during the period 3 weeks before to 4 weeks post partum was not noted to be 
significantly influenced by Mycobacterium avium subsp. paratuberculosis infection (Karcher et al., 
2008a).  
A study utilising 2-3 year old sheep naturally infected with Mycobacterium avium subsp. 
paratuberculosis, found increased expression of TLR 1-5 and TLR8 in the ileum and jejunum and 
increased expression of TLR 1-4, TLR6 and TLR8 in mesenteric lymph nodes of infected animals 
(Taylor et al., 2008). TLR1, 2 and 4 mutations were subsequently found in cattle with Mycobacterium 
avium subsp. paratuberculosis infection (Mucha et al., 2009). Given the highly conserved nature of 
TLR across mammalian species, it is hypothesised that these mutations are important for 
susceptibility to Mycobacterium avium subsp. paratuberculosis infection.  
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1.4.5 Neospora caninum 
Neospora caninum is a protozoal parasite with a complex life cycle, involving an intermediate bovine 
host and a definitive canine host. Three lifestages have been described: 
1. Bradyzoite-containing tissue cysts within the central nervous system of Canis familiaris 
(domestic dog) and Canis latrans (coyotes), bovine placenta (Shivaprasad et al., 1989) and 
skeletal muscle (Peters et al., 2001). This is the dormant stage. 
2. Tachyzoites in the brain, heart and liver, allowing amplification of the parasite and spread to 
all internal organs (Barr et al., 1991, Wouda et al., 1997). This is the penetrative stage. 
3.  Oocysts passed out in the faeces of the definitive canine host. Upon sporulation (which 
takes 48 hours under laboratory conditions (McAllister et al., 1998)), two sporocysts are 
formed, each containing four sporozoites. This sporulated form is considered the main route 
of postnatal infection (Wouda et al., 1997). 
Epidemiological studies have shown that vertical transmission of the parasite from dam to calf is the 
most common route of infection with more than 80% of calves born to infected dams, infected 
themselves (Anderson et al., 1997). It is estimated that 36% of bovine abortions diagnosed in the UK 
are attributable to neosporosis (Anon, 2002), and the prevalence of N. caninum seropositivity was 
found to be up to 55% of dairy herds in Wales (Felstead, 2005) and 81% of calves born to 
seropositive dams were found seropositive on two dairy farms in California (Paré et al., 1996). The 
buying-in of infected animals on to a farm can lead to introduction of infection into the herd – either 
through vertical transmission establishing an infected family line and by providing a source of 
contaminated tissue (cleansings or aborted material) which can be scavenged by dogs, leading to 
environmental contamination with oocysts.  Potentially this may lead to an abortion storm if naive, 
pregnant cattle ingest oocysts (Williams et al., 2009). Vertical transmission following recrudescence 
of endogenous infection during  pregnancy leads to infection of the calf in utero (Davison et al., 
1999). Oral ingestion of oocysts by cattle leads to horizontal infection (McCann et al., 2007). 
Demonstration that a Th1 response was necessary for foetal protection against an exogenous 
challenge using live N. caninum tachyzoites, was characterised by an increase in systemically 
circulating IFN  and by production of IgG2 antibodies in pregnant bovine cows (Williams et al 2000). 
Further demonstration of recrudescence of infection causing foetopathy in five out of six naturally 
infected pregnant cattle suggests that, despite this Th1 response being protective against exogenous 
challenge, pre-existing immunity in chronically infected dams is more difficult to control (Williams et 
al., 2003). The regulatory immune environment established in the dam during bovine gestation is 
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TGF  and IL-10 dominant. Only experimental immunization of cattle prior to pregnancy, with live 
subcutaneous tachyzoites, has been shown to confer protection against foetopathy (Williams et al., 
2007). This Th1 immune response, generated as a result of this immunization, is thought to be 
necessary for foeto-protection in the ensuing pregnancy.  
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1.5 This Thesis 
1.5.1 Co-infections in the field 
Table 1.6 below summarises the immune responses necessary for elimination of the common 
pathogens detailed above. Given the high herd prevalence of all these infections in the UK, it is 
highly likely that co-infection with these diseases and F. hepatica, will occur within herds and within 
individual animals.  
Table 1.6: Summary of the immune responses necessary for immune control of the diseases studied 
in this thesis 
Disease: Johnes Disease  Neospora 
caninum  
BVDv  IBR  Leptospira 
interrogans 
serovar hardjo  
Causative 
agent: 
M. avium 
subspecies 
paratuberculosis  
Apicomplexan  
Protozoal 
parasite  
Pestivirus, 
flaviviridae  
a-herpesvirus  Spirochaete 
bacterium  
Clinical 
signs: 
Gastro-
intestinal 
disease, chronic 
infection  
Abortion  Abortion, 
immune 
suppression, 
susceptibility 
to co-
infection, PI’s  
Upper 
respiratory 
tract disease, 
abortion  
Abortion, 
reduced fertility, 
mastitis, renal 
failure  
Immune 
response: 
necessary 
Th1  Th1  Th1  Th1  Th1  
 
1.5.2 Thesis Outline 
Chapter 2 aims to estimate the herd prevalence of BTB on dairy farms in England and Wales, using 
novel Bayesian methods to provide less bias. This will cast further light on the magnitude of the 
problem faced by UK farming, and outlines the importance, both from animal welfare and economic 
perspectives, of effective disease control for BTB. 
Further investigation of herd-level BTB prevalence on dairy farms in England and Wales is conducted 
in Chapter 3, where a statistical model is formulated, using proxies of variables found to be highly 
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significant predictors of BTB by other published papers. Into our model, we then test a variable 
derived from the anti-F. hepatica antibody milk ELISA, to see if it enhances the predictive power of 
our model significantly. 
The negative and highly significant, statistical association between F. hepatica burden and BTB 
presence or absence on dairy farms, shown in Chapter 3 is then studied on an animal level. In an 
area of South Wales identified as having high incidence of F. hepatica and BTB in Chapter 3, in 
Chapter 4 we obtain milk samples from SICCT test positive and negative, or IR and negative cattle, 
and compare the burdens of F. hepatica in the respective groups.  
Chapter 5 of this thesis sets out to identify associations between F. hepatica exposure and these 
infectious diseases. Information collected via questionnaires and PP values from milk samples 
analysed by the anti-F. hepatica antibody milk ELISA, will be tested via a random effects model to 
look for new associations between herd management or disease status variables, and the exposure 
of F. hepatica  by individual cattle on farms in England and Wales. 
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Chapter 2 
National estimates of herd-level bovine tuberculosis prevalence are 
biased 
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2.1 Abstract 
BTB is a notifiable disease, endemic in England and Wales. The incidence of BTB outbreaks has 
increased exponentially in the last 15 years, despite previously successful control measures being 
used. Compulsory BTB screening and disease control methods cost the UK government £108.4 
million in 2009. In this chapter, two novel methods for estimating disease prevalence in the UK dairy 
herd are designed and run; the first is a Bayesian method estimating prevalence based upon an 
imperfect test being applied to BTB diagnosis, and the second method assigning a probability of true 
positive diagnosis on a farm level, given each farm herd-size. We show that the prevalence of BTB is 
likely to be higher (0.440) than that currently reported (0.345). This has major implications for the 
current disease control methods and the use of the EU approved skin test for diagnosis of BTB ante 
mortem. 
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2.2 Introduction 
BTB, caused by the bacterium Mycobacterium bovis, is a serious threat to the UK livestock industry, 
costing the UK government £108.4 million in 2009 (DEFRA, 2011b). Despite compulsory bovine skin 
testing being in place since the 1950’s, there has been a steady increase in the incidence of disease 
in British cattle during the period 2001-09 (Buddle et al., 2009, Ely and Upton, 2010, O'Reilly and 
MacClancy, 1975). Some authors have questioned the value for money and efficiency of the BTB 
control programme as the increasing incidence despite large financial input gives the impression of 
‘throwing good money after bad’ (Torgerson and Torgerson, 2008).   
The test used to diagnose BTB in the UK is the SICCT test which relies on a delayed hypersensitivity 
reaction to bovine and avian tuberculin proteins from M. bovis and M. avium respectively. The 
animal-level sensitivity (se) and specificity (sp) of the SICCT test has been described in many studies 
as 55.1-95.5% (Neill et al., 1994, O'Reilly and MacClancy, 1975) and 94.0-100.0% (Neill et al., 1994, 
Buddle et al., 2009) respectively. This is an example of an imperfect test, but, with no other test 
performing as well in the field, it has been adopted as the routine ante mortem test for BTB testing 
in the EU (OIE, 2002).  
 In light of the large ranges in animal-level diagnostic sensitivity and specificity, an estimation of the 
herd-level prevalence of BTB in dairy herds in England and Wales has been made using the Bayesian 
methods reported by Diggle (2011). Further extension of this method of prevalence estimation was 
then conducted, taking into account both herd size and the proportion of individual animals testing 
BTB-positive per herd, when the se and sp of the SICCT test is imperfect. Test data from 3,021 dairy 
herds in England and Wales, of varying size, over the period 2004-2007, were used and the 
calculated herd prevalence can then be compared to that required for OTF status (0.1% of herds) in 
the EU (OIE, 2002). 
A large proportion (7.6%) of sample herds contained just one BTB-positive animal detected via SICCT 
test application ante mortem over the 4 year period studied. Although identification of just one BTB-
positive animal within a herd will impart cattle movement and trade restrictions on the entire herd, 
we hypothesize that a significant proportion of herds where at least one BTB-positive animal should 
be found, are not being detected due to the lack of se of the SICCT test and thus the herd prevalence 
of BTB in the study area is currently negatively biased. 
  
47 
 
2.3 Methods 
2.3.1 Bayesian estimation of BTB herd prevalence 
The true prevalence, θ, of a disease is the proportion of subjects in the population of interest having 
that disease (Diggle, 2011). The sensitivity, se, of a test is the probability that an individual with the 
disease will be accurately detected and the specificity, sp, of a test is the probability that it will 
accurately predict that an individual has not got a disease. Almost all tests are, however, inaccurate 
in real life, with se and/or sp less than 1. With such imperfect tests, there is then the possibility that 
either a false negative (se < 1) or false positive (sp < 1) result may occur. 
If we apply this imperfect test to a sample of the UK cattle population, n, of which T have a positive 
result, the standard estimator, Ô, modelled as Ô = T/n, is now biased for prevalence, θ. If we denote 
φ as the expectation of the naive estimate of Ô, the relationship between these two parameters is: 
Φ = se x θ + (1-sp) x (1- θ) = (1-sp) +(se +sp-1)θ 
If it is then assumed that both the sensitivity and specificity of a test are greater than 0.5 each (ie. 
se+sp>1), it follows that if the values of se and sp are known, a confidence interval of (a,b) for Φ can 
be converted to a confidence interval of (c,d) for θ by applying the following transformations: 
c = max[0, {a-(1-sp)}/( se+sp-1)]    and    d = min[1, {b-(1-sp)}/( se+sp-1)] 
For an unknown se and sp, θ can still be estimated, albeit with reduced precision. If we have se and 
sp with a range of values (Table 2.1), a distribution may be assigned to the number of positive herds, 
the precision of this assignment dependent on the width of the se and sp ranges.  
This Bayesian technique acknowledges variation in se and sp but not that this comes from herd size. 
The actual BTB test results recorded are effectively a prior for this technique, as they are estimates 
of the truth, forming a distribution.  
Animal-level se is considered the important factor in the field, and is thus utilised in this calculation. 
Herd-level se is expected to vary between farms and no published figures are available for this 
reason. Herd-level prevalence is the value used by the OIE to designate countries as OTF. 
An R script published by Diggle (2011; www.lancs.ac.uk/~diggle/prevalence_estimation.R) was used 
initially to calculate the herd prevalence of BTB in a sample of dairy farms in England and Wales. The 
maximum and minimum se and sp from the literature were used as priors for this analysis. The result 
of this analysis is shown in Box 1. 
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2.3.2 Estimating Herd Prevalence of Bovine Tuberculosis in Dairy Herds in England and Wales 
Herd level se and sp are functions of herd size and animal-level prevalence. se and sp are 
computable, by the method shown in (Diggle et al., paper awaiting publication). 
The herd-level se may be expected to vary considerably with geographical location of the farm in 
England and Wales, and modelling is thus more complex. In this instance, se will depend upon herd-
size and the true proportion, p, of infected animals. As p is unknown, a beta distribution must be 
fitted to the probability of a herd being considered positive (maximum likelihood parameter 
estimates a = 0.28 and b = 14.52). 
A herd-level sp of 1.00 is assumed because sp<1 would lead to all farms with more than 500 cattle 
being modelled as positive for BTB. As 72 out of 156 farms with herds greater than 500 cattle test 
negative, this is not the case. The se of the test can then be assumed at different values to create the 
estimates of BTB prevalence in England and Wales shown in Table 2.1. 
From the data, the animal-level se and sp, and hence the observed herd-level prevalence as a result, 
can be calculated. A confidence interval can then be assigned to the overall herd-level prevalence 
based upon the size of the herd (assuming 5 positive out of 100 tested is more likely to contain a 
true positive than 1 out of 5 tested, because more tests are applied to the former). A beta 
distribution is assigned to the probability of each farm testing positive based upon herd size being 
known. This can then give a more informed prevalence estimate when se is assumed. 
Theoretically, method 2.3.2 could be used to calculate a prior for herd-level se that could then be 
used in method 2.3.1 based upon animal-level se. sp would be assumed zero for this too. 
 
  
Box 1: Estimation of BTB herd prevalence given published se and sp 
Prior for se assumed uniform between limits 0.551-0.955 
Prior for sp assumed uniform between limits 0.940-1.000 
Point estimate of prevalence:  0.440 (90% CI: 0.375 – 0.580)  
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2.4 Results 
Table 2.1: Estimates of herd level BTB Prevalence in England and Wales given different SICCT test 
sensitivities 
Sensitivity of animal-
level SICCT test 
Estimate of Herd-level 
Prevalence 
Confidence Interval 
Lower Upper 
0.55 0.470 0.450 0.490 
0.75 0.400 0.380 0.420 
0.95 0.350 0.335 0.365 
1.00 0.345 - - 
 
NB. When se = 1.00, no confidence interval is calculated because this is the actual recorded 
prevalence. 
The point prevalence of BTB in England and Wales has been estimated at 0.44 using Bayesian 
method 2.3.1. This value lies within the prevalence range for a test attaining a 0.55 – 0.75 se.  
Using extended analysis, if the animal-level specificity of the test is less than 1 (reported range: 0.94 
to 1.00) a large herd is almost certain to be declared positive (e.g. herd size=1000, sp=0.99 gives 
herd-level specificity 0.00004), in this simulation. Hence a specificity of 1.00 was assumed 
throughout.   
The plausible range reported in the literature for animal-level sensitivity of SICCT test is 0.55 to 0.95. 
The crude level herd prevalence in England and Wales, not taking into account SICCT test 
performance, is 0.34. The effect of imperfect SICCT test sensitivity diminishes as sensitivity increases, 
and is probably negligible for sensitivities greater than 0.95. 
 
Figure 2.1: Estimation of herd-level prevalence, θ , assuming se = 1 (black line in each panel) and se = 
0.55 (red, top panel), se = 0.75 (red, middle panel) and se = 0.95 (red, bottom panel). In each case, 
the estimate of θ is the point at which the curve takes its minimum value of zero, whilst the vertical 
dashed lines delineate the 95% confidence intervals. Where theta equals the prevalence of BTB and 
D(theta) equals the deviance of theta. 
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2.5 Discussion 
This study has estimated the herd prevalence of BTB in dairy herds in England and Wales, assuming a 
range of SICCT test sensitivities. The fact that the crude herd-level prevalence calculated here (0.34) 
falls within the prevalence range calculated only when sensitivity is assumed to be 0.95, and lies 
outside the prevalence ranges calculated when the sensitivity is assumed to be 0.75 and 0.55, 
suggests that this figure is an underestimation of the true prevalence of BTB in England and Wales. 
Bayesian methods of prevalence estimation given the minimum and maximum se and sp reported in 
the literature also suggest that the herd prevalence is higher (0.44) than that currently estimated 
from crude data analysis. Estimation using lower test sensitivities suggests that BTB prevalence is 
substantially higher and thus cause for concern with respect to BTB control.  
Many EU countries now hold OTF status, Scotland being a recent regional addition to this list (Anon, 
2009). England, Wales, Northern Ireland and the Republic of Ireland show very little sign of reducing 
the herd-level prevalence of BTB in their respective countries. To be considered OTF by the EU, a 
country must have a herd prevalence below 0.1% for six consecutive years (EEC, 1964). Results from 
this study show the sheer magnitude of the efforts needed to control BTB. What is more, current 
estimates of BTB prevalence are, according to this study, negatively biased. Controlling BTB is likely 
to be rendered more difficult by underestimating its true prevalence.  
The methods used in this paper utilised the sensitivity of the SICCT test applied at an animal-level 
and the size of each dairy herd included in the analysis. This then allowed an estimate of herd-level 
BTB prevalence in England and Wales. All estimates made in this paper suggest that the UK is even 
further away, than currently calculated, from OTF status and BTB control.  
BTB detection in cattle leads to trade restriction on infected premises, the necessary culling of 
animals testing positive to the SICCT test, and retesting of the remaining herd. This has major 
financial repercussions on individual farms and the UK farming industry, and potential animal 
welfare implications for reactor animals (DEFRA, 2011c). Countries within the EU will not be able to 
trade livestock optimally until they gain OTF status (Gordon, 2008). 
The outbreak of FMD in Britain in 2001 saw widespread culling of livestock and subsequent 
repopulation of destocked farms, largely from BTB endemic regions of the UK (Carrique-Mas et al., 
2008). This amount of animal movement allowed the potential for non-notifiable diseases such as 
fasciolosis to be spread around the country, setting up new foci of infection, and has been blamed in 
part for the spread of BTB in the UK (Gilbert et al., 2005).  
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One contributor to the low sensitivity of the SICCT test in some herds may be the co-infection of 
cattle with the trematode parasite, Fasciola hepatica. This parasite has been shown to modulate the 
immune response of the bovine host towards an anti-inflammatory response, leading to the 
simultaneous down-regulation of a pro-inflammatory response (Flynn et al., 2007b, Flynn et al., 
2009, Claridge et al., 2012). The SICCT test relies on a functional pro-inflammatory immune response 
being elicited. False negative SICCT test results lead to infected cattle to remain in the herds or be 
moved around the country, disseminating BTB infection. This in turn means that eradication of BTB 
in British cattle is rendered even more difficult.  Reconsideration of the standard interpretation of 
the SICCT test may increase the test sensitivity and hence lead to improved control of BTB. 
Conflicts of Interest 
The second part of materials and methods for this paper was designed and run by Prof P Diggle, and 
results analysed by Jen Claridge and Peter Diggle to gain meaningful explanations for the figures 
quoted. Design of the second method was deemed outside the scope of this thesis, although an 
understanding of the theory is held by the student. 
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Chapter 3 
Fasciola hepatica is associated with failure to detect M. bovis in UK 
dairy herds 
 
 
(Nature Communications, 2012)    
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3.1 Abstract 
BTB is an intractable, chronic infection, with a large host range, caused by the bacterium 
Mycobacterium bovis. The disease is notifiable by law, and the incidence has been increasing 
exponentially in England and Wales, despite the application of previously successful control 
measures. In Chapter 2, the prevalence of BTB in England and Wales was estimated to be higher 
than currently reported. Experimental infection of cattle with BTB and the trematode parasite 
Fasciola hepatica, has been shown to reduce the sensitivity of the skin test approved for diagnosis of 
BTB in cattle, leading to more false negative results occurring. Chapter 3 studies the association 
between F. hepatica exposure, as measured by the anti-F. hepatica antibody ELISA applied to bulk 
milk tank samples, and the diagnosis of BTB by the skin test over the period 2004-07. A logistic 
regression model was designed to predict farms with BTB breakdowns in the 4 year window, based 
upon two other published models utilising climatic, animal movement and herd size variables. The 
predictive ability of the model was enhanced by addition of the F. hepatica exposure variable, with a 
significant, negative association between BTB breakdown and F. hepatica exposure demonstrable. 
The distributions of the two diseases are mapped and cluster analysis performed, using SaTScan and 
GeoDa software, to prove that geography is not the reason for the negative association noted. The 
model was then rerun assuming F. hepatica exposure was negative, to identify areas where BTB 
prevalence is currently underestimated. It is estimated that around one third of farms are currently 
being misdiagnosed as negative when tested for BTB, due to the high exposure of cattle to F. 
hepatica. Diagnoses of F. hepatica have increased substantially in the last 15 years, and the 
prevalence of F. hepatica in dairy herds has recently been estimated at 76% over England and Wales. 
We propose that F. hepatica co-infection in cattle has a negative impact on the accurate diagnosis of 
BTB by conventional methods, and that this co-infection is potential reason for the currently poor 
control of BTB in this country. 
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3.2 Introduction 
BTB, caused by the bacterium Mycobacterium bovis, is a serious disease of cattle with significant 
public health and economic consequences. Affected animals show loss of productivity and are able 
to transmit the infection to other in-contact animals (Goodchild and Clifton-Hadley, 2001). M. bovis 
has the widest host range of mycobacteria in the Mycobacterium tuberculosis complex, 
experimentally infecting any warm-blooded mammal, but predominantly cattle, sheep, goats, pigs, 
wild boar and badgers in the EU. Chronic infections in cattle are rare in the UK as cattle are often 
culled for other reasons such as poor fertility, poor production or lameness, but if left BTB would 
eventually be fatal. The economic consequences for countries with endemic BTB are exacerbated by 
international restrictions placed on bovine exports (Gordon, 2008).  M. bovis is also an important 
zoonosis, estimated to be responsible for approximately 10% of hTB in Africa (Cosivi et al., 1998) and 
historically was a major public health problem in Europe, with approximately 2,500 deaths occurring 
annually in the UK in the 1930’s before pasteurisation of milk was introduced (de la Rua-Domenech, 
2006). BTB has been eradicated in several countries including much of the EU, Australia, Canada and 
most of the USA but it is still endemic in UK, Ireland and New Zealand (Anon, 2011a).   
The UK has had a BTB eradication programme in place since the 1950s, based on ante mortem 
diagnosis using the Single Intra-dermal Comparative Cervical Tuberculin (SICCT) test and immediate 
slaughter of positive animals, yet the incidence of BTB has increased exponentially in recent years, 
the cause of which is unknown.  The number of new herd incidents in 2009 was 4,525 and 
government expenditure on the eradication programme was £108.4 million.  By comparison, in 1999 
the total cost of controlling BTB was £8.2 million with 1,666 new herd incidents recorded (DEFRA, 
2010).  Restrictions are now placed on cattle movements with pre-movement SICCT-testing 
introduced in 2005 to England and Wales, but despite this, the incidence is continuing to increase 
with spread predominantly local but with a small number of long range jumps (DEFRA, 2010, Wint et 
al., 2002). The increase in new incidents of BTB within endemic areas and the spread of infection 
into new areas of the UK suggests that infected cattle are not being identified and are being allowed 
to move across the country, silently spreading infection.  Several factors have been identified as 
contributing to this increase such as cattle movements and reservoirs of infection within wildlife 
species, notably the Eurasian badger (Meles meles) (Gilbert et al., 2005, Carrique-Mas et al., 2008).   
The SICCT test, approved for use in the EU and the principal test used in UK and Ireland for ante-
mortem identification of infected animals, measures a delayed type hypersensitivity response to the 
tuberculin antigen PPD and is dependent on functional antigen specific T cells and their capacity to 
secrete IFN-γ (OIE, 2002).  The diagnostic sensitivity of the SICCT test is estimated to be between 52-
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100% with a median value of 80% using the standard interpretation of the test (de la Rua-Domenech 
et al., 2006).  One reason for the low sensitivity of the SICCT test, which has not been fully evaluated 
in the field, is the effect of concurrent infection with pathogens that may suppress the immune 
response to M. bovis (de la Rua-Domenech et al., 2006).   
Fasciola hepatica is a common trematode parasite worldwide, in the UK predominantly affecting 
ruminant livestock.  The prevalence of F. hepatica infection in the UK has increased substantially 
between 2000-2009. Three potential reasons for this include: (i) changes in the climate that foster 
the development of the intermediate host and free living stages of the parasite (Fox et al., 2011), 
and (ii) changes in land use (McCann et al., 2010a, Bennema et al., 2011), in particular drainage 
practices. Recent estimates indicate a herd-level prevalence of 70-80% in the UK dairy herd (McCann 
et al., 2010b). Antibodies against F. hepatica decline to negative values two to ten weeks after 
triclabendazole treatment of the animal, indicating that an animal detected positive by an antibody 
detection ELISA is a good proxy for animals being infected at the time of testing (D. Williams, 
personal communication).   
In one study of BTB, Wint et al., (2002) suggested that another, undefined variable was acting 
alongside the model variables predicting where in the UK BTB was diagnosed. Johnston et al., (2011) 
found that there were reduced diagnoses of BTB in areas with clay soils. Such areas are known to be 
the most appropriate habitats for G. truncatula and hence where most F. hepatica infections are 
found in livestock (Wright and Swire, 1984, Ollerenshaw, 1970). Environmental variables in models 
by Wint et al., (2002) and soil type data in models by Johnston et al., (2011) are potentially indirect 
measures of the distribution of F. hepatica, hence F. hepatica exposure is a potentially important 
parameter to consider when modelling BTB. 
Further to this, F. hepatica is known to induce an anti-inflammatory, Th2 immune state in its host; 
pro-inflammatory, Th1 cytokine responses are suppressed, increasing susceptibility to intra-cellular 
pathogens normally controlled by pro-inflammatory responses, such as Bordetella pertussis and 
Salmonella Dublin (Brady et al., 1999, Aitken et al., 1979).   In cattle experimentally co-infected with 
F. hepatica and the attenuated M. bovis BCG, the SICCT test and PPD specific IFN-γ responses were 
negative in 7/9 and 8/9 animals respectively whereas 4/5 cattle infected with BCG alone were 
positive by both SICCT and the IFN-γ tests (Flynn et al., 2007b). This trend was true irrespective of 
whether BCG was given before or after F. hepatica.  These observations led us to investigate 
whether the spatial distribution of F. hepatica exposure in cattle is associated with the detection of 
BTB in the field, in the UK. 
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3.3 Material and Methods 
3.3.1 Fasciola hepatica data 
To determine the prevalence of exposure to F. hepatica, bulk milk samples were obtained from 3130 
dairy farms in England and Wales (McCann et al., 2010b) and tested using an antibody detection 
ELISA (Salimi-Bejestani et al., 2005a).  The test result was expressed as the Percent Positivity (PP 
value) which is the ratio of the optical density reading for the test sample and the optical density 
reading for a positive control sample. A cut off PP value of 27 was used to define a positive herd; at 
this cut off the diagnostic sensitivity of the test is 96% (95% Confidence Intervals = 89-100%) and the 
diagnostic specificity is 80% (95% Confidence Interval = 66-94%) (Salimi-Bejestani et al., 2005a).   
Samples were obtained from three major milk testing companies in England and Wales between 
November 2006 and January 2007.  Farms were mapped and located within Nomenclature of Units 
for Territorial Statistics (NUTS) 2 regions as described by Jenkins et al., (2007). 
3.3.2 Bovine tuberculosis Data  
BTB data for 3026 of the 3130 farms were obtained from the UK Department for Environment, Food 
and Rural Affairs (DEFRA) VETNET database. Incoming data contained records for farms indicating 
when letters were posted to each premises, when restrictions were automatically placed and other 
such information. A data cleaning process was undertaken to ensure only records pertaining to 
actual livestock tests were analysed.   
Two sources of uncertainty are acknowledged in the BTB data. First, SICCT test sensitivity and 
specificity are imperfect, leading to false positive and false negative results. Positive skin test results 
are normally confirmed if typical M. bovis lesions are found at post mortem examination (PME) or if 
positive culture for M. bovis is obtained. Due to low sensitivity of laboratory culture and the 
frequent absence of visible lesions, the number of animals reacting to the skin test was used to 
denote farms with BTB breakdowns, rather than the number of confirmed cases of BTB. Second, BTB 
testing occurs at different frequencies according to parish prevalence of BTB. All BTB skin tests were 
performed by Local Veterinary Investigators (LVIs). BTB testing intervals range from every 1 to every 
4 years routinely, but are also conducted when necessary for pre-movement testing, providing the 
farm has not been tested in the last 60 days; testing is repeated 60 days later if a reactor animal is 
detected. Once a herd is free from reactors it must test negative to two subsequent whole herd 
tests, 60 days apart, to be considered ‘Officially TB free’. We analysed the cumulative incidence of 
BTB in the 3026 farms from 1 January 2004 to 31 December 2007; this 4 year period was chosen to 
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(i) ensure that all farms had been tested for BTB at least once and (ii) it includes the period when the 
same farms were tested for F. hepatica.  
Herds with a BTB breakdown, described as one or more positive reactor animals on BTB skin test 
within the period 01.01.2004 – 31.12.2007, were assigned a ‘1’, all others were assigned a ‘0’. 
3.3.3 Smoothing of F. hepatica PP and BTB data 
Smoothing of both F. hepatica exposure data and BTB detection was performed by Prof Peter 
Diggle, CHICAS, Lancaster University and University of Liverpool.  
Smoothing is a statistical process which aims to capture important patterns in data while reducing 
noise.   Model-based geostatistics (Diggle and Ribeiro, 2006) were used to smooth the two sets of 
disease data.  First, the 3026 farms were randomly allocated into two sets, 1984 to be used for 
model development (designated as analysis locations), whilst the remaining 1042 (hold-out 
locations) were reserved for model validation.  The underlying statistical model is that Yi = S(xi) + Zi : 
i = 1,..., n;  where Yi is the observed value of  a response variable at location xi, S(x) is an unobserved 
spatially varying surface that is modelled as the realisation of a spatial stochastic process, and Zi is an 
independent random perturbation with variance τ 2 that accounts for sampling variation and/or 
micro-scale spatial variation in the immediate vicinity of xi (“immediate" meaning, roughly, less than 
the smallest distance between any two data-locations). The properties of the stochastic process S(·) 
are encapsulated in its mean, its variance, σ2 and the covariance, σ2ρ(µ/φ)between values of S(x) at a 
pair of locations a distance µ apart, where φ is a parameter representing the rate at which the 
spatial correlation decays with increasing distance.  For F. hepatica we used as the response variable 
square-root transformed PP, whilst for BTB we used the log-odds of prevalence.  
The theoretical variogram of Y is the function V(µ) = τ 2 + σ2(1- ρ(µ/φ)). The parametric model  ρ(µ/φ) 
= exp(-µ/φ) was specified by inspecting the sample variogram of the data, the model parameters, µ, 
σ2, φ and τ 2 were estimated by the method of maximum likelihood, and the fitted model was used to 
compute the minimum mean square error predictor of S(x) at  each of the 1984 data-locations, at 
each of the 1042 hold-out locations and on a regular grid spanning England and Wales at 5 x 5 km 
resolution so as to generate a national map of the predicted spatial variation in S(x). 
The analysis was conducted using the R open-source software environment (www.r-project.org). 
3.3.4 Covariate data 
Covariate data were obtained for published descriptions of explanatory variables for BTB (Gilbert et 
al., 2005), or close proxies of them. Considering published explanatory variables, four are 
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environmental (mean temperature; temperature variance, TVar; normalised difference vegetation 
index, NDVI; vapour pressure deficit, VPD) and three are farm-level characteristics (herd size; 
number of movements of cattle from infected areas; distance to the nearest farm with confirmed 
BTB). 
We derived environmental variables from both meteorological and satellite-derived data. 
Meteorological variables, including maximum and minimum monthly temperatures, and Vapour 
Pressure (VP) were obtained for the period 2001-2005, from the United Kingdom’s Met Office as 
raster maps with a 5 x 5 km resolution. For each variable, data for each farm location were extracted 
from the raster layer using ArcGIS (ArcMap version 9.3, ESRI, USA). In brief, the raster layer was 
fitted to the base map containing point data on farm location, using the Georeferencing tool bar. 
The raster layer was then stretched to fit the underlying base map closely in approximately 50 
positions around the coastline of the base map. The transformation option was highlighted from the 
georeferencing menu, and a 1st order transformation was decided as most acceptable.  The Root 
Mean Square (RMS) of the transformation should be less than or equal to the pixel size of the data 
set when checked. Point data pertaining to each test was added to the base map and values of the 
overlying raster layer were extracted to the attributes table for each newly created layer, contained 
in a ‘variable point’ column which contained the newly extracted raster data as point data. Microsoft 
Access 2007 was then used to assimilate a table with each farm location and each raster layer value 
for that farm. The average temperature for each farm was then calculated from the maximum and 
minimum temperatures extracted. This method produces smoother values with fewer high outliers. 
Vapour Pressure Deficit (VPD) briefly, is a measure of lack of moisture equilibrium between an object 
and the atmosphere. The higher the VPD, the more rapid the rate of desiccation (Hay and Lennon, 
1999). VPD was calculated as: 
Briefly, VPD (mb) = SVP – VP 
Where: SVP = saturation vapour deficit (mb), VP = vapour pressure (mb) and  
Log10(SVP) = 9.24349 – (2305/T) – (500/T
2) – (100000/T3) 
Where: T = mean monthly temperature, in kelvin (K).  
MODerate-resolution Imaging Spectroradiometer (MODIS) imagery data for Normalised Difference 
Vegetation Index (NDVI) and Land Surface Temperature were obtained from the NASA Terra satellite 
(Scharlemann et al., 2008). 
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NDVI was obtained for each farm location. Bidirectional Reflectance Distribution Function (BRDF) 
adjusted reflectance was initially recorded and from this, NDVI could be extracted. NDVI (Jenkins et 
al., 2007), is a measure of vegetation greenness.  
The temperature variance (TVar) was calculated using the variance in temperature of all months and 
years (Jan 2001 – Dec 2005 inclusive). TVar indicates the magnitude of the seasonality, i.e. larger 
values indicate larger differences between winters and summer extremes.   
Other covariates were derived as follows.  Herd size was obtained from the VETNET database 
managed by the Veterinary Laboratories Agency, Weybridge.  We used proxies of the two remaining 
variables.  Instead of movements onto the farm from infected areas only (Gilbert et al., 2005), we 
used the total number of movements of cattle (from any area) on to and off each farm during the 4 
year period; thereby making the assumption that more cattle movements per se may indicate an 
increased risk of the acquisition of BTB infected stock. Farm-level animal movement data for 2004-
2007 were obtained from DEFRA (Rapid Analysis and Detection of Animal-related Risk; RADAR). 
Finally, instead of recording the distance to the nearest farm with BTB, we obtained the BTB status 
of the nearest neighbour, from our analysis farms, using the Hawth’s Analysis Tools extension 
(version 3.27, www.spatialecology.com/htools/download.php) in ArcMap. 
Prior to analysis, data for herd size and movements on and off premises were square root 
transformed to normalise their distributions 
3.3.5 Analysis 
For analysis, a BTB positive farm was defined as a premises having at least one animal react 
positively to the BTB SICCT test in the 4-year period. The association between BTB and the 
explanatory variables was explored using binary logistic regression analysis (Minitab 16). Significance 
was determined at the 5% level.  
Twenty-five variables (Table 3.1) were initially available and tested in the logistic regression model. 
Variables were removed individually by backward elimination, beginning with the variable with the 
least significant p-value. This approach allowed any changes towards significance to be monitored 
with every variable removed. The final model contained only variables that were statistically 
significant (p < 0.05) and where the confidence limits around the adjusted odds ratio did not include 
one. Stepwise regression and forward regression models produced the same final model. 
Initially, 3026 farms were included in the F. hepatica ELISA dataset. Four pairs of farms had different 
county-parish-holding (CPH) numbers but shared the same co-ordinates, so were removed. Data was 
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missing from 224 farms due to incomplete coverage of raster layers. This left a total sample size of 
2794 farms for regression analysis. These were randomly divided into two sets: 1821 analysis farms, 
for model development, and 973 hold-out farms, for model validation.  
3.3.6 Testing the model at smaller spatial scales 
The data set was then split into England-only and Wales-only farms, and the multivariable logistic 
regression model run again to test the effect of smoothed square-root-transformed F. hepatica PP 
value on the odds of detection of BTB (see Tables 3.6 and 3.7). 
3.3.7 Cluster analysis  
Cluster analysis of residuals (defined as Actual BTB outcome minus Modelled BTB outcome) was 
done using SaTScan (version 8.0.1, http://www.satscan.org/, Boston, USA) and GeoDa (version 0.9.5-
i, http://geodacenter.asu.edu/, GeoDa Center for Geospatial Analysis and Computation, Arizona 
State University, USA) to look for local point-data clustering on a farm-level and global clustering on 
a county-level, respectively.  
3.3.7.1 SaTScan 
SaTScan software places circles of continuously varying radii over the spatial study area – in this case 
England and Wales. A discrete poisson model was formulated to look for clustering of farms with 
each of four disease statuses – F. hepatica positive BTB positive, F. hepatica positive BTB negative, F. 
hepatica negative BTB positive, F. hepatica negative BTB negative.  A time variable was created and 
set to the same date for each record in the results table, thereby nullifying it. A population variable 
was created for each farm and set to ‘1’ to signify each farm (the level of data available) as one 
premises. Circles were chosen as these were directly transferable to ArcGIS for visualisation and 
mapping. Elliptics could not be directly transferred to ArcGIS for mapping and results for these 
shapes were not found to differ statistically compared with circles, hence were not used.  
Both high circles with an upper limit for circle radius of 50% (representing areas with a higher 
number than expected of farms with a particular disease status) and low circles (representing areas 
with lower than expected numbers of farms with a particular disease) of variable radii were chosen 
as SaTScan will check for clusters of large and small sizes without pre-selection bias (Pfeiffer et al., 
2008). A discrete poisson model was formulated to look for clustering of farms with each of four 
disease statuses: F. hepatica positive, BTB positive; F. hepatica positive, BTB negative; F. hepatica 
negative, BTB positive; F. hepatica negative, BTB negative. The simulation was repeated 999 times to 
test for cluster significance.  
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3.3.7.2 GeoDa 
GeoDa was used to assess the clustering of aggregated residual data recorded in chloropleth maps 
produced in ArcGIS. Due to the relatively high rate of false positive clusters found in SaTScan, this 
technique was used as an adjunct to assessing point data clustering. The Moran’s I indicates the 
degree of autocorrelation present (Table 3.4). The residuals from the multivariable logistic 
regression model were arbitrarily classified into five groups, of which group 3 (-0.2 to 0.2) contains 
those residuals closest to the desired zero.  
GeoDa (version 0.9.5-i, www.geodacenter.asu.edu/software/downloads , Arizona State University, 
USA) assesses the clustering of aggregated data based upon chloropleth maps produced in ArcGIS 
9.3. Due to the relatively high rate of false positive clusters generally found in SaTScan 8.0, this 
technique is a recommended adjunct to assessing point data clustering. This program uses a method 
of global cluster analysis to assess whether clustering is present throughout the study region. The 
location of the cluster is not given, as opposed to SaTScan where co-ordinates and circle radius are 
given.  
‘Clustering’ is the term used to describe the spatial aggregation of disease events (Pfeiffer et al., 
2008). Wakefield et al., (2000) further define the term as the presence of ‘residual spatial variation 
in risk after known influences have been accounted for’.  Autocorrelation statistics, produced by this 
analysis, for aggregated data provide an estimate of the degree of spatial similarity observed among 
neighbouring values of an attribute over a study region. The Moran’s I is used here to indicate the 
degree of autocorrelation present.  Spatial weights are created, giving counties closer in space 
higher weights than those further apart. Neighbouring regions were based upon ‘Rook’ and ‘Queen’ 
adjacency patterns, giving four or eight nearest neighbours values respectively. Both Rook and 
Queen contiguities were assessed and found to be equal each time.  
A comparison between the entire dataset and one of the disease status classes is then made using 
the generated weights matrices, to produce a Morans I statistic for each.  
 
3.3.8 Model-derived predicted presence/absence of BTB.  
Our multivariate logistic regression model yielded a probability of BTB being present on each 
analysis farm, based on the model equation and a farm’s values for the covariates. Considering the 
full model including the seven covariates and smoothed PP value, we used Receiver Operating 
Characteristic (ROC) Curve analysis (a plot of sensitivity versus 1 minus specificity for all thresholds) 
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to determine which threshold probability optimised the sensitivity and specificity of our model. This 
threshold probability was 0.31 (0 - 0.31, BTB assumed absent; 0.31 – 1, BTB assumed present).  At 
this threshold, our model has a sensitivity of 73.8% and specificity of 71.1%. We then derived a 
second set of fitted probabilities, but this time with the PP value for all farms set to a value of 27 
(Table 3.3), the threshold PP value for positive detection of F. hepatica (Salimi-Bejestani et al., 
2005a).  On the basis of these probabilities, the farms were reallocated to the statuses of BTB 
present or absent, using the same threshold probability of 0.31. Running the hold-out data (n=973) 
in the same model with ROC analysis confirmed these results.  
3.3.9 Hold Out Sample 
A hold-out sample (n=973) was tested to validate the final model generated using the analysis 
sample (n=1821). When this hold-out data was run, the residuals were calculated and SaTScan and 
GeoDa systems run. SaTScan revealed no point-data level clustering. GeoDa cluster analysis revealed 
results shown in Table 3.5. Residuals were arbitrarily placed into 5 residual classes for GeoDa 
analysis. 
3.3.10 Estimation of Missing BTB-infected herds 
The difference between the two model sets (F. hepatica exposure as measured on farms cf. F. 
hepatica exposure set to a 27PP) was compared to produce a theoretical under-ascertainment value 
for England and Wales in December 2006. 
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3.4 Results 
Table 3.1: Complete list of variables initially available for analysis 
Variable Definition Source 
btbID 
PP value 
sqrtPP 
smsqPP 
btbposneg 
Total Reactors 
Total Confirmed 
 
SqrtHerd 
NUTS2 
NUTS1 
AHOID 
PCArea 
NDVI 
EVI 
SqrtMO 
Sqrt(On+1) 
 
MaxT 
MinT 
RainyDays 
RH 
VP 
MeanT 
 
VPD 
TVar 
EngWales 
Identification number for each premises 
Anti-F. hepatica antibody ELISA percentage positivity value 
Square-root transformation of PP value 
Smoothed extracted value of sqrtPP from map 
Whether a farm has tested positive for a BTB test during 2004-07 
The total number of reactor animals found between 2004-07 
The total number of animals confirmed as BTB positive on PME or 
culture 2004-07 
Square-root transformation of the herd size 
The NUTS2 classification of the premises 
The NUTS1 classification of the premises 
The Animal Health Office classification of the premises 
The postcode area of the premises 
Normalised Difference Vegetation Index 
Enhanced Vegetation Index 
Square-root transformation of cattle movements off the premises 
Square-root transformation of one plus cattle movements onto the 
premises 
C) 
C) 
The mean number of rainy days (rainfall >1mm) per year 
Mean relative humidity on the farm  
Mean vapour pressure on the farm 
The mean temperature on the farm calculated as a mean of 
maximum and minimum 
Vapour Pressure Deficit 
Temperature variance, calculated from MODIS fourier curves 
Location of a farm – England or Wales 
Assigned 
C McCann 
Calculated 
Calculated 
VETNET 
VETNET 
VETNET 
 
VETNET 
VETNET 
VETNET 
VETNET 
VETNET 
MODIS 
MODIS 
RADAR 
RADAR 
 
Met Office 
Met Office 
Met Office 
Met Office 
Met Office 
Calculated 
 
Calculated 
Calculated 
Assigned 
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Figure 3.1: Maps showing (a) the 
distribution of sample dairy herds 
classified as BTB positive (classified as 0 
or 1 according to breakdown in OTF 
status no or yes) and (b) the distribution 
of sample dairy farms classified by F. 
hepatica exposure of the milking herd, 
in England and Wales during the period 
2004-2007. 
 
a        b 
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Table 3.2. Multivariable logistic regression model including F. hepatica exposure as a variable. 
Predictor  Coefficient  SE  P  OR  L 95% CI U 95% CI  
Constant  -33.561 3.861 <0.001    
SmSqrtPP  -0.486 0.046 <0.001 0.61 0.56 0.67 
NNSmBTB 0.467 0.223 0.036 1.59 1.03 2.47 
SqrtHerd 0.163 0.022 <0.001 1.18 1.13 1.23 
NDVI  0.015 0.002 <0.001 1.02 1.01 1.02 
Sqrt MO  -0.089 0.017 <0.001 0.91 0.88 0.95 
MeanT  1.196 0.154 <0.001 3.31 2.45 4.47 
VPD -2.344 0.352 <0.001 0.10 0.05 0.19 
TVar 0.071 0.036 0.048 1.07 1.00 1.15 
Log-likelihood = -953.26 
SmSqrtPP, smoothed square root of F. hepatica percent positive ELISA reading; NNSmBTB, nearest 
neighbour’s smoothed BTB probability; SqrtHerd, square root of herd size; NDVI, normalised 
difference vegetation index, SqrtMO, square root of movements off farm; MeanT, mean 
temperature (°C); VPD, vapour pressure deficit; TVar, temperature variance; OR, odds ratio; L/U 95% 
CI, lower and upper 95% confidence intervals of OR. 
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Table 3.3: Multivariate logistic regression model excluding F. hepatica exposure. 
Predictor  Coefficient  SE  P  OR  L 95% CI U 95% CI  
Constant  -30.045 3.577 <0.001    
NNSmBTB 1.020 0.213 <0.001 2.77 1.83 4.21 
SqrtHerd 0.182 0.021 <0.001 1.20 1.15 1.25 
NDVI  0.009 0.002 <0.001 1.01 1.01 1.01 
Sqrt MO  -0.090 0.016 <0.001 0.91 0.89 0.94 
MeanT  1.350 0.147 <0.001 3.86 2.90 5.14 
VPD -2.443 0.335 <0.001 0.09 0.05 0.17 
TVar 0.158 0.034 <0.001 1.17 1.10 1.25 
Log-likelihood = -1016.374 
NNSmBTB, nearest neighbour’s smoothed BTB probability; SqrtHerd, square root of herd size; NDVI, 
normalised difference vegetation index, SqrtMO, square root of movements off farm; MeanT, mean 
temperature (°C); VPD, vapour pressure deficit; TVar, temperature variance; OR, odds ratio; L/U 95% 
CI, lower and upper 95% confidence intervals of OR. 
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Table 3.4: GeoDa cluster analysis for the residuals from the final model including F. hepatica 
exposure. 
Residual Class Morans I P 
1 0.5222 0.001 
2 -0.0653 0.344* 
3 0.2159 0.015 
4 0.3423 0.001 
5 -0.0083 0.678* 
*Indicates non-significance (p>0.05) 
Where class 1 = residuals -1.0 to -0.6, class 2 = -0.6 to -0.2, class 3 = -0.2 to 0.2, class 4 = 0.2 to 0.6 
and class 5 = 0.6 to 1.0. 
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Figure 3.2: (a) Smoothed probability of a dairy farm having been detected as BTB-positive in 2004-
2007 (b) Smoothed square root of the percent positive (PP) value from anti-Fasciola hepatica 
antibody ELISA in winter 2006. N = 2724 dairy farms in both figures. Produced by Prof P Diggle and 
published in (Claridge et al., 2012). 
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Table 3.5: Hold-out sample GeoDa results for county-level clustering of residuals 
Residual Class Residual Range Morans I P 
1 -1.0 to -0.6 -0.0762 *0.331 
2 -0.6 to -0.2 0.1614 0.039 
3 -0.2 to 0.2 0.6590 0.001 
4 0.2 to 0.6 0.2256 0.019 
5 0.6 to 1.0 0.3293 0.002 
*Indicates non-significance 
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Table 3.6: Multivariate logistic regression model including F. hepatica exposure, using England-only 
data 
Predictor  Coefficient  SE  P  OR  L 95% CI U 95% CI  
Constant  -39.814 3.801 <0.001    
SmsqPP -0.383 0.068 <0.001 0.68 0.60 0.78 
NNSmBTB 1.915    0.266 <0.001 6.79 4.03 11.43 
SqrtHerd 0.207 0.031 <0.001 1.23 1.16 1.31 
NDVI  0.015 0.002 <0.001 1.02 1.01 1.02 
Sqrt MO  -0.103 0.024 <0.001 0.90 0.86 0.95 
MeanT  1.385 0.218 <0.001 4.00 2.61 6.12 
VPD -2.391 0.493 <0.001 0.09 0.03 0.24 
TVar 0.237 0.054 <0.001 1.27 1.14 1.41 
Log-likelihood = -502.121 
SmSqrtPP, smoothed square root of F. hepatica percent positive ELISA reading; NNSmBTB, nearest 
neighbour’s smoothed BTB probability; SqrtHerd, square root of herd size; NDVI, normalised 
difference vegetation index, SqrtMO, square root of movements off farm; MeanT, mean 
temperature (°C); VPD, vapour pressure deficit; TVar, temperature variance; OR, odds ratio; L/U 95% 
CI, lower and upper 95% confidence intervals of OR. 
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Table 3.7: Multivariate logistic regression model including F. hepatica exposure, using Wales-only 
data 
Predictor  Coefficient  SE  P  OR  L 95% CI U 95% CI  
Constant  -21.876     8.500 0.010    
SmsqPP -0.486445   0.096 <0.001 0.61 0.51 0.74 
NNSmBTB -0.012  0.320 0.971 0.99 0.53 1.85 
SqrtHerd 0.130 0.037 0.001 1.14 1.06 1.23 
NDVI  0.011 0.004 0.012 1.01 1.00 1.02 
Sqrt MO  -0.092 0.030 0.002 0.91 0.86 0.97 
MeanT  0.709 0.309 0.022 2.03 1.11 3.72 
VPD -2.134 0.681 0.002 0.12 0.03 0.45 
TVar 0.210 0.093 0.024 1.23 1.03 1.48 
Log-likelihood = -314.254 
SmSqrtPP, smoothed square root of F. hepatica percent positive ELISA reading; NNSmBTB, nearest 
neighbour’s smoothed BTB probability; SqrtHerd, square root of herd size; NDVI, normalised 
difference vegetation index, SqrtMO, square root of movements off farm; MeanT, mean 
temperature (°C); VPD, vapour pressure deficit; TVar, temperature variance; OR, odds ratio; L/U 95% 
CI, lower and upper 95% confidence intervals of OR. 
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Figure 3.3: A 5km jittered map to show the differences in BTB distribution if farms are classified as F. 
hepatica negative compared with the F. hepatica exposure as measured and smoothed 
 
 
This map shows the difference in the probability of each test farm being classified as BTB negative or 
positive (range 0 to 1) according to the model, when the presence of F. hepatica in each herd was as 
measured (smsqPP) and when it was assumed to be negative (square root (PP=27) = 5.196152). 
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3.4 Results 
3.4.1 Multivariate Logistic Regression 
The prevalence of BTB during the period 2004-2007 was highest in the south and west of England 
and Wales (Figure 3.1a and 3.2a), a finding in agreement with other published studies using both 
dairy and beef cattle data (Wint et al., 2002, Gilbert et al., 2005). Three large clusters are apparent: 
northern Cornwall and Devon; the south Midlands; and the southwest of Wales. A fourth, smaller 
and less intense cluster is visible north of the Midlands, centred on Derbyshire. 
Figure 3.1b shows the intensity of the PP obtained from each farm in autumn or winter 2006, with 
highest values found in the northwest of England. The smoothed F. hepatica PP value was greatest in 
the west of Britain (Figure 3.2b).  Four major clusters are the northwest of England (Cumbria), an 
adjoining cluster stretching south through Lancashire to the north Midlands; the northwest of Wales 
and a small part of the south west of Wales. Scattered smaller locations throughout the southwest 
of England, particularly Cornwall and Devon, have moderate F. hepatica PP values. 
Comparison of Figures 3.1a and 3.1b and Figures 3.2a and 3.2b, show that there is almost no overlap 
in the west of England and Wales in the distributions of the intense clusters of BTB prevalence and F. 
hepatica PP value.  In the northwest of England and the northwest of Wales, F. hepatica PP values 
are high, indicating a high F. hepatica prevalence, whereas BTB is of very low prevalence.  In south 
Wales, the cluster of high F. hepatica PP values lies approximately between two clusters of high BTB 
prevalence (seen most clearly in Figure 3.2a and 3.2b). In the Midlands, a large area of high BTB 
prevalence is of low F. hepatica PP value.  In Cornwall and Devon, and in the north Midlands, both 
BTB prevalence and F. hepatica PP value are at moderate levels.  By contrast to the situation in the 
west of England and Wales, both BTB prevalence and F. hepatica prevalences are low in most of the 
east of England. 
Multivariable logistic regression was performed using variables or proxies of variables found to be 
significant in other publications (Gilbert et al., 2005, Wint et al., 2002; variables described in Table 
3.1). This showed that the risk of BTB being present on a farm increases with higher average 
temperature and more variable temperature and increases slightly with the normalised difference 
vegetation index (NDVI), but decreases with higher vapour pressure deficit (VPD).  The risk increases 
when the nearest neighbouring farm has a higher probability of being BTB-positive and for larger 
herd sizes, and the risk decreases with larger numbers of movements off the farm. The risk of a farm 
having a BTB breakdown decreases significantly with increased F. hepatica exposure (Table 3.2). 
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The model was then rerun excluding the F. hepatica PP variable (Table 3.3). The difference in 
deviance between the two models was calculated to be 129.6 (p<0.001). The deviance is a measure 
of how badly a model fits the observed data, thus a high deviance suggests a poor fit and is 
effectively a chi-squared test value on 1 degree of freedom.  Hence, the model including F. hepatica 
exposure fits the data significantly better. 
The final model including F. hepatica exposure was then run for England-only data and Wales-only 
data to assess whether the model works on smaller spatial areas (Tables 3.6 and 3.7). All variables, 
including F. hepatica exposure were significant for the England only subset. F. hepatica exposure was 
also a highly significant variable for predicting the probability of BTB on welsh farms, although the 
nearest neighbouring farm’s BTB status was not. This may be because the majority of welsh farms 
for which data was held, were not evenly distributed across the country, being mainly from south 
west Wales.  
3.4.2 Cluster Analysis 
GeoDa assumes the population at risk is evenly distributed, which we know it is not. There are 
higher numbers of dairy farms on the west of the country compared with the east. However, the 
sampling distribution does mirror the dairy herd population distribution for England and Wales.  
There is also an assumption that correlation and covariance of the diseases are the same in all 
directions (i.e. the data is isotropic), which we know from point data maps and chloropleth mapping, 
is not the case. There is a higher herd-level prevalence of BTB in the South West of England and 
parts of South Wales. 
GeoDa analysis shows that there is mild to moderate clustering present on a county-basis in 3 of the 
5 residual classes (Table 3.4). Class 1 is the most negative residuals, implying the model is over-
representing BTB probability in these areas. Class 3 contains the residuals closest to zero, hence 
representing the smallest deviations from the observed disease status. Class 4 represents 
intermediate residuals where the model predicts slightly less BTB than is seen. Given the variable 
proportions of farms tested per county, this level of clustering is deemed acceptable. 
Cluster analysis of point data residuals using SaTScan revealed no significant clustering. 
3.4.3 Hold Out Analysis  
The full multivariate logistic regression model was run using the hold-out subset of data, and cluster 
analysis of the residuals was analysed (Table 3.5). A Morans I of 0.4-0.5 is considered to imply mild 
to moderate spatial clustering, and is to be expected given the type of data. Residual Class 3 (Range: 
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-0.2 to 0.2) has a Morans I of 0.6590 indicating moderate clustering of farms geographically where 
the model performs best (i.e. the predicted outcome is most similar to the observed outcome). 
Maps of this produced in GeoDa indicate that the model is performing best in the Welsh Borders, 
Somerset and the West Midlands. 
Cluster analysis of point data residuals using SaTScan revealed no significant clustering as before. 
3.4.4 Calculation of missing BTB-infected herds 
The final model was run to generate a probability of each farm having BTB as per the model in Table 
3.2. The square-root transformed F. hepatica PP (smsqPP) was then set to the square root of 27 
(5.196) for every farm and the probability of each farm having BTB with negligible F. hepatica in the 
milking herd calculated. The difference in these two values was then expressed as an estimate of 
underascertainment of BTB due to the presence of F. hepatica exposure. The final 
underascertainment value was estimated as 38% of BTB-infected farms in England and Wales, and a 
map of difference between modelled BTB with F. hepatica exposure as measured and F. hepatica 
exposure set to PP=27, was plotted (Figure 3.3). 
 
3.5 Discussion 
One hypothesis for this strong negative spatial association between BTB and F. hepatica is that the 
two infections do not directly interact, but that a mutually exclusive set of environmental conditions 
favour BTB (Gilbert et al., 2005, Wint et al., 2002) and F. hepatica (McCann et al., 2010a)  
respectively.  To test this hypothesis, we developed a model for BTB, based on a previously 
published model that successfully predicted BTB presence or absence using a combination of 
environmental and farm level variables, including animal movements between farms (Wint et al., 
2002, Gilbert et al., 2005).  If BTB presence or absence is not affected by F. hepatica, then smoothed 
square-root-transformed F. hepatica PP value would not explain any additional variance in a 
statistical model for BTB driven by environmental, farm and movement variables.  When we add 
smoothed square-root-transformed F. hepatica PP value to the model, all of the aforementioned 
variables remain significant (with negligible change in coefficients and odds ratios) and  smoothed 
square-root-transformed F. hepatica PP value has an additional, significant, negative effect on the 
odds of BTB being present on a farm (OR = 0.61; 95% CI = 0.56-0.67, P < 0.001; Table 3.2). The model 
which includes smoothed square-root-transformed F. hepatica PP value fits the data significantly 
better than the model without that parameter.  The model excluding F. hepatica exposure is shown 
in Table 3.3. The significant negative association between the probability of BTB on a farm and F. 
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hepatica is also found using a smaller geographical areas (Tables 3.6 and 3.7). We therefore 
conclude that F. hepatica exposure is an additional environmental risk factor for BTB and is 
negatively associated with the odds of BTB being diagnosed on a farm.   
 
In addition, the four environmental variables found to be most significant in this paper and in 
models by Gilbert et al., (2005) are variables that accurately predict both F. hepatica exposure 
(McCann et al., 2010a) and BTB (Gilbert et al., 2005).  Some of these variables would be expected to 
become insignificant with introduction of F. hepatica exposure if they were co-dependent. 
 
The negative association between the presence of F. hepatica and detection of BTB could be 
explained by F. hepatica impairing the SICCT test used to diagnose BTB since there is evidence to 
suggest that F. hepatica infections reduced bystander IFN-γ responses and compromise SICCT tests 
in calves infected with BCG, an avirulent strain of BTB (Flynn et al., 2007b).   
Other co-infections have been shown to affect the sensitivity and specificity of the SICCT test. 
Infection of cattle with Mycobacterium avium subsp paratuberculosis (MAP; the causative bacterium 
of Johnes disease) has been reported to increase the number of false positive BTB results seen when 
the SICCT test is applied (Barry et al., 2011). These authors showed that MAP-infected cattle had a 
slow initial response to the SICCT test leading to the potential for animals to test false negative for 
BTB. The SICCT response was raised for longer once a palpable skin reaction occurred, hence 
meaning these animals potentially tested positive falsely for BTB. In either case, the relatively poor 
sensitivity and specificity of the SICCT test is further reduced with this co-infection.  
A study to test the effect of experimental co-infection in calves showed that SICCT test responses of 
co-infected cattle were significantly less than animals infected with M. bovis alone (p=0.011); and 
were significantly less at week 21 post infection compared to week 10 post infection (p=0.0013) 
(Claridge et al., 2012). In this study, six calves were experimentally infected with 150 metacercariae 
of F. hepatica, four weeks later they were challenged with a target dose of 5 x 102 CFU of a virulent 
strain of M. bovis; six calves were infected with M. bovis alone.  SICCT tests were conducted 10 and 
21 weeks after M. bovis infection.  The data were analysed using a linear mixed effects model fitted 
by maximum likelihood with week and co-infection as fixed effects and cow as a random effect.    
The effect of co-infection did not change between 10 and 21 weeks post infection (p=0.235).  These 
results showed that cattle co-infected with F. hepatica reacted less strongly to the SICCT test than 
those infected with M. bovis alone over a significant period of time.   
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This finding is consistent with findings in humans where helminth infections suppress T cell and IFN-γ 
responses to PPD and the efficacy of BCG vaccination (Babu et al., 2009, Wammes et al., 2010, Elias 
et al., 2001, Elias et al., 2008).  Although the magnitude of the response to the SICCT test in co-
infected calves was significantly less than that in calves infected with M. bovis alone, all six co-
infected animals had responses that would be considered positive under field conditions 
(comparative increase in skin thickness of more than 4mm), nevertheless the mean difference in skin 
thickness was 42% less than in those infected with M. bovis alone.  It was not feasible to replicate 
under experimental conditions the situation in the field where animals are likely to have higher F. 
hepatica burdens and we have not yet explored the interaction between intensity and relative 
timing of each infection and the impact each may have on the SICCT.  But it is plausible that a F. 
hepatica infection has the effect of pushing weak SICCT positives into a negative classification in the 
field where interpretation of the test is not always clear cut.   
An alternative explanation for both our epidemiological analysis and the results from the 
experimental infections is that F. hepatica reduces the susceptibility of cattle to BTB.  In a study in 
which 200 in-contact and 200 cattle classified as BTB-infected by SICCT (i.e. ‘reactors’) were 
investigated in depth, a consistent negative association was described between having antibodies to 
F. hepatica and having confirmed BTB, in both groups (DEFRA, 2005b).  Another study (Flynn et al., 
2009) showed that experimentally co-infected cattle had fewer BTB lesions at slaughter and fewer 
tissue samples that were culture positive for M. bovis although these differences were not shown to 
be significant.  Moreover neither of these studies investigated whether co-infection influenced the 
nature, development or distribution of lesions and bacterial spread, which could also explain these 
results.  Also both the SICCT and the PPD specific IFN-γ response were suppressed in BCG/F. hepatica 
co-infected calves and this trend was true irrespective of whether BCG was given before or after F. 
hepatica (Flynn et al., 2007b) suggesting overall that the most likely interpretation of our findings is 
that a proportion of BTB positive animals are being missed by the SICCT test.   
If, as our data suggest, F. hepatica suppresses the SICCT response of BTB infected cattle, our model 
indicates a substantial degree of under ascertainment of BTB using the SICCT test.  Undetected cases 
have the potential to spread infection to other cattle within the herd, to wildlife within the area and, 
if moved, to herds in different parts of the country.  F. hepatica is a ubiquitous parasite, whose 
prevalence is predicted to fluctuate considerably in areas of the UK over the next 50 years due to 
changes in climate (Fox et al., 2011).  It is possible that treatment of cattle with flukicidal drugs, prior 
to testing, might increase the detection rate of BTB, leading in the short term to a surge in incidence, 
but, in the longer term, improved control of the disease.  Studies in helminth-infected humans 
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suggest that vaccine responses to BCG are compromised (Elias et al., 2008) .  Extrapolating these 
findings to cattle, infection with F. hepatica may compromise induction of vaccine responses to M. 
bovis, an important consideration in view of the current intention to develop and apply vaccines to 
cattle to help control the BTB epidemic in UK and Ireland.  This is the first wide scale analysis of the 
interaction between F. hepatica and M. bovis and provides direct evidence of a significant negative 
association between the two infections, the most likely explanation for which is the impact of F. 
hepatica on the host’s immune system reducing the sensitivity of the principle diagnostic test used 
for M. bovis.  This finding has significant implications for the UK and Ireland’s BTB eradication 
programmes.  
This work was published as Claridge et al., 2012.  Both the publicity for this paper and the Nature 
Communications paper are provided in Appendices A and C respectively. 
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Chapter 4 
Does exposure to Fasciola hepatica in British dairy cattle affect the diagnosis 
of bovine tuberculosis in these cattle?  
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4.1 Abstract 
In previous chapters of this thesis, we show that BTB prevalence is likely to be higher than currently 
published and that co-infection of British cattle with BTB and the trematode parasite, F. hepatica, 
may be a reason for the poor sensitivity of the BTB skin test in the field. Chapter 4 studies the 
association between F. hepatica exposure, as measured by the anti-F. hepatica antibody ELISA, and 
the skin test BTB diagnosis, on an individual animal level. Milk samples from forty skin test positive 
and forty negative animals, and forty inconclusive animals and forty negatives, were analysed from 
Carmarthenshire, South Wales, an area of Britain identified as having a high prevalence of both 
diseases. Both paired t-tests and McNemar’s test for matched case-control studies showed no 
significant difference between the ELISA results of the inconclusive group compared to the negative 
matched cattle, nor the reactor group with the negative matched cattle. The sample size required 
for 95% confidence was not reached in this study and the resulting powers of the study classes was 
found to be low. Suggestions for this and for future work on this topic are discussed. 
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4.2 Introduction 
BTB, caused by Mycobacterium bovis, is a serious disease of cattle with significant animal welfare, 
public health (de la Rua-Domenech, 2006) and economic consequences (Gordon, 2008). Despite the 
introduction of compulsory testing in the 1950’s, the UK and Republic of Ireland have not eliminated 
BTB from their cattle populations, instead recording an increase in new herd incidents in England 
and Wales and an increase in government expenditure on the eradication programme (DEFRA, 
2010).  There are many possible explanations for this increase in BTB incidence, with climate change 
(Wint et al., 2002), increased animal movement (Carrique-Mas et al., 2008) and co-infections with 
other pathogens (Flynn et al., 2007b) being implicated in what is likely to be a multifactorial story. 
Fasciola hepatica is a trematode parasite primarily affecting ruminant species in the UK. Adult 
parasites occupy the bile ducts and gall bladder of the definitive host, causing clinical disease 
(fasciolosis) in heavily parasitized animals (Urquhart et al., 1996), reduced productivity (Charlier et 
al., 2007) in low to high infestations and immunomodulation of the host immune responses, leading 
to more severe disease manifestations when co-infection with another pathogen is present (Brady et 
al., 1999). F. hepatica is highly prevalent in England and Wales, with 70-80% of dairy herds showing 
evidence of exposure to the pathogen (McCann et al., 2010b). 
An experimental study conducted by Flynn et al., (2007b) clearly demonstrated the 
immunomodulatory powers of F. hepatica in cattle. Co-infection of calves with F. hepatica and M. 
bovis BCG, followed by application of the SICCT test and PPD specific IFN-γ responses, lead to 
negative test responses in  7/9 and 8/9 animals respectively. In the control group, 4/5 cattle infected 
with BCG alone tested positive by both SICCT and the IFN-γ tests (Flynn et al., 2007b). This trend was 
true irrespective of whether BCG was given before or after F. hepatica infection. F. hepatica ESP has 
also been shown to drive alternatively activated macrophages leading to  an anti-inflammatory (Th2) 
response (Donnelly et al., 2005) at the same time as dampening the pro-inflammatory (Th1) 
response needed for a detectable reaction to the SICCT and IFN  tests.  
It has been shown that, on a herd level, F. hepatica exposure is negatively and significantly 
associated with the probability of a BTB breakdown on a farm, and cluster analysis has shown that 
this is not due to the spatial distribution of the two pathogens in England and Wales (Claridge et al., 
2012). The current study will analyse milk samples from individual animals that are SICCT test 
positive or inconclusive, and their matched negative controls taken at the time of BTB SICCT testing 
to determine whether this negative association is true for individual animals as well as at a herd 
level. 
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4.3 Materials and Methods 
4.3.1 Sample collection 
A case-control study was designed, but the number of animals tested was constrained by the 
number of farmers agreeing to allow sampling of their animals at the time of herd BTB testing. On 
each participating farm, when an animal was found to test positive for BTB (Reactor, R) based upon 
the SICCT test standard interpretation, a milk sample was collected from it, and the next animal into 
the holding equipment testing negative (Non-reactor, NR) to the same test was also sampled. Milk 
samples from Inconclusive reactor cattle (IR) and NR animals were collected using the same 
protocol. 
Due to the limited number of farmers agreeing to participate in this study, only 40 samples from the 
R and IR groups plus 80 NR samples i.e. fewer than the required number estimated below. The study 
was conducted in Carmarthenshire with assistance from two veterinary practices. LVIs from each 
practice collected the samples on their routine BTB testing visits. Samples were collected from the 
same udder quarter for each pair, and several case-control pairs were collected from the same farm 
if those herds contained R or IR animals. No other data about the farms was collected. It is not 
known whether these herds were on 60 day herd retests, nor the exact location and parish testing 
frequency of the locality. 
4.3.2 Sample Size Estimation 
Data for the F. hepatica exposure or infection status of BTB SICCT test reactor and non-reactor 
animals was not available. Instead, data from Chapter 3 was used to estimate the sample size 
required for the current study, based upon herd level, rather than individual animal level data. 
An estimate of the sample size required is given in the box below (Thrusfield, 2005). Data about 
individual animals was not available for this calculation, thus a herd-level mean PP value for SICCT 
test positive and negative herds was generated. This herd-level data was not paired and thus the 
calculated does not consider the means to be matched. 
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4.3.3 Sample processing 
Milk was collected into bromopol and samples were centrifuged for 10 minutes at 895 g, and the 
liquid fraction separated into plain serum tubes in a Category 3 Microflow Biological Safety Cabinet 
(Walker Safety Cabinets Ltd, Glossop, UK) and stored at -20oC until testing.  
4.3.4 Anti-Fasciola hepatica antibody ELISA 
An anti-Fasciola hepatica antibody ELISA was conducted on each sample as described by Salimi-
Bejestani et al., (Salimi-Bejestani et al., 2007). In brief, Immunlon-2HB ELISA plates (Thermoscientific, 
New York, USA) were coated with 100 µl/well of 0.5µg/ml Excretory Secretory Proteins (ESP) in 0.1M 
carbonate buffer (pH 9.6). To obtain ESP, adult F. hepatica were incubated at 37°C, in RPMI medium 
for 12 hours. The medium was collected, centrifuged at 10,000g for 30 minutes at 4°C. The 
concentration of the ESP was determined according to Warburg and Christian (Warburg and 
Christiansen, 1941).  
Following overnight incubation of the ELISA plates, they were washed (two quick washes and one 5 
minute wash, then this cycle repeated) with PBS (pH 7.2) containing 0.05% Tween-20 (PBS/Tween) 
and blocked with 200 µl/well of 2% skimmed milk powder (Marvel, Premier Beverages, Stafford, UK) 
in PBS/Tween for 1 hour at 37°C. Individual milk samples were diluted 1:2 with 2% skimmed-milk 
powder in PBS/Tween solution. Plates were washed as previously described and 100 µl of each milk 
sample added to each well and incubated for 1 hour at 37°C. Plates were washed as before, then 
anti-bovine IgG conjugated to horseradish peroxidise (MAST Diagnostics, Bootle, Merseyside) was 
diluted to a 1:80,000 solution with blocking buffer and 100 µl/well incubated for 1 hour at 37°C. 
Plates were washed as before and 100 µl of freshly prepared TMB (3,3’,5,5’-tetramethylbenzidine 
Sample Size Estimation from herd level data 
Mean PP from BTB+ herds = 55.64545 
Mean PP from BTB- herds = 68.06049 
Common standard deviation = 40.48 
Sample Size Estimation = 2 x (σ(μα+μβ)/(x1 – x2))
2 
= 167 pairs 
Where σ = 40.48, μα = 1.96, μβ = 0.84, x1 = 63.06049, x2 = 55.64545 
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and hydrogen peroxide; Uptima) was added to each well. Plates were incubated at room 
temperature for 20 minutes in complete darkness. The colour change was recorded on an automatic 
ELISA reader at 450 nm wavelength. The results were given as a mean optical density (OD) obtained 
from the duplicate samples. The percent positivity was then calculated using the following formula: 
Percent Positive (PP) = (Mean OD of test sample/Mean OD of High Positive Control) x 100  
On each plate, the high positive, mid positive and negative controls were included in quadruplicate. 
A PP value of greater than 20 was considered to be positive (Salimi-Bejestani et al., 2007). 
 
4.3.5 Statistical Analyses 
Data was recorded in an Excel spreadsheet (Microsoft 2007) and analysed in two ways detailed 
below. Firstly, PP values were kept as a continuous variable within each BTB SICCT test category, and 
analysed using a paired t-test for matched data. Both raw PP values and square root transformed PP 
values were analysed (Tables 4.2 and 4.3). 
Secondly, PP values were classed as positive/negative for F. hepatica exposure, as defined by Salimi-
Bejestani et al., (2007), and analysed using a McNemar’s matched chi-square test for case-control 
studies, alongside the SICCT test result for each animal (Tables 4.4 and 4.5).  
Further to the McNemar’s tests, data were then square-root transformed and centred around the 
mean PP of the respective group, in an attempt to compensate for the potential effects of a large 
number of F. hepatica exposure positive cattle found (Table 4.6 and 4.7). All results were generated 
using SPSS (PASW Statistics 17).  
An estimation of the power of each group was made retrospectively. 
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4.4 Results 
There was a wide range of PP values for each category of animal (Table 4.1 and Figure 4.1) with the 
95-97.5% of cattle testing positive for antibody to F. hepatica (PP>20; Salimi-Bejestani et al., 2007).  
 Table 4.1: Descriptive statistics for milk PP values in the four groups 
 R NR IR NR 
% F. hepatica ELISA PP positive 95.0 97.5 95.0 97.5 
Mean PP value 60.3 66.3 71.0 67.0 
SE Mean PP 6.7 11.3 8.0 5.9 
Standard Deviation of PP 42.4 71.4 50.7 37.2 
Minimum PP 2.3 3.2 4.3 5.2 
First Quartile PP 22.2 18.4 37.1 33.7 
Median PP 57.9 46.0 54.8 66.9 
Third Quartile PP 87.6 91.8 98.4 90.5 
Maximum PP 168.3 345.4 226.9 143.0 
Colour of columns indicates matching 
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Figure 4.1: Box plots of anti-Fasciola hepatica ELISA PP values, showing range, mean and quartiles of 
collected paired data 
4321
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Box Plots of the pp ranges generated per group of cattle paired by SICCT test result
Where Group 1 = R, Group 2 = NR, Group 3 = IR, Group 4 = NR; Groups 1 and 2 are paired, Groups 3 
and 4 are paired. 
4.4.1 Paired t-test analyses 
Paired t-tests were applied to untransformed PP values and to square-root transformed PP values 
from both SICCT test comparison groups. The results of the untransformed analysis are shown in 
Table 4.2. Square-root transformation of PP values was done to normalise the data (as used in 
Chapter 3) but there was no significant difference between the four groups (Table 4.3). 
Table 4.2 Results of paired t-tests to test if F. hepatica exposure of R versus NR cattle, and IR versus 
NR cattle. 
Pairing p-value 
R vs NR 0.6068 
IR vs NR 0.5814 
 
p<0.05 indicates significance 
 
 
88 
 
Table 4.3 F. hepatica exposure was square root transformed to normalise it and the paired t-tests 
conducted 
 
Pairing p-value 
R vs NR 0.9547 
IR vs NR 0.8358 
 
p<0.05 indicates significance 
 
4.4.2 McNemar’s test analyses 
In addition to analysing the results using PP as a continuous variable, since the range of PP values 
was high,  the PP value for each animal was converted to a binary infected (1) or non-infected (0) 
score based upon the cut-off of PP>20 being considered positive (Salimi-Bejestani et al., 2007).  
The data was summarised in two 2x2 tables (Tables 4.4a and b). In these 2x2 tables, there are a total 
of 40 pairs of samples allocated according to whether the two individuals in the pair were SICCT test 
positive (or inconclusive reactor) or negative and anti-F. hepatica antibody positive or negative. A 
McNemar’s matched chi-square test was used to analyse the data (Table 4.5). There were no 
significant differences between the matched groups, in the number of F. hepatica exposure positive 
animals. 
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Table 4.4: 2x2 tables showing the distribution of F. hepatica exposure positive and negative animals, 
classified according to BTB test result, showing a) R-NR pairs and b) IR-NR pairs 
 
a) R – NR matched pairs SICCT test negative  
F. hepatica 
exposure 
positive 
F. hepatica 
exposure 
negative 
Total 
SICCT test 
positive 
F. hepatica 
exposure 
positive 
34 0 34 
F. hepatica 
exposure 
negative 
2 4 6 
 Total 36 4 40 
 
b) IR – NR matched pairs SICCT test negative  
F. hepatica 
exposure 
positive 
F. hepatica 
exposure 
negative 
Total 
SICCT test IR F. hepatica 
exposure 
positive 
36 2 38 
F. hepatica 
exposure 
negative 
1 1 2 
 Total 37 3 40 
 
 
Table 4.5: Results of McNemar’s matched chi-square test results for R-NR and IR-NR groups 
Pair McNemar’s test p value 
R-NR 0.494 
IR-NR 1.000 
 
p<0.05 indicates significance 
 
When F. hepatica exposure PP values for cases and controls are square-root transformed and then 
mean-centred, two 2x2 tables were generated (Tables 4.6a and b), and the McNemar’s test was 
applied again (Table 4.7). 
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Table 4.6: 2x2 tables showing the distribution of F. hepatica exposure positive and negative animals 
squared-root transformed and mean centred, classified according to BTB test result, showing a) R-NR 
pairs and b) IR-NR pairs 
 
a) R – NR matched pairs SICCT test negative  
F. hepatica 
exposure 
positive 
F. hepatica 
exposure 
negative 
Total 
SICCT test 
positive 
F. hepatica 
exposure 
positive 
13 8 21 
F. hepatica 
exposure 
negative 
5 14 19 
 Total 18 22 40 
 
b) IR – NR matched pairs SICCT test negative  
F. hepatica 
exposure 
positive 
F. hepatica 
exposure 
negative 
Total 
SICCT test IR F. hepatica 
exposure 
positive 
12 9 21 
F. hepatica 
exposure 
negative 
5 14 19 
 Total 17 23 40 
 
Table 4.7 BTB SICCT test categorised, McNemar’s test results for square-root transformed, mean 
centred PP values 
 
Pair McNemar’s test p value 
R-NR 0.5791 
IR-NR 0.4227 
 
p<0.05 indicates significance 
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4.4.3 Study Power 
With the results generated from this study and using PP value in its untransformed state, the power 
of the studies conducted were estimated (R vs NR or IR vs NR; 
www.statisticalsolutions.net/pss_calc.php) (Table 4.8). For both groups, the power is low indicating 
that any significant differences between R and NR, and IR and NR groups, may not be detectable. 
Table 4.8 Study Power 
Pair Power 
R-NR 0.06 
IR-NR 0.06 
 
Power > 0.8 is deemed appropriate for most studies 
 
4.5 Discussion 
F. hepatica is a pathogen affecting ruminants in the UK, with a herd prevalence of 76% in England 
and Wales (McCann et al., 2010b).  Over the last 15 years, diagnoses of F. hepatica have increased in 
the UK, attributed to increased cattle movements allowing new foci of infection to be created and 
climate changes favouring environmental life stage development and intermediate snail habitats 
(Daniel and Mitchell, 2002, Carrique-Mas et al., 2008, Gilbert et al., 2005, Pritchard et al., 2005, 
Poulin, 2006). 
Research conducted over the last decade has highlighted the effects on the host immune system 
that F. hepatica has, presumably to enhance the survival of the parasite within its host. Newly 
excysted juvenile flukes are known to modulate the innate host immune system by secretion of 
thioperoxiredoxin enzymes in ESP that induce alternative activation of macrophages, polarising the 
immune system towards an anti-inflammatory response that will allow parasite survival (Donnelly et 
al., 2005, Donnelly et al., 2008). The lack of classical activation of macrophages during initial 
infection stages, leaves the host animal more susceptible to pathogens relying on a pro-
inflammatory response for clearance and to prolonged bacterial infections with more severe clinical 
signs (Aitken et al., 1979, Aitken et al., 1981, Brady et al., 1999). The effect of pre-treatment of 
murine macrophages with the ESP enzyme, FheCL1, has been shown to decrease subsequent 
secretion of pro-inflammatory mediators upon stimulation of TLR 3 with the synthetic agonist, 
polyIC, and survival of mice after lipopolysacarride treatment is significantly increased if previous 
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exposure to ESP has occurred, suggesting down-regulation of TLR3 and TLR4 by ESP (Donnelly et al., 
2010a, Donnelly et al., 2008).  
In this paper, the F. hepatica exposure of cattle testing positive and negative, or inconclusive and 
negative to the Single Intra-dermal Comparative Cervical Tuberculin (SICCT) test, that has been 
approved for BTB surveillance and screening in the EU, were compared. There were considerable 
practical difficulties in collecting samples from animals testing positive to the SICCT test and an 
unwillingness amongst farmers to participate in this study at such an emotive time. Hence, the small 
sample size made interpretation of results difficult. In addition, almost all cattle tested were exposed 
to F. hepatica, suggesting that future studies should involve a larger number of farms over a wider 
area of England and Wales with variable levels of infection. The matching of samples could also be 
done differently by a R animal taken from one farm being matched with a NR from a different farm, 
matched on various climatic, husbandry and F. hepatica exposure data.  The statistical power of this 
study was low, hence either an increased number of samples or a change in the study design  should 
be considered in future studies. 
Other factors, which we were unable to measure in this study, should also be considered in any 
future study. For example, the age of cattle were not recorded and the previous BTB history of the 
premises was not known; a significant correlation between the age of the animal and the likelihood 
of it being BTB infected has been documented (de la Rua Domenech et al., 2006). In chapter 5, the 
stage of lactation is significantly correlated with F.  hepatica exposure and this may be due to the 
time lapsed since last dry period when a flukicidal dose is often given. With time since last dry period 
we would expect that, assuming equal risk of exposure to metacercariae, the risk of infection would 
increase with time and season. Type of grazing; zero grazing, housing for winter and diet will all 
impact upon this risk in different ways and were not measured in this study (Urquhart et al., 1996).  
A further consideration is that other infectious diseases may also affect the outcome of the SICCT 
test. Bovine Viral Diarrhoea virus (BVDv) is a common pathogen of cattle that has been shown to 
reduce lymphocyte proliferation in response to PPD-A and PPD-B and the IFNγ assay in BTB infected 
animals co-infected with BVDv. This virus has an immunosuppressive effect on the bovine host 
immune system that could last for over 3 weeks in acute infections (Charleston et al., 2001). Calves 
experimentally infected with BVDv also shed significantly higher amounts of M. bovis indicating the 
potential for silent BTB transmission with this co-infection as well. 
Due to problems with the study design and execution, it was not possible to determine if there was 
any association between diagnosis of BTB and presence of F. hepatica exposure in individual cattle.  
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Thus at the individual animal level, we were unable to demonstrate our previous finding shown at 
the herd level. 
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Chapter 5 
Does exposure to common on-farm diseases affect the 
susceptibility of British dairy cattle to Fasciola hepatica? 
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5.1 Abstract 
The trematode parasite, Fasciola hepatica, has been shown experimentally to modulate its host’s 
immune responses towards an anti-inflammatory response, and this modulation has been shown to 
have dramatic effects on the ability of the host to eliminate other pathogens requiring a pro-
inflammatory response. However, little work has been done to ascertain the association between F. 
hepatica exposure and other infectious diseases of cattle in the UK. 
Forty dairy farms in England and Wales were recruited. Each farm submitted ten milk samples from 
individual animals and completed a questionnaire about animal management and husbandry, and 
the occurrence of other infectious diseases on the farm. In addition, anti-F. hepatica and anti-
Neospora caninum antibody ELISAs were performed on all 400 individual milk samples. A multilevel 
random effects model was designed, with the dependent variable set as F. hepatica exposure. Data 
collected was either specific for the individual animal or the same for all animals from that farm, 
hence hierarchical in nature. The final model was obtained after backward sequential removal of 
insignificant variables. 
Herd vaccination against Bovine Viral Diarrhoea virus was positively associated with F. hepatica 
exposure, whereas vaccination against Leptospira spp was negatively associated. The number of 
suspect cases of Johnes disease was negatively associated with F. hepatica exposure, whereas the 
number of suspect cases of Salmonella Dublin was positively associated, a finding in agreement with 
other published studies. The abortion rate of the herd was negatively associated with F. hepatica 
exposure of each animal but, despite Neospora caninum being the most frequently diagnosed cause 
of abortion in the UK, N. caninum exposure of the animal was not found to be significantly 
associated in this study. Other husbandry, animal movement and farm management factors were 
also found to be significantly associated with F. hepatica exposure which could be explained by their 
effect on the life cycle of F. hepatica.  
We concluded that several infectious diseases of dairy cattle are associated with exposure to F. 
hepatica. The immunoregulatory effect  of F. hepatica on the efficacy of vaccines against Bovine 
Viral Diarrhoea virus and Leptospira spp is currently unknown. 
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5.2 Introduction 
The trematode parasite, Fasciola hepatica, is an important pathogen of ruminant species in the UK 
with a dairy herd prevalence of 76% in England and Wales (McCann et al., 2010b). Subclinical 
infections, caused by low numbers of parasites, have significant effects on the production 
capabilities of infected cattle with reductions in milk quality and quantity and live weight gain 
reported (Charlier et al., 2007, Hope-Cawdery et al., 1977). Clinical infections in UK cattle are usually 
chronic, but acute infections can occur, leading to clinical signs of fasciolosis such as anaemia, 
hypoalbuminaemia, hepatic fibrosis, hyperplastic cholangitis and weight loss (Urquhart et al., 1996), 
in addition to production deficits. Clinical fasciolosis has been estimated to cost 299 Є per clinical 
case in Switzerland (Schweizer et al., 2005), whilst subclinical costs are unknown but thought to be 
significant.   
 
In recent years, there has been an acceleration in our understanding of the relationship between the 
immune system and F. hepatica. Newly excysted juvenile (NEJ) F. hepatica, upon penetration of the 
duodenal wall, are highly resistant to killing by reactive oxygen and nitrogen species (Piedrafita et 
al., 2000). In addition, F. hepatica is known to induce alternative activation of macrophages, 
reducing their antibacterial activity (Donnelly et al., 2005, Donnelly et al., 2010a), they secrete ESP 
that dampen the pro-inflammatory immune response via their effect on toll-like receptors 3 and 4 
resulting in an anti-inflammatory immune environment (Donnelly et al., 2010a), and a reduction in 
lymphocyte responsiveness through an increase in the regulatory cytokine, IL-10 (Flynn and 
Mulcahy, 2008b).  
 
Less common are studies in cattle into the consequences of co-infections. Those that have been 
conducted have shown that cattle co-infected with F. hepatica and other Salmonella Dublin suffer 
greater disease severity and delayed elimination of those pathogens (Aitken et al., 1978, Aitken et 
al., 1979). Co-infection of calves with F. hepatica and live, attenuated Bacille Calmette Guerin (BCG) 
strain of M. bovis, leads to suppression of the diagnostic tests for bovine tuberculosis (BTB), 
irrespective of whether BCG or F. hepatica is given first (Flynn et al., 2007b, Flynn et al., 2009). When 
co-infection of cattle is done using an initial, low F. hepatica burden and subsequent live, virulent M. 
bovis, the measured IFN  concentration is significantly suppressed, indicating down-regulation of the 
pro-inflammatory immune response (Flynn et al., 2009). Experimental co-infections of mice with F. 
hepatica and the gram negative bacterium, Bordetella pertussis also show that the usual pro-
inflammatory immune response stimulated by B. pertussis infection is abrogated by subsequent 
infection with F. hepatica and is not demonstrable at all when F. hepatica infection is given first 
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(Brady et al., 1999). The rate of bacterial elimination in such co-infected mice is also significantly 
slower. These studies all demonstrate that co-infection of cattle, the norm on most farms, leads to 
significantly compromised immune responses to pathogens requiring a pro-inflammatory immune 
response for clearance, potentially leaving animals more susceptible to such infections. 
 
This study aims to investigate the associations between an individual animal’s exposure to F. 
hepatica measured by detecting anti-F. hepatica antibody and other common on-farm diseases in 
the UK. 
 
5.3 Materials and Methods 
 
5.3.1 Sample size 
Sample size was calculated as per the formula for clustered samples (Thrusfield, 2005).  The formula 
used is shown in Table 5.1. This formula allows the researcher to define the total number of samples 
to be analysed and calculates the number of clusters (in this case farms) to be tested. 
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Table 5.1: Sample size calculation for study 
 
Three hundred and ninety-eight samples were analysed as described below. Two samples were 
damaged in transport and not replaced. 
 
5.3.2 Farm Recruitment 
Ethical approval for this study was granted by the University of Liverpool Ethics Committee 
(Reference Number: RETH000382). The Animal Health Veterinary Laboratories Agency (AHVLA) holds 
a register of all livestock owners in the UK. From this register, 400 dairy farms in England and Wales 
were randomly selected and invited to participate in this study. Farms were sent a letter explaining 
the study format, requirements of farm participation, a copy of the questionnaire to be completed 
over the telephone, and a set of instructions for how to take and submit the 10 individual milk 
samples and the bulk milk tank sample from one milking. The first and last animal entering each side 
g = 1.962TsVc / (d
2Ts – 1.96
2Pexp(1-Pexp)) 
 
Symbol Meaning Variable Used Value Input 
g Number of 
clusters to 
sample 
Total number of farms to be 
sampled 
Calculated as 37.1 
farms 
Pexp Expected 
prevalence 
Prevalence of F. hepatica exposure 
in dairy cattle in England and 
Wales, previously tested for F. 
hepatica 
 
0.30 
d Desired 
absolute 
precision 
Confidence to 95% 0.05 
Ts Total number 
animals to be 
sampled 
Individual milk samples chosen to 
be tested 
400 
Vc Between-
cluster 
variance 
Variation in ELISA pp between 
farms on an individual animal basis 
0.089 as calculated 
 
 
Thus 10 samples each from 40 farms were collected.  
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of the milking parlour was milk sampled until ten samples had been collected. This eliminated the 
risk of farmers submitting samples only from ‘ill’ or ‘suspect’ cases. 
Farms that were interested in participating contacted the University of Liverpool, Veterinary 
Parasitology Group.  Each farmer was sent a pack containing sample pots, a consent form and a pre-
paid addressed envelope for sample return. 
 
The veterinary surgeon(s) for each farm were also contacted and asked to verify the disease status 
of the farm with respect to infectious diseases. 
 
5.3.3 Anti-Fasciola hepatica antibody ELISA 
An anti-Fasciola hepatica antibody ELISA was conducted on each sample as described by Salimi-
Bejestani et al., (Salimi-Bejestani et al., 2007). In brief, Immunlon-2HB ELISA plates (Thermoscientific, 
New York, USA) were coated with 100 µl/well of 0.5µg/ml Excretory Secretory antigens (ESP) in 0.1M 
carbonate buffer (pH 9.6). To obtain ESP, adult F. hepatica were incubated at 37°C, in RPMI medium 
for 12 hours. The medium was collected, centrifuged at 10,000g for 30 minutes at 4°C. The 
concentration of the ESP was determined according to Warburg and Christian (Warburg and 
Christiansen, 1941). 
 
Following overnight incubation, the plates were washed (two quick washes and one 5 minute wash, 
then this cycle repeated) with PBS (pH 7.2) containing 0.05% Tween-20 (PBS/Tween) and blocked 
with 200 µl/well of 2% skimmed milk powder (Marvel, Premier Beverages, Stafford, UK) in 
PBS/Tween for 1 hour at 37°C. Individual milk samples were diluted 1:2 with 2% skimmed-milk 
powder in PBS/Tween solution. Bulk tank milk samples were tested neat. Plates were washed as 
previously described and 100 µl of each milk sample added to each well and incubated for 1 hour at 
37°C. Plates were washed as before, then anti-bovine IgG conjugated to horseradish peroxidise 
(from C. Hartley) was diluted to a 1:80,000 solution with blocking buffer and 100 µl/well incubated 
for 1 hour at 37°C. Plates were washed as before and 100 µl of freshly decanted TMB (3,3’,5,5’-
tetramethylbenzidine; Uptima) was added to each well. Plates were incubated at room temperature 
for 20 minutes in complete darkness. The colour change was recorded on an automatic ELISA reader 
at 450 nm wavelength. The results were given as a mean optical density (OD) obtained from the 
duplicate samples. The percentage of the positive control was then calculated using the following 
formula: 
 
Percent Positivity (PP) = (Mean OD of test sample/Mean OD of High Positive Control) x 100 
100 
 
On each plate, the high positive, mid positive and negative controls were included in quadruplicate. 
 
5.3.4 Anti-Neospora caninum antibody milk ELISA 
Immunlon-1HB ELISA 96-well plates (ThermoScientific, Manchester, UK) were coated with whole 
formalin-fixed Neospora caninum tachyzoites (Williams et al., 1997). Plates were stored vacuum-
packed until required at 4°C. 
 
Control sera were diluted 1:400 with PBS (pH 7.2) containing 0.05% Tween-20 (PBS/Tween) and 
samples were diluted to 1:400. 100μl of each diluted sample or control is added to each ELISA plate 
well. The plate was then covered and allowed to incubate at 37°C for 30 minutes. 
After incubation, the plate was washed as previously described. Anti-bovine IgG conjugated to 
horseradish peroxidise was diluted to 1:50,000 with PBS/Tween and 100 µl/well incubated for 30 
minutes at 37°C. The plate was washed and 100μl TMB substrate was added to each well. The plate 
was then incubated at room temperature for 10 minutes in the dark. This reaction was stopped by 
the addition of 100μl 0.5M Hydrochloric acid to all wells. The colour change was recorded on an 
automatic ELISA reader at 450 nm wavelength. The results were given as a mean optical density (OD) 
obtained from the duplicate samples. The percentage of the positive control was then calculated 
using the following formula: 
 
Percent Positivity (PP) = (Mean OD of test sample/Mean OD of High Positive Control) x 100 
 
5.3.5 Questionnaire Completion and Variable Capture 
Results of ELISA tests were reported to the farmer after the telephone questionnaire had been 
completed. Results were sent via email to farmers if possible, but in some cases a paper copy was 
preferred. Discussion of results and flukicidal treatment protocols were only done with the farm 
veterinary surgeon and, because the authors had not visited these farms, very little additional 
information or advice could be given. All questions were asked as per the questionnaire, to eliminate 
bias from question wording. A final letter outlining the findings of the study was mailed to 
participating farms and veterinary surgeons at the end of the study. 
 
Variables recorded from the questionnaire are contained in Table 5.2. A copy of the questionnaire is 
included in Appendix B. 
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5.3.6 Data Analysis 
Data from the questionnaires and ELISAs were recorded anonymously in a Microsoft Excel 
spreadsheet (Excel 2007, Microsoft). The data was subsequently inputted into Minitab (vs 16). A 
Spearman correlation was used to assess which variables were closely correlated such that co-linear 
variables could be excluded. Histograms of all data items were checked for normality, and the Ryan-
Joiner test for distribution normality was performed on all continuous variables. The result of the 
normality test on log10(PP) is shown in Figure 5.1, thus it was decided that animal-level ELISA PP 
should be transformed by log10(PP) as the raw data and other transformations showed  less 
significant normal distribution. The number of days each animal was into its lactation (LACTSTAGE) 
was also found to be more normally distributed on a Ryan-Joiner test, if square-root transformed 
(see Figure 5.2) compared to other transformations.  
 
A multilevel analysis was deemed most appropriate for this data and a multi-level model was run 
using MLwiN (version 2.23, Centre for Multilevel Modelling, University of Bristol) due to the 
inherently hierarchical nature of the data collected. Some of the variables collected were animal-
specific and hence there was variation between animals on the same farm as well as variance 
between animals from different farms, whereas some variables collected were farm-specific and 
hence would be the same for all animals from that farm. 
 
A random effects, two-level model (where Farm = level 2, Animal = level 1) was set up, with the 
dependent, y variable set as log10(PP) and the independent, x variables tried as those listed in Table 
5.1. Incomplete data was recorded as not all farms recorded all data asked in the questionnaire (see 
Appendix B). The initial model contained all variables and backwards sequential removal was done 
based upon the p-value of each variable.  The intercept was allowed to vary at both farm and animal 
level, defined as the constant, β0ij, multiplied by a constant value (set as 1) in the data.  
 
Once the final model was obtained, it was then checked for interaction terms, which were entered 
into the model as one term multiplied by another. One interaction term was found to remain in the 
final model as significant. The intra-class correlation coefficient, a measure of the extent to which 
the y values of the individual animals from the same farm resemble each other, compared to those 
from individuals from different farms, was calculated for each model. The same model-building 
principal was then applied using only variables with no missing cases. 
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5.4 Results  
Milk samples from 398 animals from 40 dairy farms were collected and tested for exposure to F. 
hepatica and Neospora caninum. Data from each of the 40 farms were collected by questionnaire, 
some variables about each individual animal sampled and some variables about the farm that the 
animals originate from. The variables collected are shown in Table 5.2. 
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Table 5.2: Variables recorded or generated 
 
Variable Description Number of farms (animals, as 
appropriate) data held for 
FID 
 
 
Farm Identification Number 40  
ANIMAL  
 
Individual animals are 
numbered 1-10, bulk milk tank 
sample is 11 
40 (398/398) 
FlukePP  
 
The ELISA result generated 
from the milk sample presented 
40 (398/398) 
Log10(PP) Log10 transformation of FlukePP 40 (398) 
BVDVacc  
 
Is the herd vaccinated against 
BVD virus? (0= no, 1= yes) 
40 
IBRVacc  
 
Is the herd vaccinated against 
IBR virus? (0= no, 1= yes) 
40 
LEPTOVacc  
 
Is the herd vaccinated against 
Leptospirosis? (0= no, 1= yes) 
40 
AOA  Age of animal (years, months) (398/398) 
LACTSTAGE 
 
Number of days since last 
calving 
(398/398) 
SCCAv 
 
Average somatic cell count 
reading from last recording 
(,000) – NB. Some farms don’t 
test 
(154/398) 
AvYIELD  
 
Average yield (x1000 litres) of 
the cow’s last lactation – NB. 
Not all farms recorded this 
40 
MASTITIS  
 
Has this animal had mastitis 
since the start of her previous 
lactation? (answer is no. cases) 
40 (398/398) 
OTHERDz  Has this animal had any other 
diseases in the last 2 lactations? 
(answer is categorical: 
FERTILITY, LAMENESS, etc) 
40 (398/398) 
BVDHist 
 
BVD virus history of the herd 
(0= no history of disease, 1= 
history of disease) 
40 
IBRHist  
 
IBR virus history of the herd (0= 
no history of disease, 1= history 
of disease) 
40 
LEPTOHist  Leptospirosis history of the 
herd (0= no history of disease, 
1= history of disease) 
40 
DUBLINsus  
 
Salmonella Dublin suspect 
cases on farm (answer is 
number) 
40 
DUBLINDx 
 
Salmonella Dublin diagnosed 
cases on farm (answer is 
40 
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number) 
JOHNESsus Johnes disease suspect cases 
on farm (answer is number) 
40 
JOHNESDx 
 
Johnes disease diagnosed cases 
on farm (answer is number) 
40 
NEOSPORAsus  
 
Neospora caninum suspect 
cases on farm (answer is 
number) 
40 
NEOSPORAdx 
 
Neospora caninum diagnosed 
cases on farm (answer is 
number) 
40 
ABORTIONrate  
 
Number of bovine pregnancies 
resulting in abortion as a 
percentage of total bovine 
pregnancies for last 12 months 
40 
ABORTIONdx 
 
If known, categorical. All 
diagnoses were Neospora 
caninum or ‘unknown’ 
40 
Btbstatus Bovine TB status (Y/N; 1,0) 40 
TESTfreq 
 
1=every year, to 4 = every 4 
years 
40 
SHEEPcog 
 
Do sheep graze any of the land 
also used for dairy cow grazing, 
not necessarily at the same 
time?  
40 
BEEFcog  Do beef cows graze any of the 
land also used for dairy cow 
grazing, not necessarily at the 
same time? (0= no, 1= yes) 
40 
DCalvesBI 
 
The number of dairy calves 
bought-in in the last 12 months 
40 
DheifersBI 
 
The number of dairy heifers 
bought-in in the last 12 months 
40 
DcowsBI  
 
The number of dairy cows 
bought-in in the last 12 months 
40 
BCowsBI  
 
The number of beef cows 
bought-in in the last 12 months 
40 
BcalvesB  
 
The number of beef calves 
bought-in in the last 12 months 
40 
SBI  
 
The number of sheep bought-in 
in the last 12 months 
40 
CCI 
 
Calving to conception interval; 
the time from calving to getting 
pregnant again 
35 (348/398) 
C1st  Calving to 1st service interval 31 (308/398) 
S/Concept  
 
Services (inseminations) per 
conception 
35 (348/398) 
HousingCALVING 
 
Where do calvings occur during 
the housing period? Categorical 
variable. 
40 
GrazingCALVING Where do calvings occur during 40 
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 the grazing period? Categorical 
variable 
FARMSIZE  The size of the farm (in acres) 40 
FLUKICIDALuse 
 
Are dairy animals given a 
flukicidal treatment at the start 
of the dry period? (0= no, 1= 
yes) 
40 
ANTHELMuse  
 
Are dairy animals given an 
anthelmintic treatment (0= no, 
1= yes) 
40 
RESISTANCE  
 
Has there been a reported 
diagnosis of anthelmintic 
resistance on the premises? (0= 
no, 1= yes) 
40 
NoDCows  
 
Number of dairy cows on farm 
at time of testing 
40 
NoDHeifers  
 
Number of dairy heifers on 
farm at time of testing 
40 
NoDairyCalves Number of dairy calves on farm 
at time of testing 
40 
NoBCows Number of beef cows on farm 
at time of testing 
40 
NoBCalves 
 
Number of beef calves on farm 
at time of testing 
40 
%HomeBred Percentage of dairy herd home 
bred 
40 
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The frequency of infectious disease occurrence on the sample farms is shown in Table 5.3.  
Leptospirosis and BVDv were the diseases most commonly vaccinated against (25/40 and 24/40 
respectively); vaccination was used to protect against perceived disease risks on farms and when 
disease outbreaks had occurred. IBR was less commonly vaccinated against and most farms only 
utilised this vaccine if a previous outbreak of IBR had been diagnosed on the farm (participating 
farmers, personal communication). BTB was diagnosed on one sample farm, but milk samples were 
taken from cattle testing negative to BTB tests. This positive BTB diagnosis was a new case on a 
previously BTB test-negative farm. Johnes disease had been diagnosed on fifteen farms. The decision 
to use ‘suspect’ case numbers instead of ‘diagnosed’ case numbers was made because many farmers 
would classify cases with appropriate presenting signs as infected, without getting a formal 
diagnosis, after several cases of the disease were confirmed. Clinical disease due to Salmonella 
Dublin was only reported on 5 farms. Clinical mastitis, the cause of which was not recorded, had 
occurred in 108/398 animals during the previous lactation. Some animals suffered repeat bouts of 
clinical mastitis after an apparent resolution of clinical signs, during the same lactation. The history 
of each case was not investigated and culture data or samples were not available. 
 
Table 5.3: Infectious disease and vaccination history for the sample farms 
Disease/Vaccine Number of farms (animals) positive, out of 40 farms or 398 
animals 
F. hepatica exposure 22/40 (186/398) 
BVDv vaccination 24/40 
IBR vaccination 15/40 
Leptospirosis vaccination 25/40 
Bovine tuberculosis 1/40 (0/398) 
Johnes Disease 15/40 
Salmonella Dublin 5/40 
Neospora caninum 11/40 
Mastitis (108/398) 
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Figure 5.1: Normality plot of F. hepatica PP transformation  
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This plot demonstrates that a log transformation of the anti-F. hepatica antibody ELISA improves the 
normal distribution of this variable, as demonstrated by the approximate straight line of the points 
on the graph and but the distribution cannot be considered significantly normal as p<0.05. This is 
due to outliers at the extremes of the PP scale. 
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Figure 5.2: Normality plot of the stage of lactation of each animal (LACTSTAGE) 
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This plot demonstrates that a square-root transformation of the lactation-stage of each animal in 
the study is more normally distributed, as demonstrated by the approximate straight line of the 
points on the graph and but the distribution cannot be considered significantly normal as p<0.05. 
This is due to outliers at the extremes. 
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Table 5.4 shows the results of the random effects model for all the variables described in Table 5.2. 
All variables were initially put into the model and sequential backwards removal of variables 
occurred until only those variables with significant (p<0.05) p-values remained. BVDv vaccination 
(BVDVacc), Lactation stage (LACTSTAGE), Average yield of the herd (AvYIELD), Salmonella Dublin 
suspect cases (DUBLINsus), number of beef cows bought-in (BCowsBI), number of sheep bought-in 
(SBI), services per conception (S/Concept) and the number of beef cows kept on the farm (NoBCows) 
were all positively and significantly associated with F. hepatica exposure. Leptospirosis vaccination 
use in the dairy herd (LEPTOVacc), the number of cases of Johnes Disease suspected in a herd 
(JOHNESsus), the abortion rate of the herd (ABORTIONrate), calving-to-conception index (CCI) and 
the size of the farm in acres (FARMSIZE) were all significantly negatively and significantly associated 
with F. hepatica exposure. 
 
  
110 
 
Table 5.4: Random effects analysis 
 
Variable Coefficient SE Coefficient P 
BVDVacc 0.418 0.103 <0.001 
LEPTOVacc -0.269 0.094 0.004 
LACTSTAGE 0.001 0.00002 <0.001 
AvYIELD 0.010 0.0009  <0.001 
DUBLINsus 0.268 0.060 <0.001 
JOHNESsus -0.043 0.009 <0.001 
ABORTIONrate -0.058 0.026 0.024 
BCowsBI 0.717 0.176 <0.001 
SBI 0.009 0.001 <0.001 
CCI -0.007 0.001 <0.001 
S/Concept 0.278 0.055 <0.001 
FARMSIZE -0.001 0.00001 <0.001 
NoBCows 0.006 0.003 0.023 
y=log(PP), n=348/398 animals 
 
Intra-class correlation coefficient  = 100*(u0j/(e0j+u0j)) 
     = 100*(0.02/(0.02+0.111)) 
     = 15.267 % 
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The intra-class correlation coefficient gives the percentage of the total variation present, after 
allowing for included variables, that occurs at each level of the model. The intra-class correlation 
coefficient for this model was calculated as 15.267%. This suggests that farm level variables play a 
significant role in the likely F. hepatica exposures found in individual animals on that farm. 
 
All biologically plausible interaction terms were tested to see if any could, on their own, be a 
significant predictor variable for log10(PP). A difference in -2log-likelihood  greater than 3.84 is 
equivalent to a chi-squared test result on 1 degree of freedom, hence has a p value <0.05, indicating 
significance. Only three such interaction terms were individually identified (highlighted yellow in 
Table 5.5).  When all three individually significant interaction terms were added to the model 
together, only JOHNESsus*S/concept was significant (p=0.023). When LEPTOVacc*NoBCows was 
then removed, only LEPTOVacc*AvYIELD remained significant (p = 0.022).  Thus only 
LEPTOVacc*AvYIELD was kept in the final model (Table 5.6). Inclusion of this interaction term 
created a final model with an intra-class correlation coefficient of 11.905%. This means that the 
proportion of the total residual variation that is due to differences between farms is reduced by 
inclusion of this interaction variable. 
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Table 5.5: Interaction terms offered to the final model 
Interaction Difference in -
2loglikelihood 
p-value 
BVDVacc*LEPTOVacc 0.93 Insignificant 
BVDVacc*LACTSTAGE 0.319 Insignificant 
BVDVacc*AvYIELD 0.565 Insignificant 
BVDVacc*DUBLINsus 0.916 Insignificant 
BVDVacc*JOHNESsus 0.007 Insignificant 
BVDVacc*ABORTIONrate 1.946 Insignificant 
BVDVacc*BcowsBI 0.000 Insignificant 
BVDVacc*SBI 0.905 Insignificant 
BVDVacc*CCI 0.046 Insignificant 
BVDVacc*S/concept 2.163 Insignificant 
BVDVacc*FARMSIZE 1.988 Insignificant 
BVDVacc*NoBCows 0.436 Insignificant 
LACTSTAGE*LEPTOVacc 0.097 Insignificant 
LEPTOVacc*AvYIELD 6.114 0.013 
DUBLINsus*LEPTOVacc 0.916 Insignificant 
LEPTOVacc*JOHNESsus 0.289 Insignificant 
ABORTIONrate*LEPTOVacc 1.484 Insignificant 
BcowsBI*LEPTOVacc 0.000 Insignificant 
SBI*LEPTOVacc 0.299 Insignificant 
CCI*LEPTOVacc 0.558 Insignificant 
S/Concept*LEPTOVacc 0.002 Insignificant 
FARMSIZE*LEPTOVacc 0.603 Insignificant 
NoBcows*LEPTOVacc 4.364 0.037 
DUBLINsus*JOHNESsus 0.820 Insignificant 
DUBLINsus*SBI 0.379 Insignificant 
DUBLINsus*CCI 0.247 Insignificant 
DUBLINsus*S/concept 1.532 Insignificant 
JOHNESsus*SBI 1.437 Insignificant 
JOHNESsus*BcowsBI 0.000 Insignificant 
JOHNESsus*ABORTIONrate 0.199 Insignificant 
JOHNESsus*CCI 1.543 Insignificant 
JOHNESsus*S/concept 4.493 0.034 
JOHNESsus*NoBCows 1.319 Insignificant 
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Table 5.6: Final Random Effects Analysis 
Variable Coefficient SE Coefficient P 
BVDVacc 0.418 0.103 <0.001 
LEPTOVacc -0.269 0.094 0.004 
LACTSTAGE 0.001 0.00002 <0.001 
AvYIELD 0.010 0.0009 <0.001 
DUBLINsus 0.268 0.060 <0.001 
JOHNESsus -0.043 0.009 <0.001 
ABORTIONrate -0.058 0.026 0.024 
BCowsBI 0.717 0.176 <0.001 
SBI 0.009 0.001 <0.001 
CCI -0.007 0.001 <0.001 
S/Concept 0.278 0.055 <0.001 
FARMSIZE -0.001 0.00001 <0.001 
NoBCows 0.006 0.003 0.023 
LEPTOVacc*AvYIELD 0.011 0.0009 0.022 
y=log(PP), n=348/398 animals 
 
Intra-class correlation coefficient    = 100*(u0j/(e0j+u0j)) 
       = 100*(0.015/(0.015+0.111)) 
       = 11.905 % 
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The intercepts for the different farms are the level 2 residuals, u0j and these are distributed around 
zero with a variance of 0.110 (standard error 0.028). The actual data points for each farm will not lie 
along straight lines but will instead vary about the lines of best fit by the level 1 residual, eij, 
estimated at 0.132 (standard error 0.010). Figure 5.3a shows that there is variation between farms 
when the farm-level residuals are plotted. The confidence intervals for the residuals of the two 
lowest ranking and two highest ranking farms do not overlap indicating that these farms differ 
significantly from the average at the 5% level. This could be down to the geographical location of the 
farms sampled in the UK. Figure 5.3b shows the Normality of variables collected at the farm-level. 
Previous Ryan-Joiner calculations have demonstrated that log10(PP) on an animal-level is not 
normally distributed, but given the lack of another appropriate distribution and the fact that only the 
outliers are not positioned along the straight line, the assumption of Normality was deemed 
appropriate in this case.  
At an animal-level, the assumption of normality is correct overall as the ranked animal-level 
residuals form a straight line when plotted against corresponding points of a normal distribution 
curve. Only one outlier exists on this plot (Figure 5.3c).  
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Figure 5.3: Plots for farm-level (a and b) and animal-level  (c) residuals  
a)  
a) Plot of Farm-level Residuals: 4 farms (2 lowest ranking and 2 highest ranking) have confidence 
intervals for their residuals that do not overlap. 
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b)  
b) Farm-level Normal Plot: This plot shows ranked residuals plotted against corresponding points of 
a normal distribution curve. The points form a roughly straight line, thus the assumption of 
normality is appropriate.  
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c)  
c) Animal-level Normal Plot: This plot shows ranked residuals plotted against corresponding points 
of a normal distribution curve. The points form an approximate straight line, thus the assumption of 
normality is correct overall. There is one point (bottom left) that deviates from this distribution, 
indicating one outlier. 
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As data on every variable utilised in the final model was only held for 348 animals out of 398, 
attempts were made to design a model where data from all 398 animals was held. The results of this 
are shown in Table 5.7. The intra-class correlation coefficient for the model outlined in Table 5.7 was 
calculated as 45.455%, indicating that there is more variation present between farms in this model, 
compared with the previous model. The fact that so many of the infectious disease variables for the 
398 animals included in this study are missing from this model, leaving four out of seven variables 
pertaining to husbandry and stock management, means that this model was not investigated more. 
 
 Table 5.7: Model formulated using only variables that are present for every test farm 
Variable Coefficient SE Coefficient P 
IBRVacc_1 0.304 0.127 0.016 
LACTSTAGE 0.001 0.00002 <0.001 
DUBLINsus 0.259 0.104 0.013 
bTBstatus_1 1.119 0.407 0.006 
SHEEPcog 0.001 0.00008 0.005 
BEEFcog 0.013 0.005 0.016 
DCalvesBI -0.046 0.022 0.032 
y=log(PP), n=398/398 animals 
 
Intra-class correlation coefficient  = 100*(u0j/(e0j+u0j)) 
     = 100*(0.110/(0.110+0.132)) 
     = 45.455 % 
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5.5 Discussion 
It should first be noted that although measurement of anti-F. hepatica antibodies by ELISA can only 
confirm exposure to this parasite, unpublished data has shown that circulating antibodies against F. 
hepatica decline to negative within about 10 weeks post treatment with a flukicidal drug, (D. 
Williams, personal communication). Although treatment is a possibility in the animals sampled, a 
positive exposure to F. hepatica as indicated by a positive PP value, is likely to indicate current 
infection as flukicidal drugs available in the UK are not licensed for use in lactating animals.  
Very little information exists regarding the interaction between exposure to  F. hepatica  on 
vaccination efficacy in cattle. Studies in mice co-infected with F. hepatica and the bacterium, B. 
pertussis, demonstrated an alteration in the immune response from a Th1 phenotype to a Th2 
phenotype (Brady et al., 1999). F. hepatica ESP was found to suppress IFN-γ production in mice pre-
inoculated with B. pertussis whole cell vaccine (O'Neill et al., 2001). This suggests, at least in this 
mouse model, that new F. hepatica infection can have an immunomodulatory effect on pre-existing 
immune responses. 
Lactation stage (LACTSTAGE) was found to be a significant positive predictor for log PP. A possible 
explanation is that animals further into their lactation stage have had more time to acquire F. 
hepatica infection since their last anthelminthic treatment. As there are no licensed flukicidal drugs 
for use in lactating animals in the UK, most treatments against F. hepatica are administered to dairy 
cows during their dry period. This dry period represents approximately the last 2 months of 
pregnancy where milk production ceases and mammary gland involution and repair takes place. The 
withdrawal period for triclabendazole is 55-67 days (NOAH compendium 2012), hence the dry period 
is generally long enough to allow an animal to re-enter the milking herd soon after calving. The 
further into the lactation an animal is, the more time has passed since the last flukicidal treatment, 
and hence the more likely the cow is to have picked up a F. hepatica infection, explaining the 
positive association seen in this model. 
Average yield (AvYIELD) of the herd was found to be positively and significantly associated with F. 
hepatica exposure in this model, with farms with increased yields having cattle with higher F. 
hepatica exposure. Other studies that suggest that when a 50% rise in anti-F. hepatica antibody titre 
occurs there is a reduction in average milk yield of 0.7kg/cow/day, average milk fat of 0.06% and an 
increase in calving interval of 4.7 days for dairy cows (Charlier et al., 2007), but the effect of yield has 
not been studied on the exposure of cattle to F. hepatica. Results found by Mezo et al., (2011) 
support those of Charlier et al., demonstrating a 1.5 kg milk/cow per day production drop by highly 
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positive herds compared with negative herds, and a 2.0kg milk/day decrease in production in highly 
positive individuals compared with those testing negative. Dairy cow production considered on a 
herd level, as this variable was, will be due to many other factors apart from F. hepatica exposure 
and unforeseen confounding factors may be responsible for this finding.  
It was concluded from an in vivo study in cattle that prior F. hepatica infection resulted in increased 
susceptibility to S. Dublin infection with all co-infected animals becoming persistent faecal carriers of 
S. Dublin (Aitken et al., 1979). Prior F. hepatica infection did not affect the survival of cattle given a 
sublethal dose of S. Dublin, but did extend persistence of the bacteria in faeces (Aitken et al., 1981). 
F. hepatica infection did not predispose to a more severe bacteraemia in orally infected cattle given 
sublethal doses of S. Dublin (Hall et al., 1981).  A case-control study found that S. Dublin infection 
was highly associated with F. hepatica infection in dairy cattle in the Netherlands (Vaessen et al., 
1998). In this study, we demonstrate that increased S Dublin suspect cases in the herd are associated 
with a higher individual animal PP (Log10(PP)).  This finding suggests that S. Dublin infection in the 
herd may affect the susceptibility of cattle to F. hepatica exposure. As a causal link between these 
two infections cannot be established, it might be that prior exposure to F. hepatica increases the 
likelihood of prolonged infection with S. Dublin. 
Johne’s disease is caused by Mycobacterium avium subsp. paratuberculosis (MAP), a closely related 
bacterium to the causative agent of BTB. The clinical condition manifests as severe weight loss and 
terminal, chronic, profuse diarrhoea in cattle (Begg et al., 2011) with reductions in milk yield, milk 
quality and fertility seen in subclinical and clinical conditions (Beaudeau et al., 2007, Smith et al., 
2010). The number of suspected cases as opposed to the number of diagnosed cases was chosen for 
inclusion in the current analyses because most farmers confirmed that once infection was diagnosed 
on the farm, animals presenting with similar clinical signs were considered to have the disease, 
without the need for confirmatory diagnostic tests. It was thus considered that the number of 
suspected cases on the farm would be a more accurate representation of the actual number of 
animals with infection, rather than the number diagnosed. The negative effect of Johnes disease 
suspect cases on F. hepatica exposure can be viewed in several ways: 1. that Johnes disease is 
protective against seroconversion to F. hepatica or 2. that each disease has a distinct geographical 
distribution and thus should not be expected to co-exist.  This does not appear to be the case from 
other epidemiological studies (Anon, 2012c, Anon, 2001). 
It is no longer a requirement to investigate bovine abortions since the relaxation of compulsory 
brucellosis testing in the UK in April 2007 (DEFRA, 2011a). Reporting of abortions is still encouraged 
but testing and investigation now occurs in only a percentage of cases. The most commonly 
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diagnosed cause of abortion in UK cattle is Neospora caninum (Anon, 2002).  Abortion Rate of the 
herd was found to have a significant negative effect on F. hepatica exposure in this study, but N. 
caninum PP was not found to be a significant predictor, indicating no association between N. 
caninum exposure and F. hepatica exposure in this case. The negative association between abortion 
rate and F. hepatica exposure suggests that abortion may be due to other pathogens, nutrition or 
stresses or again a protective role of F. hepatica exposure against abortion. 
Data regarding the flukicidal treatment and quarantine protocols utilised on the test farms in this 
study were not included in the final analysis. All farms with a high F. hepatica PP used a flukicidal 
drench in dry cows, thus this variable made all others insignificant. Quarantine information was not 
available. The number of beef cows bought-in (BcowsBI), the number of beef cows kept on the 
premises (NoBCows) and the number of sheep bought-in (Sbi) were all found to have significant 
positive effects on F. hepatica exposure in dairy animals. This may represent the introduction of new 
hosts onto the farm carrying burdens of F. hepatica to contribute to the overall farm burden, or that 
the presence of another susceptible host species may enable the F. hepatica lifecycle to continue 
when dairy cattle are not present on the pastures for example when they have been housed for 
winter. 
Calving to conception index (CCI) and services per conception (S/Concept) are key performance 
indicators utilised on farms to assess herd fertility. The calving to conception index is the number of 
days from calving, that a cow takes to conceive to a service; the higher this index in general, the 
lower the fertility of the herd. The services per conception number is the mean number of times a 
cow is mated or artificially inseminated before being diagnosed as pregnant; the higher this number, 
the lower the fertility of the herd. Charlier et al., (2007) found an increase in the calving interval (the 
number of days from one calving to the next in individual cows) of 4.7 days for dairy cattle infected 
with F. hepatica. Two different measures of fertility were used in the current study. Data was 
missing for both variables but more so for calving to conception index. The effect of decreasing 
calving to conception index leads to increased F. hepatica exposure. Services per conception were 
positively associated with F. hepatica exposure of cattle in the current study, suggesting that poorer 
fertility was associated with higher exposure to F. hepatica. The effects of these key performance 
indicators on F. hepatica exposure have never been studied before, however, F. hepatica is 
documented to have a negative effect on production in other published studies (Charlier et al., 2007, 
Hope-Cawdery et al., 1977). 
Farm size (FARMSIZE), measured in acres, was found to be a negative predictor of F. hepatica 
exposure in milking animals. This finding has several potential explanations: 1. Smaller farms graze 
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their pastures more intensively, either with multiple species or one species at higher density than on 
larger farms, 2. Smaller farms tend to be found in areas with higher F. hepatica prevalence, such as 
the northwest of England and Wales (McCann et al., 2010b), or 3. Larger farms may have more land 
available for pasture rotation systems, allowing crops, fallow land and grazing to be managed more 
easily (Urquhart et al., 1996). A greater sample size may reduce the effect of location on the results, 
as might the offering of farm-specific variables to the analysis such as those obtained for soil type, 
weather conditions and climate fluctuations utilised in Chapter 3 of this thesis and in studies by 
McCann et al., (2007, 2010a, 2010b). 
The interaction term found to be significant in this study was LeptoVacc*AvYield. This implies that 
the simultaneous influence of LeptoVacc and AvYield is not additive on the independent variable, 
Log(PP). LeptoVacc is a binary variable represented as a 0 for unvaccinated herds and 1 as 
vaccinated herds. The effect observed with the combination of exposures is different to that which 
would be expected based on each exposure individually. The positive and significant association 
between these two variables within the interaction variable suggests that the average yield varies 
differently dependent upon whether the herd is vaccinated against Leptospirosis. The reason for this 
interaction is currently unknown. By centring (subtracting) the mean AvYield from all herd AvYield 
values, the mean AvYield becomes zero. Including this new value into the random effects model, the 
coefficient is similar to that in the model specified in Table 5.6 (centred AvYield coefficient 0.011, 
standard error 0.001, p<0.001), suggesting little effect on the inclusion of the independent variables 
separately. The interaction term is non-significant when this new value of centred AvYield is included 
instead of the original AvYield.  
In conclusion, this study has highlighted new associations between F. hepatica exposure and other 
infectious diseases and management factors that lend themselves to further investigation.  
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Chapter 6 
Discussion 
  
124 
 
This thesis describes a collection of studies investigating the epidemiological associations between 
the trematode parasite, F. hepatica and other infectious diseases common in dairy cattle in the UK, 
at both the herd level and animal level. 
Much work has been described in mouse models and in in vitro studies to assess the 
immunomodulatory effects that this parasite has on the host immune system (Flynn and Mulcahy, 
2008b, Hacariz et al., 2009, Sekiya et al., 2006), parasite evasion from appropriate immune killing 
(Flynn et al., 2007a, Flynn and Mulcahy, 2008a, O'Neill et al., 2000), and the knock-on effects of 
infection with F. hepatica when an animal becomes co-infected with another pathogen (Brady et al., 
1999, Aitken et al., 1980, Aitken et al., 1978, Flynn et al., 2007b, Flynn et al., 2009). Only work by the 
latter two groups has addressed infections commonly found in cattle, and the experimental nature 
of the studies has meant that sample sizes have been small. Despite this, important findings have 
been reported (Flynn et al., 2007b, Flynn et al., 2009) and have provided the crucial ground work 
upon which this thesis is based. 
Of particular importance to the farming community in the UK is the screening for, spread of, and 
control of the notifiable endemic disease, BTB. The UK remains a long way from being OTF and is one 
of the top five developed countries in the world with respect to BTB herd prevalence. This provides a 
starting point for this thesis, building on the experimental studies demonstrating that co-infection of 
cattle with F. hepatica has a negative effect on BTB diagnosis, regardless of whether low doses of F. 
hepatica are given before or after an intranasal dose of BCG or virulent M. bovis (Flynn et al., 2007b, 
Flynn et al., 2009).  
Chapter 2 provides an innovative and novel method to calculate a herd level prevalence for BTB, 
incorporating herd sizes for the dairy farms in our sample data and SICCT test sensitivities reported 
in the literature by different studies. Results from this study suggest that BTB herd prevalence in 
England and Wales is higher than that currently reported by the government, and, depending on 
how sensitive the SICCT test really is in the field, may be worryingly underestimated.   
BTB eradication is compulsory in the EU and legislation is transcribed into member state law to 
incorporate screening tests on cattle, the frequency of which depends on the parish prevalence of 
BTB in their locality. Despite a rigorous and expensive country-wide programme, England, Wales, 
Northern Ireland and the Republic of Ireland all have a herd prevalence far exceeding that required 
to become OTF (0.1% of herds annually under restriction for BTB; OIE, 2002). This leads to almost 
25% of cattle herds being under restriction at any one time in England with trade implications for 
milk sales, meat production, local livestock trading and live cattle exports to the continent for 
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affected farmers. We cannot hope to get a better handle on disease control until we can accurately 
detect BTB-infected animals within herds. With no other ante mortem tests for BTB performing as 
well as the SICCT test and IFN  assay, when used in parallel, and with the EU dictating only their use 
as a first-line screening tool, it is down to research to find ways to optimise SICCT sensitivity and 
specificity.  
Chapter 3 of this thesis describes the development and testing of a logistic regression model to 
predict BTB herd breakdown given climatic, animal movement and herd size predictor variables. 
Proxies of variables for predicting BTB on farms in England and Wales have been sourced to mirror 
those found significantly important in other studies (Wint et al., 2002, Gilbert et al., 2005). The 
further addition of a measure of F. hepatica exposure in the sample farms, improved the predictive 
power of the multivariable logistic regression model and, in the theoretical absence of F. hepatica 
exposure, the detection rate for BTB in dairy herds could increase by approximately one third 
(Claridge et al., 2012). 
Cattle-to-cattle transmission via exhaled  aerosol from infected and shedding cattle to susceptible 
cattle, is considered the major route of BTB transmission in the UK (Goodchild and Clifton-Hadley, 
2001). If the SICCT test is working suboptimally, then this needs to be improved to enable accurate 
detection of infection in cattle. Giving a flukicidal drug to cattle on farms known to have a significant 
F. hepatica exposure may help to restore the sensitivity of the SICCT, and alongside increased 
frequency of testing (i.e. the retesting every 60 days until two whole herd tests have been passed) 
and the parallel use of the IFN  assay, may help to detect more truly infected cases earlier, hence 
reducing the prevalence of BTB in England and Wales. It must be noted here that a temporary 
increase in prevalence will be seen initially, as the currently ‘silent shedders’ of BTB will be detected, 
but after their removal, prevalence should decline. 
Given the estimates for herd prevalence calculated for England and Wales, the magnitude of the BTB 
problem in the UK could be far greater than previously reported, with up to 28% of herds not testing 
positive despite harbouring BTB infection in at least one animal. This lack of detection of a notifiable, 
and potentially zoonotic, disease is serious. 
Collaboration with other research groups has provided complementary experimental work that is 
not part of this thesis, but that has been published alongside findings from this PhD. These data 
support the finding that BTB testing in England and Wales is compromised by the co-infection of 
cattle with F. hepatica, leading to a reduction in the comparative skin thickness at the site of injected 
PPD-B (Claridge et al., 2012). The inoculating dose of metacercariae given to the experimentally 
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infected cattle was low. Further work is needed to confirm if higher burdens of F. hepatica would 
have more profound dampening effects on the immune system, but this is likely,  especially when 
the bovine and ovine immune responses have been shown to alter the relative quantities of 
regulatory cytokines according to the stage and size of F. hepatica infections (Flynn and Mulcahy, 
2008b, Hacariz et al., 2009). 
Building on the results from Chapter 3, Chapter 4 attempts to ascertain whether the negative 
association between BTB diagnosis and F. hepatica is also demonstrable at an animal-level. Milk 
samples were taken from paired SICCT test reactor and negative cattle or inconclusive reactor (IR) 
and negative cattle, and the anti-F. hepatica antibody ELISA was applied. The PP values were then 
analysed to assess whether there was a significant difference in F. hepatica exposure between SICCT 
test IR animals and NR controls. There was no difference between SICCT test R and NR animals but IR 
animals were found to have significantly higher exposure to F. hepatica compared with their 
negative controls. It is possible that F. hepatica exposure was so high in the majority of animals 
tested that the true picture remains unclear, but it may be that IR animals would be testing positive 
if F. hepatica infection were removed (Claridge et al., 2012). A continuation of this study using 
matched farms, as discussed in Chapter 4, may help to ascertain whether this is possibility or not. 
A review of literature pertaining to BTB transmission in the UK has highlighted a potential for 
‘environmental contamination’ (Figure 6.1), and with surveys of badger and deer hosts suggesting 
significant numbers of BTB infected individuals, coupled with the opportunity for transmission to 
livestock due to husbandry measures, we cannot rule out the use of wildlife culling in the UK. Ideally, 
a far more cautious method of testing then culling would be used, rather than regional elimination 
of badgers irrespective of disease status. The cost of such a strategy may be prohibitive initially, 
although if the UK government are already paying out £108 million a year in control measures and 
still seeing a steady increase in BTB incidence. We have to wonder whether a multi-pronged 
approach would be more advisable. 
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Figure 6.1: Transmission routes for spread of M. bovis 
 
Table 6.1: Citations relating to Figure 6.1 transmission routes 
Number in 
figure 
Transmission Citations 
1 
2 
3 
4 
5 
6 
7 
 
8 
9 
 
10 
 
11 
Human-Cattle: aerosol 
Cattle-Human: milk 
Cattle-Human: aerosol 
Cattle-Human: uncooked meat  
Cattle-Cattle: aerosol? 
Environment-Cattle: slurry 
Environment-Cattle: faecal/urine  
 
Badger-Environment: urine 
Badger-Environment: faeces 
 
Human-Human: aerosol 
 
Deer-Environment: feed 
(Ocepek et al., 2005, Fritsche et al., 2004) 
(Konuk et al., 2007, Jalava et al., 2007)  
(Rua-Domenech, 2006, Awah Ndukum et al., 
2010)  
(Gopal et al., 2006, Costello et al., 1998)  
(Ramirez-Villaescusa et al., 2010) 
(Courtenay et al., 2006, Scantlebury et al., 
2004, Phillips et al., 2003, Garnett et al., 2002)  
(Courtenay et al., 2006) 
(Courtenay et al., 2006, Hutchings and Harris, 
1999) 
(Etchechoury et al., 2010, Sunder et al., 2009, 
Evans et al., 2007)  
(Ward et al., 2009, Palmer et al., 2004) 
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On December 14th 2011, it was reported that two pilot badger culls were expected to occur in 
England in the following year ‘to test the safety, efficacy and humaneness of controlled shooting as a 
culling method’ (Anon, 2011c, Anon, 2011b). The theory behind the badger culls is simple: ‘to reduce 
bovine TB in cattle by reducing the number of infected badgers, thus reducing the rate of 
transmission of the disease to cattle’ (Anon, 2011b). Looking at Figure 6.1, this equates to reducing 
environmental contamination more than reducing direct badger-to-cattle transmission, which is not 
reported formally in the literature. Culling is known to increase the amount of overlap of badger 
summer ranges between neighbouring setts and increase animal movement between neighbouring 
and cull setts, encouraging more mixing of animals with different disease status’ (Riordan et al., 
2011). Couple with this the fact that only 34-43% of badgers are removed from a target sett (Riordan 
et al., 2011) and that focus on BTB-infected animals is not possible, and that the BTB SICCT test is 
compromised in cattle with only mild burdens of F. hepatica (Flynn et al., 2007b), meaning that we 
cannot accurately distinguish infected from uninfected animals, we surely cannot justify the local 
elimination of a wildlife species unless we have better control over disease diagnosis in cattle. The 
government proposal (Anon, 2011b) also states that ‘on-farm biosecurity controls [designed to keep 
badgers away from farm yards] are likely only to reduce, not eliminate, TB transmission risks from 
infectious badgers’. Environmental contamination by badgers will still occur but then cattle-to-cattle 
transmission will become more important on such farms, as the main route of BTB transmission. 
Cattle-to-cattle transmission relies on an infected animal having close and prolonged contact with 
susceptible individuals, hence this relies on an infected individual not being diagnosed as such, and 
remaining in the herd to transmit. If the diagnostic tests required to accurately detect BTB-infected 
cattle are compromised by co-infections such as F. hepatica, this must be the crucial step towards 
transmission cessation and thus BTB control. 
On January 28th, 2012, an article was published in the Veterinary Record, announcing the locations of 
the pilot badger culls proposed by DEFRA (Anon, 2012d). This means that farmers from two areas of 
England, west Gloucestershire and west Somerset, will be able to apply for a license to shoot 
badgers on their land. A list of restrictions and criteria for license grants is included and appears to 
be based upon good advice and science. Already though, the final paragraph of this short article is 
cause for concern stating, ‘We already have robust measures to control its [BTB] spread among 
cattle, which we plan to strengthen further’. With the high burdens of F. hepatica in dairy cattle in 
these proposed cull areas (McCann et al., 2010b), and co-infection with F. hepatica and BTB 
compromising the SICCT test accuracy, we have to be suspicious of this statement. Further concern 
is also voiced by The Badger Trust, which legally challenged the badger culls in the High Court but 
129 
 
lost, saying that badger culling could further enhance the spread of BTB and hence neither save 
farmers’ money nor badgers their lives (Anon, 2012a). 
On the 20 March, 2012, John Griffiths, Chief Veterinary Officer for Wales, announced that the Welsh 
Government’s Strategic Framework would be trialling badger vaccination rather than cull plans 
(Anon, 2012g). Although not necessarily a crucial part of the current UK BTB control plan, this spares 
badger lives and will help to reduce the number of susceptible badgers in the local environment of 
Pembrokeshire, where vaccination was initiated on 11 June 2012 (Anon, 2012b). Getting the BTB 
SICCT test working optimally will be the most crucial step, and the new Bovine TB Eradication 
Advisory Group (TBEAG) set up to advice on the development and implementation of BTB control 
this summer seeks to do this, utilising a ‘comprehensive and evidence-based package of measures’ 
(Anon, 2012e). 
Potential steps to be considered in BTB control for England and Wales 
1. In areas where exposure to F. hepatica are considered substantial (McCann et al., 2010b), 
herds with demonstrable exposure to the parasite could be treated with a flukicidal drug 
several weeks prior to SICCT test application, to allow a more functional pro-inflammatory 
response to be elicited if necessary and thus enhance the effectiveness of this test in 
identifying infected cattle. Given that all flukicidal drugs described in the NOAH 
Compendium of Data Sheets for Animal Medicines, at the time of writing this thesis, state a 
milk withhold of 55-67 days in lactating cattle, such a blanket treatment of dairy cattle may 
be impossible unless a move to seasonal calving for the milking herd or beef animal 
production is made on repeat breakdown herds. 
2. In areas with repeat restrictions in place, once SICCT test sensitivity has been restored by 
removal of F. hepatica, identification of badger and deer populations and the testing of 
these populations for signs of BTB may aid in farmer compliance and the eradication of BTB. 
This approach does not utilise the indiscriminate cull methods perceived by many as 
ineffective and inhumane (Wilkinson et al., 2009, Gard, 2011), but targets significant wildlife 
populations that could be contributing to environmental contamination, increasing the 
likelihood of cattle becoming infected. 
3. In areas where pasture contamination with BTB is considered substantial, a move towards 
some form of zero grazing and full time housing of cattle may help reduce transmission, 
provided that grass cut for cattle consumption can be sourced from low-risk pastures with 
minimal badger faecal or urine contamination present (Hutchings and Harris, 1999, 
Hutchings and Harris, 1997) and steps are taken to limit badger access to farm yards. This 
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may involve recruitment of specialist ecologists and veterinary surgeons to survey land for 
such usage.  
4. Point 3 could potentially increase the risk of cattle-to-cattle transmission of BTB, hence on 
farms where badger setts are minimal, a move towards extensive grazing may be more 
appropriate. This would reduce cattle-to-cattle transmission. Coupled with an improvement 
in SICCT test sensitivity by removal of F. hepatica as outlined in point 1, point 3 may still be 
valid. 
5. In endemic regions, herds that continually test positive (one or more reactor or inconclusive 
animals per herd test) may benefit from depopulation and resting of land for a fixed time 
after to lower the burden of environmental BTB on the premises. 
Republic of Ireland, Northern Ireland, New Zealand, Wales and England are considered to have the 
highest herd-level BTB prevalence in the developed world. All have significant F. hepatica prevalence 
in farm stock, plus the potential for wildlife sources to complicate eradication attempts further (e.g. 
possums in New Zealand (Barron et al., 2011), Eurasian badgers and deer populations in Wales, 
England, Republic of Ireland and Northern Ireland (White and Benhin, 2004, Ward et al., 2009)). 
These countries also have significant F. hepatica exposure in livestock (Charleston et al., 1990, 
McCann et al., 2010b, Ross, 1970, Parr and Gray, 2000). It is tempting to blame the BTB situations in 
such countries on the presence of an endemically infected wildlife reservoir, but some countries, 
such as Germany and France, have a lower BTB herd prevalence and are OTF respectively, despite 
the presence of badgers (IUCN, 2012). 
Could it be that co-infection of cattle with F. hepatica and BTB is a major reason for endemically BTB 
infected countries to struggle to detect and eliminate BTB from the national herd? The evidence so 
far would suggest that such a co-infection will only ever render BTB eradication efforts significantly 
harder. 
In New Zealand, a three-pronged approach has been utilised to reduce BTB herd prevalence from 
seven times greater than that in the UK, in 1990, to forty times smaller than the UK herd prevalence 
in 2010 (Anon, 2012h). A test and cull approach, coupled with movement restrictions placed at a 
herd- and area-level are demonstrated alongside a wildlife reservoir control program. It may be this 
stopping of movement of silently -infected cattle in the wider area will stop the spread of BTB more 
efficiently than the herd-only movement restrictions placed in the UK. 
Chapter 5 investigates associations between F. hepatica exposure and on-farm diseases and 
management choices. BTB was only reported on one farm out of the forty sampled, and a milk 
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sample from the infected animal was not tested. However, associations between the use of BVDv 
and leptospirosis vaccinations were demonstrable. Although a humoral response is generated by all 
vaccines against these diseases, the coefficients found in this random effects model suggest 
different associations between diseases. Cattle with high F. hepatica exposure are more likely to 
come from a farm that vaccinates against BVDv but less likely to come from a farm that vaccinates 
against leptospirosis. Spatial distributions of BVDv, Leptospira spp and F. hepatica as explanations of 
why these positive and negative correlations exist are unlikely due to the wide distributions of these 
diseases in the UK.  
Studies conducted in the late 1970s and early 1980s found that co-infection of cattle with 
Salmonella Dublin and F. hepatica led to increased severity of clinical disease, a longer disease 
course and increased likelihood of co-infected animals becoming carriers of S. Dublin. Results from 
Chapter 5 are consistent with this finding suggesting that infection with one pathogen may make 
susceptibility to the other more likely.  
Cattle with a high F. hepatica exposure are less likely to come from a farm with higher numbers of 
suspect Johnes Disease cases. The association between F. hepatica exposure and BTB diagnosis 
could be explained biologically by the down-regulation of the pro-inflammatory immune response 
when F. hepatica infection was present, leading to false negative SICCT test results. The diagnostic 
tests used for Johnes Disease detection in the UK, however, all measure the humoral response to 
infection with Mycobacterium avium subsp. paratuberculosis produced by the animal. Here we are 
invited to consider whether the immunomodulation caused by F. hepatica is likely to be sufficiently 
polarised to reduce antibody production against other pathogens. The answer is not currently 
known. Alternatively, the clinical signs of suspected cases may be considered sufficient to diagnose 
animals with Johnes Disease on a farm, hence the type of test used to formally diagnose such 
animals would be irrelevant. Basing screening for Johnes Disease upon clinical signs is always going 
to produce a grave underestimation of disease on a farm due to the long subclinical incubation of 
the disease and the clinical cases representing the ‘tip of the iceberg’ (Begg et al., 2011). As a 
consequence, the true association between F. hepatica and Johnes Disease may be far more 
pronounced or may be reversed with F. hepatica reducing antibody production in co-infected 
animals, aiding the silent spread of this infection as appears to be the case with F. hepatica and BTB 
(Claridge et al., 2012). One further possibility is that F. hepatica infection has a protective role 
against Johnes Disease, reducing the susceptibility of cattle to co-infection. 
A significant, negative association between the abortion rate of the herd and the F. hepatica 
exposure of the cattle was also observed. Anti-Neospora caninum milk antibody ELISA results were 
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available for analysis but were found to be non-significant in the analysis. As abortion rate is a farm 
level measurement and F. hepatica exposure is measured for each individual animal, the 
interpretation of this finding is not so clear cut. It may be that on the forty farms sampled, Neospora 
caninum was not the abortive agent responsible in high-abortion herds. The negative association 
suggests that abortion occurs more on farms with animals with lower F. hepatica exposures, 
suggesting that F. hepatica may potentially have a protective role against abortion. Other common 
infectious causes of abortion in UK cattle include Salmonella spp and Campylobacter spp. Further 
work would be needed to study the immunology of these agents in co-infected individuals.  
Beef cattle and sheep are important host species for F. hepatica and aid the perpetuation of the 
lifecycle on a farm, increasing the parasite burden available to dairy cattle. Chapter 5 highlights the 
importance of these species in dairy cattle infections with both variables, and the buying-in of beef 
animals onto a farm, being significantly associated with F. hepatica exposure of the dairy cattle. 
Although flukicidal treatment of sheep is routinely done, there are no licensed products offering high 
percentage killing of flukes, for use in lactating animals. The current milk withhold for such drugs is 
57-65 days, making flukicidal treatment a less attractive option, particularly for subclinical infection 
control.  
There is a clear need for a reliable method of control for F. hepatica in cattle. In light of the increase 
in prevalence of infection with F. hepatica in British dairy cattle, the increased spread of disease 
(Pritchard et al., 2005) and the increase in reports describing F. hepatica resistance to 
triclabendazole, vaccination against this trematode offers a safe approach to therapy (Mulcahy et al., 
1999). Research into vaccine development is briefly discussed in the introduction to this thesis, but 
there are currently no vaccine candidates likely to become commercially available in the near future. 
When this does occur, control of F. hepatica will be more successful and subsequently, control over 
other infectious diseases in cattle, such as BTB will be easier. 
In 2005, a DEFRA report showed a consistent, negative association between F. hepatica antibody 
levels and the risk of BTB infection confirmed by PME and laboratory culture results of cattle; a 
finding that was most significant in dairy cattle (DEFRA, 2005b). Furthermore, flukicidal medication 
of cattle was found to be more common among reactor animals compared with in-contacts, 
suggesting that elimination of F. hepatica increases the sensitivity of the SICCT test. Experimental 
investigation of this association showed that co-infection of cattle with F. hepatica and M. bovis does 
appear to reduce the likelihood of BTB diagnosis by modulation of the bovine host immune response 
(Flynn et al., 2007a, Flynn et al., 2007b, Flynn and Mulcahy, 2008a, Flynn et al., 2009, Flynn et al., 
2010). This thesis has studied the association between BTB and F. hepatica exposure in dairy cattle, 
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under field conditions. The result is that a significant negative association has been identified in such 
cattle, in the UK, and the possible under-ascertainment of BTB diagnosis in England and Wales may 
be up to one third (Chapter 3). When looking at this association in individual animals, we show that 
those testing inconclusively to the SICCT test have high F. hepatica exposure (Chapter 4). One 
explanation for these findings is that co-infection with F. hepatica reduces the Th1 response able to 
be mounted against PPD-B utilised by the SICCT test and, as a consequence, the immune response is 
dampened, being pushed from a larger, positive ‘reactor’ result to a lesser, inconclusive result. As we 
have selected our animals on the basis of their SICCT test result and we know this may not be the 
case, we may have a biased sample. Future work should include gathering information about PME 
and laboratory culture of all animals to ascertain true BTB status and F. hepatica burden and 
exposure. 
 
Future work 
There are several further studies that would complement, continue and clarify the work described 
within this thesis.  
1. In chapter 4, we conducted a small scale study comparing F. hepatica burden between SICCT 
test positive and negative cattle (R vs NR) and inconclusive reactor and negative reactor 
cattle (IR vs NR).  Continuation of this study should include individuals from different regions 
of the UK to see if the hypersaturation of F. hepatica PP was clouding a more interesting 
picture of the effects of these two diseases in the field. In different areas of the UK, the 
number of animals testing positive or negative to F. hepatica exposure varied considerably 
and it is feasible that pilot tests in other regions may offer more variety between R-NR or IR-
NR matches. 
2. Permission should be obtained to apply for data on age, lactation stage, yield and 
concurrent disease status for each of the animals tested Chapter 4, and its extensions, to set 
up a model to utilise this information more appropriately. 
3. More in-depth studies, outside of the capabilities of this thesis, need to be done to 
understand the pathogenesis, disease progression beyond the acute phase, immunological 
requirements to a) control and b) eliminate BTB infection in outbred bovine animals. 
Alongside this work, a more in-depth study of co-infection of cattle with F. hepatica and M. 
bovis needs to occur along the lines of previously reported work (Flynn et al., 2009) including 
the PME depth of other reports (DEFRA, 2005), incorporating larger sample sizes than 
experimental infection studies so far have, animals of different production systems (e.g. 
dairy vs. beef), different doses of M. bovis and for differing infection times. Some of the 
results from this and point 4, below, will go to explaining why mathematical models predict 
that we should be finding significantly greater numbers of PME or slaughterhouse cases of 
BTB than are found. 
4. Give varying doses of F hepatica – larger challenges and differing timings – to cattle to 
understand the associations found between SICCT test result intensity and F. hepatica 
134 
 
exposure more clearly. The PME results could shed more light on the relationship between 
‘intensity of infection’ and the likelihood of testing SICCT test positive. 
5. Application to the Scottish Agricultural College for data regarding BTB testing and in 
particular pre- and post-movement testing by Scottish cattle herds, along with bulk milk tank 
samples from a large number of dairy herds, and a similar analysis run to that outlined in 
Chapter 3, to study the differences in management, climate and testing protocols that may 
have allowed Scotland to become OTF. 
  
135 
 
References 
ABRIL, C., ENGELS, M., LIMAN, A., HILBE, M., ALBINI, S., FRANCHINI, M., SUTER, M. & ACKERMANN, 
M. 2004. Both viral and host factors contribute to neurovirulence of bovine herpesviruses 1 
and 5 in interferon receptor-deficient mice. J Virol, 78, 3644-53. 
ABROUS, M., RONDELAUD, D. & DREYFUSS, G. 1999. Paramphistomum daubneyi and Fasciola 
hepatica: influence of temperature changes on the shedding of cercariae from dually 
infected Lymnaea truncatula. Parasitol Res, 85, 765-9. 
ABROUS, M., RONDELAUD, D. & DREYFUSS, G. 2000. A field study of natural infections in three 
freshwater snails with Fasciola hepatica and/or Paramphistomum daubneyi in central 
France. J.Helminthol., 74, 189-194. 
AITKEN, M. M., HUGHES, D. L. & JONES, P. W. 1980. Effects of Fasciola hepatica infection on 
responses of rats to reinfection with Salmonella dublin. Res.Vet.Sci., 28, 250-253. 
AITKEN, M. M., HUGHES, D. L., JONES, P. W., HALL, G. A. & COLLIS, K. A. 1978. Effects of intravenous 
Salmonella dublin on cattle at different stages of Fasciola hepatica infection. J.Comp Pathol., 
88, 433-442. 
AITKEN, M. M., HUGHES, D. L., JONES, P. W., HALL, G. A. & SMITH, G. S. 1979. Immunological 
responses of fluke-infected and fluke-free cattle to Salmonella dublin and other antigens. 
Res.Vet.Sci., 27, 306-312. 
AITKEN, M. M., JONES, P. W., HALL, G. A., HUGHES, D. L. & BROWN, G. T. 1981. Responses of fluke-
infected and fluke-free cattle to experimental reinfection with Salmonella dublin. Res Vet 
Sci, 31, 120-6. 
AL-HABBIB, W. 1974. The effect of constant and changing temperatures on the development of 
larval stages of Fasciola hepatica (L.). PhD Thesis, University of Dublin, Ireland. 
ANDERSON, M. L., REYNOLDS, J. P., ROWE, J. D., SVERLOW, K. W., PACKHAM, A. E., BARR, B. C. & 
CONRAD, P. A. 1997. Evidence of vertical transmission of Neospora sp infection in dairy 
cattle. J Am Vet Med Assoc, 210, 1169-72. 
ANDERSON, R. M., MERCER, J. G., WILSON, R. A. & CARTER, N. P. 1982. Transmission of Schistosoma 
mansoni from man to snail: experimental studies of miracidial survival and infectivity in 
relation to larval age, water temperature, host size and host age. Parasitology, 85 (Pt 2), 
339-60. 
ANDREWS, S. 1999. The Life Cycle of Fasciola hepatica. In: Fasciolosis, Edited by J.P. Dalton, 1-30. 
ANON 2001. BVD Control - Position Paper. EU thematic network on control of bovine viral diarrhoea 
virus (BVDv), QLRT 2001-01573. 
ANON 2002. Veterinary Investigation Surveillance Report 2002 and 1995-2002 (VIDA) HMSO, Central 
Veterinary Laboratory, New Haw, Surrey. 9. 
ANON 2009. Scotland to apply for bovine TB-free status. Veterinary Record, 165, 246. 
ANON 2011a. Bovine tuberculosis statistics and costs. http://www.bovinetb.info/. 
ANON 2011b. The Government's policy on Bovine TB and badger control in England. 
www.defra.gov.uk/publications/2011/12/14/pb13691-bovine-tb-badger-control/, 1-38. 
ANON 2011c. Pilot badger culls to go ahead in England. Veterinary Record, 169, 668. 
ANON 2012a. Badger Trust threatens legal challenge to culling decision. Veterinary Record, 170, 166. 
ANON 2012b. Badger vaccination starts in Wales. Veterinary Record, 170, 633. 
ANON 2012c. Bovine Viral Diarrhoea (BVD). http://vla.defra.gov.uk/science/sci_bvd.htm, AHVLA. 
ANON 2012d. Defra announces locations of pilot badger culls. Veterinary Record, 170, 89. 
ANON 2012e. New group formed to advise on TB eradication. Veterinary Record, 170, 659. 
ANON 2012f. Tuberculosis. 
http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuid
ance/Browsable/DH_4985677. 
ANON 2012g. Vaccination, not badger culling, to help control bovine TB in Wales. Veterinary Record, 
170, 297. 
136 
 
ANON 2012h. Ways in which New Zealand has reduced bovine TB. bovinetb.info/newzealand.php. 
ANTOGNOLI, M. C., HIRST, H. L., GARRY, F. B. & SALMAN, M. D. 2007. Immune response to and 
faecal shedding of Mycobacterium avium ssp. paratuberculosis in young dairy calves, and 
the association between test results in the calves and the infection status of their dams. 
Zoonoses Public Health, 54, 152-9. 
AWAH NDUKUM, J., KUDI, A. C., BRADLEY, G., ANE-ANYANGWE, I. N., FON-TEBUG, S. & 
TCHOUMBOUE, J. 2010. Prevalence of bovine tuberculosis in abattoirs of the littoral and 
Western highland regions of cameroon: a cause for public health concern. Vet Med Int, 
2010, 495015. 
AYELE, W. Y., NEILL, S. D., ZINSSTAG, J., WEISS, M. G. & PAVLIK, I. 2004. Bovine tuberculosis: an old 
disease but a new threat to Africa. Int.J.Tuberc.Lung Dis., 8, 924-937. 
BABIUK, L. A., OHMANN, H. B., GIFFORD, G., CZARNIECKI, C. W., SCIALLI, V. T. & HAMILTON, E. B. 
1985. Effect of bovine alpha 1 interferon on bovine herpesvirus type 1-induced respiratory 
disease. J Gen Virol, 66 ( Pt 11), 2383-94. 
BABU, S., BHAT, S. Q., KUMAR, N. P., ANURADHA, R., KUMARAN, P., GOPI, P. G., KOLAPPAN, C., 
KUMARASWAMI, V. & NUTMAN, T. B. 2009. Attenuation of toll-like receptor expression and 
function in latent tuberculosis by coexistent filarial infection with restoration following 
antifilarial chemotherapy. PLoS Negl Trop Dis, 3, e489. 
BALCEWICZ-SABLINSKA, M. K., KEANE, J., KORNFIELD, H. & REMOLD, H. G. 1998. Pathogenic 
Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, 
resulting in activation of TNF-alpha. Journal of Immunology, 161, 2636-2641. 
BANCHEREAU, J. & STEINMAN, R. M. 1998. Dendritic cells and the control of immunity. Nature, 392, 
245-52. 
BARR, B. C., ANDERSON, M. L., DUBEY, J. P. & CONRAD, P. A. 1991. Neospora-like protozoal 
infections associated with bovine abortions. Vet Pathol, 28, 110-6. 
BARRON, M., PECH, R., WHITFORD, J., YOCKNEY, I., DE LISLE, G. & NUGENT, G. 2011. Longevity of 
Mycobacterium bovis in brushtail possum (Trichosurus vulpecula) carcasses, and contact 
rates between possums and carcasses. N Z Vet J, 59, 209-17. 
BARRY, C., CORBETT, D., BAKKER, D., ANDERSEN, P., MCNAIR, J. & STRAIN, S. 2011. The Effect of 
Mycobacterium avium Complex Infections on Routine Mycobacterium bovis Diagnostic 
Tests. Vet Med Int, 145092. 
BEAUDEAU, F., BELLIARD, M., JOLY, A. & SEEGERS, H. 2007. Reduction in milk yield associated with 
Mycobacterium avium subspecies paratuberculosis (Map) infection in dairy cows. Vet Res, 
38, 625-34. 
BEGG, D. J., DE SILVA, K., CARTER, N., PLAIN, K. M., PURDIE, A. & WHITTINGTON, R. J. 2011. Does a 
Th1 over Th2 dominancy really exist in the early stages of Mycobacterium avium subspecies 
paratuberculosis infections? Immunobiology, 216, 840-846. 
BELKAID, Y., BLANK, R. B. & SUFFIA, I. 2006. Natural regulatory T cells and parasites: a common quest 
for host homeostasis. Immunol Rev, 212, 287-300. 
BENNEMA, S. C., DUCHEYNE, E., VERCRUYSSE, J., CLAEREBOUT, E., HENDRICKX, G. & CHARLIER, J. 
2011. Relative importance of management, meteorological and environmental factors in the 
spatial distribution of Fasciola hepatica in dairy cattle in a temperate climate zone. 
Int.J.Parasitol., 41, 225-233. 
BENNETT, R. M., CHRISTIANSEN, K. & CLIFTON-HADLEY, R. S. 1999. Estimating the costs associated 
with endemic diseases of dairy cattle. J Dairy Res, 66, 455-9. 
BISHOP, H., ERKELENS, J. & VAN WINDEN, S. 2010. Indications of a relationship between buying-in 
policy and infectious diseases on dairy farms in Wales. Vet Rec, 167, 644-7. 
BLACK, G. F., WEIR, R. E., FLOYD, S., BLISS, L., WARNDORFF, D. K., CRAMPIN, A. C., NGWIRA, B., 
SICHALI, L., NAZARETH, B., BLACKWELL, J. M., BRANSON, K., CHAGULUKA, S. D., DONOVAN, 
L., JARMAN, E., KING, E., FINE, P. E. & DOCKRELL, H. M. 2002. BCG-induced increase in 
137 
 
interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in 
Malawi and the UK: two randomised controlled studies. Lancet, 359, 1393-401. 
BOCK, N. & REICHMAN, L. B. 2004. Tuberculosis and HIV/AIDS: epidemiological and clinical aspects 
(world perspective). Semin Respir Crit Care Med, 25, 337-44. 
BODNAR, K. A., SERBINA, N. V. & FLYNN, J. L. 2001. Fate of Mycobacterium tuberculosis within 
murine dendritic cells. Infect Immun, 69, 800-9. 
BORAY, J. C. 1969. Experimental fascioliasis in Australia. Adv Parasitol, 7, 95-210. 
BORAY, J. C., CROWFOOT, P. D., STRONG, M. B., ALLISON, J. R., SCHELLENBAUM, M., VON, O. M. & 
SARASIN, G. 1983. Treatment of immature and mature Fasciola hepatica infections in sheep 
with triclabendazole. Vet.Rec., 113, 315-317. 
BORGSTEEDE, F. H., MOLL, L., VELLEMA, P. & GAASENBEEK, C. P. 2005. Lack of reversion in 
triclabendazole-resistant Fasciola hepatica. Vet.Rec., 156, 350-351. 
BOSSAERT, K., FARNIR, F., LECLIPTEUX, T., PROTZ, M., LONNEUX, J. F. & LOSSON, B. 2000. Humoral 
immune response in calves to single-dose, trickle and challenge infections with Fasciola 
hepatica. Vet.Parasitol., 87, 103-123. 
BRACKENBURY, L. S., CARR, B. V. & CHARLESTON, B. 2003. Aspects of the innate and adaptive 
immune responses to acute infections with BVDV. Vet Microbiol, 96, 337-44. 
BRADY, C., O'GRADY, D., O'MEARA, F., EGAN, J. & BASSETT, H. 2008. Relationships between clinical 
signs, pathological changes and tissue distribution of Mycobacterium avium subspecies 
paratuberculosis in 21 cows from herds affected by Johne's disease. Vet Rec, 162, 147-52. 
BRADY, M. T., O'NEILL, S. M., DALTON, J. P. & MILLS, K. H. 1999. Fasciola hepatica suppresses a 
protective Th1 response against Bordetella pertussis. Infect.Immun., 67, 5372-5378. 
BREWER, T. F. & HEYMANN, S. J. 2004. To control and beyond: moving towards eliminating the 
global tuberculosis threat. J Epidemiol Community Health, 58, 822-5. 
BROWN, M., MIIRO, G., NKURUNZIZA, P., WATERA, C., QUIGLEY, M. A., DUNNE, D. W., WHITWORTH, 
J. A. & ELLIOTT, A. M. 2006. Schistosoma mansoni, nematode infections, and progression to 
active tuberculosis among HIV-1-infected Ugandans. Am J Trop Med Hyg, 74, 819-25. 
BROWN, R. A., BLUMERMAN, S., GAY, C., BOLIN, C., DUBY, R. & BALDWIN, C. L. 2003. Comparison of 
three different leptospiral vaccines for induction of a type 1 immune response to Leptospira 
borgpetersenii serovar Hardjo. Vaccine, 21, 4448-4458. 
BROWN, W. C., DAVIS, W. C., DOBBELAERE, D. A. & RICE-FICHT, A. C. 1994a. CD4+ T-cell clones 
obtained from cattle chronically infected with Fasciola hepatica and specific for adult worm 
antigen express both unrestricted and Th2 cytokine profiles. Infect Immun, 62, 818-27. 
BROWN, W. C., DAVIS, W. C., DOBBELAERE, D. A. & RICE-FICHT, A. C. 1994b. CD4+ T-cell clones 
obtained from cattle chronically infected with Fasciola hepatica and specific for adult worm 
antigen express both unrestricted and Th2 cytokine profiles. Infect.Immun., 62, 818-827. 
BROWNLIE, J. 1990. Pathogenesis of mucosal disease and molecular aspects of bovine virus 
diarrhoea virus. Vet Microbiol, 23, 371-82. 
BROWNLIE, J., CLARKE, M. C. & HOWARD, C. J. 1989. Experimental infection of cattle in early 
pregnancy with a cytopathic strain of bovine virus diarrhoea virus. Res Vet Sci, 46, 307-11. 
BROWNLIE, J., NUTTALL, P. A., STOTT, E. J., TAYLOR, G. & THOMAS, L. H. 1980. Experimental 
infection of calves with two strains of bovine virus diarrhoea virus: certain immunological 
reactions. Vet Immunol Immunopathol, 1, 371-8. 
BRUSCHKE, C. J., HAGHPARAST, A., HOEK, A., RUTTEN, V. P., WENTINK, G. H., VAN RIJN, P. A. & VAN 
OIRSCHOT, J. T. 1998. The immune response of cattle, persistently infected with 
noncytopathic BVDV, after superinfection with antigenically semi-homologous cytopathic 
BVDV. Vet Immunol Immunopathol, 62, 37-50. 
BRYANT, N. A., DAVIS-POYNTER, N., VANDERPLASSCHEN, A. & ALCAMI, A. 2003. Glycoprotein G 
isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding 
proteins. EMBO J, 22, 833-46. 
138 
 
BUDDLE, B. M., LIVINGSTONE, P. G. & DE LISLE, G. W. 2009. Advances in ante-mortem diagnosis of 
tuberculosis in cattle. N.Z.Vet.J., 57, 173-180. 
CANCELA, M., ACOSTA, D., RINALDI, G., SILVA, E., DURAN, R., ROCHE, L., ZAHA, A., CARMONA, C. & 
TORT, J. F. 2008. A distinctive repertoire of cathepsins is expressed by juvenile invasive 
Fasciola hepatica. Biochimie, 90, 1461-1475. 
CARRIQUE-MAS, J. J., MEDLEY, G. F. & GREEN, L. E. 2008. Risks for bovine tuberculosis in British 
cattle farms restocked after the foot and mouth disease epidemic of 2001. Prev Vet Med, 84, 
85-93. 
CASSIDY, J. P., BRYSON, D. G., GUTIERREZ CANCELA, M. M., FORSTER, F., POLLOCK, J. M. & NEILL, S. 
D. 2001. Lymphocyte subtypes in experimentally induced early-stage bovine tuberculous 
lesions. J Comp Pathol, 124, 46-51. 
CASTRUCCI, G., FERRARI, M., TRALDI, V. & TARTAGLIONE, E. 1992. Effects in calves of mixed 
infections with bovine viral diarrhea virus and several other bovine viruses. Comp Immunol 
Microbiol Infect Dis, 15, 261-70. 
CHAMBERS, M. A., WHELAN, A. O., SPALLEK, R., SINGH, M., CODDEVILLE, B., GUERARDEL, Y. & ELASS, 
E. 2010. Non-acylated Mycobacterium bovis glycoprotein MPB83 binds to TLR1/2 and 
stimulates production of matrix metalloproteinase 9. Biochem Biophys Res Commun, 400, 
403-8. 
CHARLESTON, B., HOPE, J. C., CARR, B. V. & HOWARD, C. J. 2001. Masking of two in vitro 
immunological assays for Mycobacterium bovis (BCG) in calves acutely infected with non-
cytopathic bovine viral diarrhoea virus. Vet Rec, 149, 481-4. 
CHARLESTON, W. A., KISSLING, R. C., PETREY, L. A., MARSHALL, B. L. & ROYAL, W. A. 1990. Liver fluke 
(Fasciola hepatica) in slaughtered sheep and cattle in New Zealand, 1984-85. N Z Vet J, 38, 
69-71. 
CHARLIER, J., BENNEMA, S. C., CARON, Y., COUNOTTE, M., DUCHEYNE, E., HENDRICKX, G. & 
VERCRUYSSE, J. 2011. Towards assessing fine-scale indicators for the spatial transmission risk 
of Fasciola hepatica in cattle. Geospat Health, 5, 239-45. 
CHARLIER, J., DE, M. L., CLAEREBOUT, E., WILLIAMS, D. & VERCRUYSSE, J. 2008. Qualitative and 
quantitative evaluation of coprological and serological techniques for the diagnosis of 
fasciolosis in cattle. Vet.Parasitol., 153, 44-51. 
CHARLIER, J., DUCHATEAU, L., CLAEREBOUT, E., WILLIAMS, D. & VERCRUYSSE, J. 2007. Associations 
between anti-Fasciola hepatica antibody levels in bulk-tank milk samples and production 
parameters in dairy herds. Prev.Vet.Med., 78, 57-66. 
CHIODINI, R. J., VAN KRUININGEN, H. J. & MERKAL, R. S. 1984. Ruminant paratuberculosis (Johne's 
disease): the current status and future prospects. Cornell Vet, 74, 218-62. 
CLARIDGE, J., DIGGLE, P., MCCANN, C. M., MULCAHY, G., FLYNN, R., MCNAIR, J., STRAIN, S., WELSH, 
M., BAYLIS, M. & WILLIAMS, D. J. L. 2012. Fasciola hepatica is associated with the failure to 
detect bovine tuberculosis in dairy cattle. Nature Communications. 
CLERY, D., TORGERSON, P. & MULCAHY, G. 1996. Immune responses of chronically infected adult 
cattle to Fasciola hepatica. Vet.Parasitol., 62, 71-82. 
CLERY, D. G. & MULCAHY, G. 1998. Lymphocyte and cytokine responses of young cattle during 
primary infection with Fasciola hepatica. Res.Vet.Sci., 65, 169-171. 
COLLINS, C. H. & GRANGE, J. M. 1983. The bovine tubercle bacillus. J Appl Bacteriol, 55, 13-29. 
COOKE, F. N., PENNINGTON, K. A., YANG, Q. & EALY, A. D. 2009. Several fibroblast growth factors are 
expressed during pre-attachment bovine conceptus development and regulate interferon-
tau expression from trophectoderm. Reproduction, 137, 259-69. 
CORBA, J., ARMOUR, J., ROBERTS, R. J. & URQUHART, G. M. 1971. Transfer of immunity to Fasciola 
hepatica infection by lymphoid cells. Res.Vet.Sci., 12, 292-295. 
COSIVI, O., GRANGE, J. M., DABORN, C. J., RAVIGLIONE, M. C., FUJIKURA, T., COUSINS, D., ROBINSON, 
R. A., HUCHZERMEYER, H. F., DE KANTOR, I. & MESLIN, F. X. 1998. Zoonotic tuberculosis due 
to Mycobacterium bovis in developing countries. Emerg Infect Dis, 4, 59-70. 
139 
 
COSTELLO, E., DOHERTY, M. L., MONAGHAN, M. L., QUIGLEY, F. C. & O'REILLY, P. F. 1998. A study of 
cattle-to-cattle transmission of Mycobacterium bovis infection. Vet.J., 155, 245-250. 
COURTENAY, O., REILLY, L. A., SWEENEY, F. P., HIBBERD, V., BRYAN, S., UL-HASSAN, A., NEWMAN, C., 
MACDONALD, D. W., DELAHAY, R. J., WILSON, G. J. & WELLINGTON, E. M. 2006. Is 
Mycobacterium bovis in the environment important for the persistence of bovine 
tuberculosis? Biol.Lett., 2, 460-462. 
COUSSENS, P. M. 2004. Model for immune responses to Mycobacterium avium subspecies 
paratuberculosis in cattle. Infect Immun, 72, 3089-96. 
COUSSENS, P. M., PUDRITH, C. B., SKOVGAARD, K., REN, X., SUCHYTA, S. P., STABEL, J. R. & 
HEEGAARD, P. M. 2005. Johne's disease in cattle is associated with enhanced expression of 
genes encoding IL-5, GATA-3, tissue inhibitors of matrix metalloproteinases 1 and 2, and 
factors promoting apoptosis in peripheral blood mononuclear cells. Vet Immunol 
Immunopathol, 105, 221-34. 
DANIEL, R. & MITCHELL, S. 2002. Fasciolosis in cattle and sheep. Vet.Rec., 151, 219. 
DAVIES, C. & GOOSE, J. 1981. Killing of newly excysted juveniles of Fasciola hepatica in sensitized 
rats. Parasite Immunol, 3, 81-96. 
DAVISON, H. C., OTTER, A. & TREES, A. J. 1999. Estimation of vertical and horizontal transmission 
parameters of Neospora caninum infections in dairy cattle. Int J Parasitol, 29, 1683-9. 
DE CHASTELLIER, C. 2009. The many niches and strategies used by pathogenic mycobacteria for 
survival within host macrophages. Immunobiology, 214, 526-42. 
DE LA RUA-DOMENECH, R. 2006. Human Mycobacterium bovis infection in the United Kingdom: 
Incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis. 
Tuberculosis (Edinb), 86, 77-109. 
DE LA RUA-DOMENECH, R., GOODCHILD, A. T., VORDERMEIER, H. M., HEWINSON, R. G., 
CHRISTIANSEN, K. H. & CLIFTON-HADLEY, R. S. 2006. Ante mortem diagnosis of tuberculosis 
in cattle: a review of the tuberculin tests, gamma-interferon assay and other ancillary 
diagnostic techniques. Res Vet Sci, 81, 190-210. 
DEFRA 2005a. Government Strategic Framework for the Sustainable Control of Bovine Tuberculosis 
(bTB) in Great Britain. DEFRA, London. 
DEFRA 2005b. Pathogenesis and diagnosis of tuberculosis in cattle - complementary field studies. In: 
SE3013, P. (ed.) DEFRA Research Project Final Report SID5. 
http://randd.defra.gov.uk/Default.aspx?Menu=Menu&Module=More&Location=None&Proj
ectID=9317. 
DEFRA 2007. Options for vaccinating cattle against bovine tuberculosis. 
http://archive.defra.gov.uk/foodfarm/farmanimal/diseases/atoz/tb/vaccination/index.htm, 
1-79. 
DEFRA 2010. Bovine tuberculosis: infection status in cattle. Mid-year surveillance report for the 
period July 2009-June 2010. 
DEFRA 2011a. http://archive.defra.gov.uk/foodfarm/farmanimal/diseases/atoz/brucellosis/. 
DEFRA. 2011b. 
http://archive.defra.gov.uk/foodfarm/farmanimal/diseases/atoz/tb/stats/county.htm 
[Online]. 
DEFRA 2011c. www.defra.gov.uk/animal-diseases/a-z/bovine-tb/about-bovine-tb/. 
DEKA, D., RAMNEEK, MAITI, N. K. & OBEROI, M. S. 2005. Detection of bovine herpesvirus-1 infection 
in breeding bull semen by virus isolation and polymerase chain reaction. Rev Sci Tech, 24, 
1085-94. 
DIAZ, A. & ALLEN, J. E. 2007. Mapping immune response profiles: the emerging scenario from 
helminth immunology. Eur J Immunol, 37, 3319-26. 
DIEGUEZ, F. J., ARNAIZ, I., SANJUAN, M. L., VILAR, M. J. & YUS, E. 2008. Management practices 
associated with Mycobacterium avium subspecies paratuberculosis infection and the effects 
of the infection on dairy herds. Vet Rec, 162, 614-7. 
140 
 
DIGGLE, P. J. 2011. Estimating Prevalence Using an Imperfect Test. Epidemiology Research 
International, 2011, 1-5. 
DIGGLE, P. J. & RIBEIRO, P. J. 2006. Model-based Geo-statistics, Springer. 
DIXON, K. E. 1966. The physiology of excystment of the metacercaria of Fasciola hepatica L. 
Parasitology, 56, 431-456. 
DONNELLY, S., O'NEILL, S. M., SEKIYA, M., MULCAHY, G. & DALTON, J. P. 2005. Thioredoxin 
peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages. 
Infect.Immun., 73, 166-173. 
DONNELLY, S., O'NEILL, S. M., STACK, C. M., ROBINSON, M. W., TURNBULL, L., WHITCHURCH, C. & 
DALTON, J. P. 2010a. Helminth cysteine proteases inhibit TRIF-dependent activation of 
macrophages via degradation of TLR3. J.Biol.Chem., 285, 3383-3392. 
DONNELLY, S., O'NEILL, S. M., STACK, C. M., ROBINSON, M. W., TURNBULL, L., WHITCHURCH, C. & 
DALTON, J. P. 2010b. Helminth cysteine proteases inhibit TRIF-dependent activation of 
macrophages via degradation of TLR3. J Biol Chem, 285, 3383-92. 
DONNELLY, S., STACK, C. M., O'NEILL, S. M., SAYED, A. A., WILLIAMS, D. L. & DALTON, J. P. 2008. 
Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving 
alternatively activated macrophages. FASEB J., 22, 4022-4032. 
DOW, C., ROSS, J. G. & TODD, J. R. 1968. The histopathology of Fasciola hepatica infections in sheep. 
Parasitology, 58, 129-35. 
DOWLING, D. J., HAMILTON, C. M., DONNELLY, S., LA COURSE, J., BROPHY, P. M., DALTON, J. & 
O'NEILL, S. M. 2010. Major secretory antigens of the helminth Fasciola hepatica activate a 
suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 
immune responses. Infect Immun, 78, 793-801. 
DOY, T. G. & HUGHES, D. L. 1982. In vitro cell adherence to newly excysted Fasciola hepatica: failure 
to affect their subsequent development in rats. Res.Vet.Sci., 32, 118-120. 
DOY, T. G., HUGHES, D. L. & HARNESS, E. 1980. The selective adherence of rat eosinophils to newly 
excysted Fasciola hepatica in vitro. Res.Vet.Sci., 29, 98-101. 
DUFFUS, W. P. & FRANKS, D. 1981. The interaction in vitro between bovine immunoglobulin and 
juvenile Fasciola hepatica. Parasitology, 82, 1-10. 
DUTRA, L. H., MOLENTO, M. B., NAUMANN, C. R., BIONDO, A. W., FORTES, F. S., SAVIO, D. & 
MALONE, J. B. 2010. Mapping risk of bovine fasciolosis in the south of Brazil using 
Geographic Information Systems. Vet.Parasitol., 169, 76-81. 
EEC 1964. Coucil Directive 64/432/EEC on animal health problems affecting intra-community trade in 
bovine animals and swine. Official Journal, 121, 1977-2012. 
EISENBERG, S., NIELEN, M., HOEBOER, J., BOUMAN, M., HEEDERIK, D. & KOETS, A. 2011. 
Mycobacterium avium subspecies paratuberculosis in bioaerosols after depopulation and 
cleaning of two cattle barns. Vet Rec, 168, 587-561. 
ELIAS, D., AKUFFO, H., THORS, C., PAWLOWSKI, A. & BRITTON, S. 2005. Low dose chronic 
Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG 
infection in mice. Clin Exp Immunol, 139, 398-404. 
ELIAS, D., BRITTON, S., ASEFFA, A., ENGERS, H. & AKUFFO, H. 2008. Poor immunogenicity of BCG in 
helminth infected population is associated with increased in vitro TGF-beta production. 
Vaccine, 26, 3897-902. 
ELIAS, D., WOLDAY, D., AKUFFO, H., PETROS, B., BRONNER, U. & BRITTON, S. 2001. Effect of 
deworming on human T cell responses to mycobacterial antigens in helminth-exposed 
individuals before and after bacille Calmette-Guerin (BCG) vaccination. Clin Exp Immunol, 
123, 219-25. 
ELLIOTT, A. M., KYOSIIMIRE, J., QUIGLEY, M. A., NAKIYINGI, J., WATERA, C., BROWN, M., JOSEPH, S., 
FRENCH, N., GILKS, C. F. & WHITWORTH, J. A. 2003. Eosinophilia and progression to active 
tuberculosis in HIV-1-infected Ugandans. Trans R Soc Trop Med Hyg, 97, 477-80. 
141 
 
ELLIOTT, A. M., MAWA, P. A., WEBB, E. L., NAMPIJJA, M., LYADDA, N., BUKUSUBA, J., KIZZA, M., 
NAMUJJU, P. B., NABULIME, J., NDIBAZZA, J., MUWANGA, M. & WHITWORTH, J. A. 2010. 
Effects of maternal and infant co-infections, and of maternal immunisation, on the infant 
response to BCG and tetanus immunisation. Vaccine, 29, 247-55. 
ELLIS, W. A., O'BRIEN, J. J., BRYSON, D. G. & MACKIE, D. P. 1985. Bovine leptospirosis: some clinical 
features of serovar hardjo infection. Vet Rec, 117, 101-4. 
ELLIS, W. A., O'BRIEN, J. J. & CASSELLS, J. 1981. Role of cattle in the maintenance of Leptospira 
interrogans serotype hardjo infection in Northern Ireland. Vet Rec, 108, 555-7. 
ELY, E. R. & UPTON, P. A. 2010. Bovine tuberculosis: infection status in cattle. Mid-year surveillance 
report for the period July 2009-June 2010. Commissioned by the DEFRA under project 
SB4500. 
ESTES, D. M., HIRANO, A., HEUSSLER, V. T., DOBBELAERE, D. A. & BROWN, W. C. 1995. Expression 
and biological activities of bovine interleukin 4: effects of recombinant bovine interleukin 4 
on T cell proliferation and B cell differentiation and proliferation in vitro. Cell Immunol, 163, 
268-79. 
ETCHECHOURY, I., VALENCIA, G. E., MORCILLO, N., SEQUEIRA, M. D., IMPERIALE, B., LOPEZ, M., 
CAIMI, K., ZUMARRAGA, M. J., CATALDI, A. & ROMANO, M. I. 2010. Molecular typing of 
Mycobacterium bovis isolates in Argentina: first description of a person-to-person 
transmission case. Zoonoses Public Health, 57, 375-81. 
EVANS, J. T., SMITH, E. G., BANERJEE, A., SMITH, R. M., DALE, J., INNES, J. A., HUNT, D., TWEDDELL, 
A., WOOD, A., ANDERSON, C., HEWINSON, R. G., SMITH, N. H., HAWKEY, P. M. & 
SONNENBERG, P. 2007. Cluster of human tuberculosis caused by Mycobacterium bovis: 
evidence for person-to-person transmission in the UK. Lancet, 369, 1270-1276. 
EVERETT, R. D. 2000. ICP0, a regulator of herpes simplex virus during lytic and latent infection. 
Bioessays, 22, 761-70. 
FAIRWEATHER, I. 2009. Triclabendazole progress report, 2005-2009: an advancement of learning? J 
Helminthol, 83, 139-50. 
FELSTEAD, S. 2005. Prevalence of Neospora caninum in dairy cattle in England and Wales using a 
recently developed and validated N. caninum Bulk Milk ELISA. PhD Thesis: Manuscript II. 
FIGUEIREDO, E. E., RAMOS, D. F., MEDEIROS, L., SILVESTRE, F. G., LILENBAUM, W., SILVA, J. T., 
PASCHOALIN, V. M. & DELLAGOSTIN, O. A. 2011. Multiple strains of Mycobacterium bovis 
revealed by molecular typing in a herd of cattle. Veterinary Journal. 
FLYNN, R. J., IRWIN, J. A., OLIVIER, M., SEKIYA, M., DALTON, J. P. & MULCAHY, G. 2007a. Alternative 
activation of ruminant macrophages by Fasciola hepatica. Vet.Immunol.Immunopathol., 120, 
31-40. 
FLYNN, R. J., MANNION, C., GOLDEN, O., HACARIZ, O. & MULCAHY, G. 2007b. Experimental Fasciola 
hepatica infection alters responses to tests used for diagnosis of bovine tuberculosis. 
Infect.Immun., 75, 1373-1381. 
FLYNN, R. J. & MULCAHY, G. 2008a. Possible role for Toll-like receptors in interaction of Fasciola 
hepatica excretory/secretory products with bovine macrophages. Infect.Immun., 76, 678-
684. 
FLYNN, R. J. & MULCAHY, G. 2008b. The roles of IL-10 and TGF-beta in controlling IL-4 and IFN-
gamma production during experimental Fasciola hepatica infection. Int.J.Parasitol., 38, 1673-
1680. 
FLYNN, R. J., MULCAHY, G. & ELSHEIKHA, H. M. 2010. Coordinating innate and adaptive immunity in 
Fasciola hepatica infection: implications for control. Vet.Parasitol., 169, 235-240. 
FLYNN, R. J., MULCAHY, G., WELSH, M., CASSIDY, J. P., CORBETT, D., MILLIGAN, C., ANDERSEN, P., 
STRAIN, S. & MCNAIR, J. 2009. Co-Infection of cattle with Fasciola hepatica and 
Mycobacterium bovis- immunological consequences. Transbound.Emerg.Dis., 56, 269-274. 
FOX, N. J., WHITE, P. C., MCCLEAN, C. J., MARION, G., EVANS, A. & HUTCHINGS, M. R. 2011. 
Predicting impacts of climate change on Fasciola hepatica risk. PLoS One, 6, e16126. 
142 
 
FRITSCHE, A., ENGEL, R., BUHL, D. & ZELLWEGER, J. P. 2004. Mycobacterium bovis tuberculosis: from 
animal to man and back. Int.J.Tuberc.Lung Dis., 8, 903-904. 
FROYD, G. 1975. Liver fluke in Great Britain: a survey of affected livers. Vet.Rec., 97, 492-495. 
FUENTES, M. V., SAINZ-ELIPE, S., NIETO, P., MALONE, J. B. & MAS-COMA, S. 2005. Geographical 
Information Systems risk assessment models for zoonotic fascioliasis in the South American 
Andes region. Parassitologia, 47, 151-156. 
FULTON, R. W., PURDY, C. W., CONFER, A. W., SALIKI, J. T., LOAN, R. W., BRIGGS, R. E. & BURGE, L. J. 
2000. Bovine viral diarrhea viral infections in feeder calves with respiratory disease: 
interactions with Pasteurella spp., parainfluenza-3 virus, and bovine respiratory syncytial 
virus. Can J Vet Res, 64, 151-9. 
GANNON, B. W., HAYES, C. M. & ROE, J. M. 2007. Survival rate of airborne Mycobacterium bovis. Res 
Vet Sci, 82, 169-72. 
GARD, R. 2011. Importance of Understanding Badgers. Veterinary Practice, 46. 
GARNETT, B. T., DELAHAY, R. J. & ROPER, T. J. 2002. Use of cattle farm resources by badgers (Meles 
meles) and risk of bovine tuberculosis (Mycobacterium bovis) transmission to cattle. 
Proc.Biol.Sci., 269, 1487-1491. 
GETTINBY, G., HOPE-CAWDERY, M. J. & GRAINGEN, J. N. 1974. Forecasting the incidence of 
fascioliasis from climatic data. Int.J.Biometeorol., 18, 319-323. 
GIACOMINI, E., IONA, E., FERRONI, L., MIETTINEN, M., FATTORINI, L., OREFICI, G., JULKUNEN, I. & 
COCCIA, E. M. 2001. Infection of human macrophages and dendritic cells with 
Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates 
T cell response. J Immunol, 166, 7033-41. 
GILBERT, M., MITCHELL, A., BOURN, D., MAWDSLEY, J., CLIFTON-HADLEY, R. & WINT, W. 2005. Cattle 
movements and bovine tuberculosis in Great Britain. Nature, 435, 491-6. 
GOMOT, A. 1990. Photoperiod and temperature interaction in the determination of reproduction of 
the edible snail, Helix pomatia. J Reprod Fertil, 90, 581-5. 
GONZALEZ, J., GEIJO, M. V., GARCIA-PARIENTE, C., VERNA, A., CORPA, J. M., REYES, L. E., FERRERAS, 
M. C., JUSTE, R. A., GARCIA MARIN, J. F. & PEREZ, V. 2005. Histopathological classification of 
lesions associated with natural paratuberculosis infection in cattle. J Comp Pathol, 133, 184-
96. 
GONZALEZ, L. C., ESTEBAN, J. G., BARGUES, M. D., VALERO, M. A., ORTIZ, P., NAQUIRA, C. & MAS-
COMA, S. 2011. Hyperendemic human fascioliasis in Andean valleys: an altitudinal transect 
analysis in children of Cajamarca province, Peru. Acta Trop, 120, 119-29. 
GOODCHILD, A. V. & CLIFTON-HADLEY, R. S. 2001. Cattle-to-cattle transmission of Mycobacterium 
bovis. Tuberculosis.(Edinb.), 81, 23-41. 
GOODRIDGE, H. S., MARSHALL, F. A., ELSE, K. J., HOUSTON, K. M., EGAN, C., AL-RIYAMI, L., LIEW, F. 
Y., HARNETT, W. & HARNETT, M. M. 2005. Immunomodulation via novel use of TLR4 by the 
filarial nematode phosphorylcholine-containing secreted product, ES-62. J Immunol, 174, 
284-93. 
GOOSE, J. 1978. Possible role of excretory/secretory products in evasion of host defences by Fasciola 
hepatica. Nature, 275, 216-217. 
GOPAL, R., GOODCHILD, A., HEWINSON, G., DE LA RUA DOMENECH, R. & CLIFTON-HADLEY, R. 2006. 
Introduction of bovine tuberculosis to north-east England by bought-in cattle. Vet Rec, 159, 
265-71. 
GORDON, S. 2003. Alternative activation of macrophages. Nat Rev Immunol, 3, 23-35. 
GORDON, S. V. 2008. Bovine TB: stopping disease control would block all live exports. Nature, 456, 
700. 
GRACZYK, T. & FRIED, B. 1999. Development of Fasciola hepatica in the Intermediate Host. In: 
Fasciolosis, Edited by J.P. Dalton, 31-46. 
GROOMS, D. L. 2006. Reproductive losses caused by bovine viral diarrhea virus and leptospirosis. 
Theriogenology, 66, 624-8. 
143 
 
HACARIZ, O., SAYERS, G., FLYNN, R. J., LEJEUNE, A. & MULCAHY, G. 2009. IL-10 and TGF-beta1 are 
associated with variations in fluke burdens following experimental fasciolosis in sheep. 
Parasite Immunol., 31, 613-622. 
HALL, G. A., HUGHES, D. L., JONES, P. W., AITKEN, M. M., PARSONS, K. R. & BROWN, G. T. 1981. 
Experimental oral Salmonella dublin infection in cattle: effects of concurrent infection with 
Fasciola hepatica. J.Comp Pathol., 91, 227-233. 
HAMILTON, C. M., DOWLING, D. J., LOSCHER, C. E., MORPHEW, R. M., BROPHY, P. M. & O'NEILL, S. 
M. 2009. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and 
function. Infect Immun, 77, 2488-98. 
HAY, S. I. & LENNON, J. J. 1999. Deriving meteorological variables across Africa for the study and 
control of vector-borne disease: a comparison of remote sensing and spatial interpolation of 
climate. Trop Med Int Health, 4, 58-71. 
HEINEMANN, M. B., GARCIA, J. F., NUNES, C. M., MORAIS, Z. M., GREGORI, F., CORTEZ, A., 
VASCONCELLOS, S. A., VISINTIN, J. A. & RICHTZENHAIN, L. J. 1999. Detection of leptospires in 
bovine semen by polymerase chain reaction. Aust Vet J, 77, 32-4. 
HENDERSON, G., ZHANG, Y. & JONES, C. 2005. The Bovine herpesvirus 1 gene encoding infected cell 
protein 0 (bICP0) can inhibit interferon-dependent transcription in the absence of other viral 
genes. J Gen Virol, 86, 2697-702. 
HICKMAN, S. P., CHAN, J. & SALGAME, P. 2002. Mycobacterium tuberculosis induces differential 
cytokine production from dendritic cells and macrophages with divergent effects on naive T 
cell polarization. J Immunol, 168, 4636-42. 
HIGGINS, R. J., HARBOURNE, J. F., LITTLE, T. W. & STEVENS, A. E. 1980. Mastitis and abortion in dairy 
cattle associated with Leptospira of the serotype hardjo. Vet Rec, 107, 307-10. 
HILLYER, G. V. & SANTIAGO DE WEIL, N. 1979. Use of immunologic techniques to detect 
chemotherapeutic success in infections with Fasciola hepatica. II. The enzyme linked 
immunosorbent assay in infected rats and rabbits. J Parasitol, 65, 680-4. 
HOPE-CAWDERY, M. J., STRICKLAND, K. L., CONWAY, A. & CROWE, P. J. 1977. Production effects of 
liver fluke in cattle I. The effects of infection on liveweight gain, feed intake and food 
conversion efficiency in beef cattle. British Veterinary Journal, 133, 145-159. 
HOPE, J. C., THOM, M. L., MCCORMICK, P. A. & HOWARD, C. J. 2004. Interaction of antigen 
presenting cells with mycobacteria. Vet Immunol Immunopathol, 100, 187-95. 
HOPE, J. C. & VILLARREAL-RAMOS, B. 2008. Bovine TB and the development of new vaccines. Comp 
Immunol Microbiol Infect Dis, 31, 77-100. 
HUTCHINGS, M. R. & HARRIS, S. 1997. Effects of farm management practices on cattle grazing 
behaviour and the potential for transmission of bovine tuberculosis from badgers to cattle. 
Vet J, 153, 149-62. 
HUTCHINGS, M. R. & HARRIS, S. 1999. Quantifying the risks of TB infection to cattle posed by badger 
excreta. Epidemiol.Infect., 122, 167-173. 
IUCN 2012. IUCN Red List of Threatened Species. www.iucnredlist.org/apps/redlist/details/29673/0, 
2012.1. 
JACOBS, B. L. & LANGLAND, J. O. 1996. When Two Strands Are Better Than One: The Mediators and 
Modulators of the Cellular Responses to Double-Stranded RNA. Virology, 219, 339-349. 
JALAVA, K., JONES, J. A., GOODCHILD, T., CLIFTON-HADLEY, R., MITCHELL, A., STORY, A. & WATSON, 
J. M. 2007. No increase in human cases of Mycobacterium bovis disease despite resurgence 
of infections in cattle in the United Kingdom. Epidemiol.Infect., 135, 40-45. 
JENKINS, G., PERRY, M. & PRIOR, J. 2007. The climate of the United Kingdom and recent trends. 
UKCIP08, Hadley Centre, Met Office, Exeter, 1-25. 
JENSEN, J. & SCHULTZ, R. D. 1990. Bovine natural cell mediated cytotoxicity (NCMC): activation by 
cytokines. Vet Immunol Immunopathol, 24, 113-24. 
JOHNSTON, W. T., VIAL, F., GETTINBY, G., BOURNE, F. J., CLIFTON-HADLEY, R. S., COX, D. R., CREA, P., 
DONNELLY, C. A., MCINERNEY, J. P., MITCHELL, A. P., MORRISON, W. I. & WOODROFFE, R. 
144 
 
2011. Herd-level risk factors of bovine tuberculosis in England and Wales after the 2001 
foot-and-mouth disease epidemic. Int J Infect Dis. 
JONES, C. & CHOWDHURY, S. 2007. A review of the biology of bovine herpesvirus type 1 (BHV-1), its 
role as a cofactor in the bovine respiratory disease complex and development of improved 
vaccines. Anim Health Res Rev, 8, 187-205. 
JONES, C., GEISER, V., HENDERSON, G., JIANG, Y., MEYER, F., PEREZ, S. & ZHANG, Y. 2006. Functional 
analysis of bovine herpesvirus 1 (BHV-1) genes expressed during latency. Vet Microbiol, 113, 
199-210. 
JONES, T., HUNT, R. & KING, N. 1997. Veterinary Pathology. Sixth Edition, Lippincott Williams and 
Wilkins. 
KAO, R. R., GRAVENOR, M. B., CHARLESTON, B., HOPE, J. C., MARTIN, M. & HOWARD, C. J. 2007. 
Mycobacterium bovis shedding patterns from experimentally infected calves and the effect 
of concurrent infection with bovine viral diarrhoea virus. J.R.Soc.Interface, 4, 545-551. 
KARCHER, E. L., BEITZ, D. C. & STABEL, J. R. 2008a. Modulation of cytokine gene expression and 
secretion during the periparturient period in dairy cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis. Vet Immunol Immunopathol, 123, 277-88. 
KARCHER, E. L., BEITZ, D. C. & STABEL, J. R. 2008b. Parturition invokes changes in peripheral blood 
mononuclear cell populations in Holstein dairy cows naturally infected with Mycobacterium 
avium subsp. paratuberculosis. Vet Immunol Immunopathol, 124, 50-62. 
KAROLEMEAS, K., MCKINLEY, T. J., CLIFTON-HADLEY, R. S., GOODCHILD, A. V., MITCHELL, A., 
JOHNSTON, W. T., CONLAN, A. J., DONNELLY, C. A. & WOOD, J. L. 2011. Recurrence of bovine 
tuberculosis breakdowns in Great Britain: risk factors and prediction. Prev Vet Med, 102, 22-
9. 
KENDALL, S. & MCCULLOUGH, F. 1951. The emergence of the cercariae of Fasciola hepatica from the 
snail Limnaea truncatula. Journal of Helminthology, 25, 77-92. 
KENDALL, S. B. & PARFITT, J. W. 1959. Studies on the susceptibility of some species of Lymnaea to 
infection with Fasciola gigantic and F. hepatica. Ann Trop Med Parasitol, 53, 220-7. 
KOMMISRUD, E., VATN, T., LANG-REE, J. R. & LOKEN, T. 1996. Bovine virus diarrhoea virus in semen 
from acutely infected bulls. Acta Vet Scand, 37, 41-7. 
KONUK, M., KORCAN, E., DULGERBAKI, S. & ALTINDIS, M. 2007. Isolation and identification of 
Mycobacteria from raw milk samples in Afyonkarahisar district of Turkey. Int J Food 
Microbiol, 115, 343-7. 
KOPPERS-LALIC, D., REITS, E. A., RESSING, M. E., LIPINSKA, A. D., ABELE, R., KOCH, J., MARCONDES 
REZENDE, M., ADMIRAAL, P., VAN LEEUWEN, D., BIENKOWSKA-SZEWCZYK, K., 
METTENLEITER, T. C., RIJSEWIJK, F. A., TAMPE, R., NEEFJES, J. & WIERTZ, E. J. 2005. 
Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter 
associated with antigen processing. Proc Natl Acad Sci U S A, 102, 5144-9. 
LANE, G. 1998. Anthelmintic Resistance. The Veterinary Record, 143, 232. 
LAWMAN, M. J., GIFFORD, G., GYONGYOSSY-ISSA, M., DRAGAN, R., HEISE, J. & BABIUK, L. A. 1987. 
Activity of polymorphonuclear (PMN) leukocytes during bovine herpes virus-1 induced 
respiratory disease: effect of recombinant bovine interferon alpha I1. Antiviral Res, 8, 225-
37. 
LE CABEC, V., COLS, C. & MARIDONNEAU-PARINI, I. 2000. Nonopsonic Phagocytosis of Zymosan and 
Mycobacterium kansasii by CR3 (CD11b/CD18) Involves Distinct Molecular Determinants and 
Is or Is Not Coupled with NADPH Oxidase Activation. Infect Immun, 68, 4736-45. 
LEE, J., HARTMAN, M. & KORNFELD, H. 2009. Macrophage apoptosis in tuberculosis. Yonsei Med J, 
50, 1-11. 
LEE, S. R., PHARR, G. T., BOYD, B. L. & PINCHUK, L. M. 2008. Bovine viral diarrhea viruses modulate 
toll-like receptors, cytokines and co-stimulatory molecules genes expression in bovine 
peripheral blood monocytes. Comp Immunol Microbiol Infect Dis, 31, 403-18. 
145 
 
LEEMANS, J. C., JUFFERMANS, N. P., FLORQUIN, S., VAN ROOIJEN, N., VERVOORDELDONK, M. J., 
VERBON, A., VAN DEVENTER, S. J. H. & VAN DER POLL, T. 2001. Depletion of Alveolar 
Macrophages Exerts Protective Effects in Pulmonary Tuberculosis in Mice. The Journal of 
Immunology, 166, 4604-4611. 
LIANG, X., CHOW, B., RAGGO, C. & BABIUK, L. A. 1996. Bovine herpesvirus 1 UL49.5 homolog gene 
encodes a novel viral envelope protein that forms a disulfide-linked complex with a second 
virion structural protein. J Virol, 70, 1448-54. 
LIANG, X., TANG, M., MANNS, B., BABIUK, L. A. & ZAMB, T. J. 1993. Identification and deletion 
mutagenesis of the bovine herpesvirus 1 dUTPase gene and a gene homologous to herpes 
simplex virus UL49.5. Virology, 195, 42-50. 
LIPINSKA, A. D., KOPPERS-LALIC, D., RYCHLOWSKI, M., ADMIRAAL, P., RIJSEWIJK, F. A., BIENKOWSKA-
SZEWCZYK, K. & WIERTZ, E. J. 2006. Bovine herpesvirus 1 UL49.5 protein inhibits the 
transporter associated with antigen processing despite complex formation with glycoprotein 
M. J Virol, 80, 5822-32. 
LIU, T., DHANASEKARAN, S. M., JIN, H., HU, B., TOMLINS, S. A., CHINNAIYAN, A. M. & PHAN, S. H. 
2004. FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol, 164, 1315-26. 
LIU, T., KHANNA, K. M., CHEN, X., FINK, D. J. & HENDRICKS, R. L. 2000. CD8(+) T cells can block herpes 
simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med, 191, 
1459-66. 
LOPEZ-NAVARRETE, G., RAMOS-MARTINEZ, E., SUAREZ-ALVAREZ, K., AGUIRRE-GARCIA, J., LEDEZMA-
SOTO, Y., LEON-CABRERA, S., GUDINO-ZAYAS, M., GUZMAN, C., GUTIERREZ-REYES, G., 
HERNANDEZ-RUIZ, J., CAMACHO-ARROYO, I., ROBLES-DIAZ, G., KERSHENOBICH, D., 
TERRAZAS, L. I. & ESCOBEDO, G. 2011. Th2-associated alternative Kupffer cell activation 
promotes liver fibrosis without inducing local inflammation. Int J Biol Sci, 7, 1273-86. 
LU, Z., MITCHELL, R. M., SMITH, R. L., VAN KESSEL, J. S., CHAPAGAIN, P. P., SCHUKKEN, Y. H. & 
GROHN, Y. T. 2008. The importance of culling in Johne's disease control. J Theor Biol, 254, 
135-46. 
MACHIN, D., CAMPBELL, M., FAYERS, P. & PINOL, A. 1997. Sample size tables for clinical studies. 
Second Edition, Blackwell Science [ISBN 0-86542-870-0], 145-146. Also published online at 
www.stattools.net/SSizmatchedpair_Exp.php accessed 15.11.2012 
MADAN-LALA, R., PEIXOTO, K. V., RE, F. & RENGARAJAN, J. 2011. Mycobacterium tuberculosis Hip1 
dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation. 
Infect Immun, 79, 4828-38. 
MALONE, J. B., GOMMES, R., HANSEN, J., YILMA, J. M., SLINGENBERG, J., SNIJDERS, F., 
NACHTERGAELE, F. & ATAMAN, E. 1998. A geographic information system on the potential 
distribution and abundance of Fasciola hepatica and F. gigantica in east Africa based on Food 
and Agriculture Organization databases. Vet.Parasitol., 78, 87-101. 
MARCOS, L. A., TERASHIMA, A., YI, P., ANDRADE, R., CUBERO, F. J., ALBANIS, E., GOTUZZO, E., 
ESPINOZA, J. R. & FRIEDMAN, S. L. 2011. Mechanisms of liver fibrosis associated with 
experimental Fasciola hepatica infection: roles of Fas2 proteinase and hepatic stellate cell 
activation. J Parasitol, 97, 82-7. 
MARCOS, L. A., YI, P., MACHICADO, A., ANDRADE, R., SAMALVIDES, F., SANCHEZ, J. & TERASHIMA, A. 
2007. Hepatic fibrosis and Fasciola hepatica infection in cattle. J Helminthol, 81, 381-6. 
MCALLISTER, M. M., DUBEY, J. P., LINDSAY, D. S., JOLLEY, W. R., WILLS, R. A. & MCGUIRE, A. M. 1998. 
Dogs are definitive hosts of Neospora caninum. Int J Parasitol, 28, 1473-8. 
MCCANN, C. M., BAYLIS, M. & WILLIAMS, D. J. 2010a. The development of linear regression models 
using environmental variables to explain the spatial distribution of Fasciola hepatica 
infection in dairy herds in England and Wales. Int.J.Parasitol., 40, 1021-1028. 
MCCANN, C. M., BAYLIS, M. & WILLIAMS, D. J. 2010b. Seroprevalence and spatial distribution of 
Fasciola hepatica-infected dairy herds in England and Wales. Vet.Rec., 166, 612-617. 
146 
 
MCCANN, C. M., MCALLISTER, M. M., GONDIM, L. F., SMITH, R. F., CRIPPS, P. J., KIPAR, A., WILLIAMS, 
D. J. & TREES, A. J. 2007. Neospora caninum in cattle: experimental infection with oocysts 
can result in exogenous transplacental infection, but not endogenous transplacental 
infection in the subsequent pregnancy. Int J Parasitol, 37, 1631-9. 
MCCLURKIN, A. W., LITTLEDIKE, E. T., CUTLIP, R. C., FRANK, G. H., CORIA, M. F. & BOLIN, S. R. 1984. 
Production of cattle immunotolerant to bovine viral diarrhea virus. Can J Comp Med, 48, 
156-61. 
MCGONIGLE, L., MOUSLEY, A., MARKS, N. J., BRENNAN, G. P., DALTON, J. P., SPITHILL, T. W., DAY, T. 
A. & MAULE, A. G. 2008. The silencing of cysteine proteases in Fasciola hepatica newly 
excysted juveniles using RNA interference reduces gut penetration. Int.J.Parasitol., 38, 149-
155. 
MCSHANE, H. 2009. Vaccine strategies against tuberculosis. Swiss Med Wkly, 139, 156-60. 
MEYERS, G. & THIEL, H. J. 1996. Molecular characterization of pestiviruses. Adv Virus Res, 47, 53-118. 
MEZO, M., GONZALEZ-WARLETA, M., CASTRO-HERMIDA, J. A., MUINO, L. & UBEIRA, F. M. 2011. 
Association between anti-F. hepatica antibody levels in milk and production losses in dairy 
cows. Vet Parasitol, 180, 237-42. 
MIKKELSEN, H., JUNGERSEN, G. & NIELSEN, S. S. 2009. Association between milk antibody and 
interferon-gamma responses in cattle from Mycobacterium avium subsp. paratuberculosis 
infected herds. Vet Immunol Immunopathol, 127, 235-41. 
MILBOURNE, E. A. & HOWELL, M. J. 1990. Eosinophil responses to Fasciola hepatica in rodents. 
Int.J.Parasitol., 20, 705-708. 
MITCHELL, G. B., MARIS, L. & BONNIWELL, M. A. 1998. Triclabendazole-resistant liver fluke in 
Scottish sheep. Vet.Rec., 143, 399. 
MOHAGHEGHPOUR, N., VAN VOLLENHOVEN, A., GOODMAN, J. & BERMUDEZ, L. E. 2000. Interaction 
of Mycobacterium avium with human monocyte-derived dendritic cells. Infect Immun, 68, 
5824-9. 
MOLL, L., GAASENBEEK, C. P., VELLEMA, P. & BORGSTEEDE, F. H. 2000. Resistance of Fasciola 
hepatica against triclabendazole in cattle and sheep in The netherlands. Vet Parasitol, 91, 
153-8. 
MORETTA, L., CICCONE, E., POGGI, A., MINGARI, M. C. & MORETTA, A. 1994. Origin and functions of 
human natural killer cells. Int J Clin Lab Res, 24, 181-6. 
MUCHA, R., BHIDE, M. R., CHAKURKAR, E. B., NOVAK, M. & MIKULA, I., SR. 2009. Toll-like receptors 
TLR1, TLR2 and TLR4 gene mutations and natural resistance to Mycobacterium avium subsp. 
paratuberculosis infection in cattle. Vet Immunol Immunopathol, 128, 381-8. 
MUGERWA, R. 1998. Tuberculosis in the era of HIV: problems, challenges and hopes for Africa. 
African Health, 20, 23-25. 
MULCAHY, G., O'CONNOR, F., CLERY, D., HOGAN, S. F., DOWD, A. J., ANDREWS, S. J. & DALTON, J. P. 
1999. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines. 
Res.Vet.Sci., 67, 27-33. 
MULCAHY, G., O'CONNOR, F., MCGONIGLE, S., DOWD, A., CLERY, D. G., ANDREWS, S. J. & DALTON, J. 
P. 1998. Correlation of specific antibody titre and avidity with protection in cattle immunized 
against Fasciola hepatica. Vaccine, 16, 932-939. 
NAIMAN, B. M., ALT, D., BOLIN, C. A., ZUERNER, R. & BALDWIN, C. L. 2001. Protective Killed 
Leptospira borgpetersenii Vaccine Induces Potent Th1 Immunity Comprising Responses by 
CD4 and γδ T Lymphocytes. Infect Immun, 69, 7550-8. 
NANDI, S., KUMAR, M., MANOHAR, M. & CHAUHAN, R. S. 2009. Bovine herpes virus infections in 
cattle. Anim Health Res Rev, 10, 85-98. 
NATARAJ, C., EIDMANN, S., HARIHARAN, M. J., SUR, J. H., PERRY, G. A. & SRIKUMARAN, S. 1997. 
Bovine herpesvirus 1 downregulates the expression of bovine MHC class I molecules. Viral 
Immunol, 10, 21-34. 
147 
 
NEILL, S. D., CASSIDY, J., HANNA, J., MACKIE, D. P., POLLOCK, J. M., CLEMENTS, A., WALTON, E. & 
BRYSON, D. G. 1994. Detection of Mycobacterium bovis infection in skin test-negative cattle 
with an assay for bovine interferon-gamma. Vet.Rec., 135, 134-135. 
NEUHAUS, W. 1953. [The chemical sense of miracidia of Fasciola hepatica]. Z Parasitenkd, 15, 476-
90. 
O'NEILL, S. M., BRADY, M. T., CALLANAN, J. J., MULCAHY, G., JOYCE, P., MILLS, K. H. & DALTON, J. P. 
2000. Fasciola hepatica infection downregulates Th1 responses in mice. Parasite Immunol., 
22, 147-155. 
O'NEILL, S. M., MILLS, K. H. & DALTON, J. P. 2001. Fasciola hepatica cathepsin L cysteine proteinase 
suppresses Bordetella pertussis-specific interferon-gamma production in vivo. Parasite 
Immunol., 23, 541-547. 
O'REILLY, L. & MACCLANCY, B. 1975. A comparison of the accuracy of human and bovine tuberculin 
PPD for testing cattle with a comparative cervical test. Irish Veterinary Journal, 29, 63-70. 
OCEPEK, M., PATE, M., ZOLNIR-DOVC, M. & POLJAK, M. 2005. Transmission of Mycobacterium 
tuberculosis from human to cattle. J Clin Microbiol, 43, 3555-7. 
ODDO, M., RENNO, T., ATTINGER, A., BAKKER, T., MACDONALD, H. R. & MEYLAN, P. R. 1998. Fas 
ligand-induced apoptosis of infected human macrophages reduces the viability of 
intracellular Mycobacterium tuberculosis. J Immunol, 160, 5448-54. 
OIE 2002. Manual of Standards Diagnostic Tests and Vaccines. World Health Organisation for Animal 
Health, Part 2, www.oie.int/. 
OLDHAM, G. & WILLIAMS, L. 1985. Cell mediated immunity to liver fluke antigens during 
experimental Fasciola hepatica infection of cattle. Parasite Immunol, 7, 503-16. 
OLLERENSHAW, C. B. 1959. The ecology of the liver fluke (Fasciola hepatica). The Veterinary Record, 
71, 957-963. 
OLLERENSHAW, C. B. 1970. Some Aspects of the Epidemiology of Fascioliasis in Britain. Proceedings 
of the Malacological Society. 
OLLERENSHAW, C. B. 1971. The ecology of the liver fluke (Fasciola hepatica). The Veterinary Record, 
71, 957-963. 
OLLERENSHAW, C. B. & SMITH, L. P. 1969. Meteorological factors and forecasts of helminthic 
disease. Adv.Parasitol., 7, 283-323. 
ORTIZ, P. L., CLAXTON, J. R., CLARKSON, M. J., MCGARRY, J. & WILLIAMS, D. J. L. 2000. The specificity 
of antibody responses in cattle naturally exposed to Fasciola hepatica. Veterinary 
Parasitology, 93, 121-134. 
OTT, S. L., WELLS, S. J. & WAGNER, B. A. 1999. Herd-level economic losses associated with Johne's 
disease on US dairy operations. Prev Vet Med, 40, 179-92. 
OVEREND, D. J. & BOWEN, F. L. 1995. Resistance of Fasciola hepatica to triclabendazole. Aust.Vet.J., 
72, 275-276. 
PALMER, C. & LONG, M. 1966. Effects of infection with atypical mycobacteria on BCG vaccination 
and tuberculosis. American Review of Respiratory Disease, 94, 553-568. 
PALMER, M. V., WATERS, W. R. & WHIPPLE, D. L. 2004. Investigation of the transmission of 
Mycobacterium bovis from deer to cattle through indirect contact. Am J Vet Res, 65, 1483-9. 
PANDEY, A. K. & SASSETTI, C. M. 2008. Mycobacterial persistence requires the utilization of host 
cholesterol. Proc Natl Acad Sci U S A, 105, 4376-80. 
PARÉ, J., THURMOND, M. C. & HIETALA, S. K. 1996. Congenital Neospora caninum infection in dairy 
cattle and associated calfhood mortality. Can J Vet Res, 60, 133-9. 
PARR, S. L. & GRAY, J. S. 2000. A strategic dosing scheme for the control of fasciolosis in cattle and 
sheep in Ireland. Vet Parasitol, 88, 187-97. 
PENNY, C. D., LOW, J. C., NETTLETON, P. F., SCOTT, P. R., SARGISON, N. D., STRACHAN, W. D. & 
HONEYMAN, P. C. 1996. Concurrent bovine viral diarrhoea virus and Salmonella 
typhimurium DT104 infection in a group of pregnant dairy heifers. Vet Rec, 138, 485-9. 
148 
 
PETERHANS, E. & SCHWEIZER, M. 2010. Pestiviruses: how to outmaneuver your hosts. Vet Microbiol, 
142, 18-25. 
PETERS, M., LUTKEFELS, E., HECKEROTH, A. R. & SCHARES, G. 2001. Immunohistochemical and 
ultrastructural evidence for Neospora caninum tissue cysts in skeletal muscles of naturally 
infected dogs and cattle. Int J Parasitol, 31, 1144-8. 
PFEIFFER, D., ROBINSON, T., STEVENSON, M., STEVENS, K., ROGERS, D. & CLEMENTS, A. 2008. Spatial 
Analysis in Epidemiology, Oxford, Oxford University Press. 
PHELPS, E. D., SWEENEY, K. R. & BLADER, I. J. 2008. Toxoplasma gondii rhoptry discharge correlates 
with activation of the early growth response 2 host cell transcription factor. Infect Immun, 
76, 4703-12. 
PHILLIPS, C. J., FOSTER, C. R., MORRIS, P. A. & TEVERSON, R. 2003. The transmission of 
Mycobacterium bovis infection to cattle. Res.Vet.Sci., 74, 1-15. 
PIEDRAFITA, D., SPITHILL, T. W., DALTON, J. P., BRINDLEY, P. J., SANDEMAN, M. R., WOOD, P. R. & 
PARSONS, J. C. 2000. Juvenile Fasciola hepatica are resistant to killing in vitro by free radicals 
compared with larvae of Schistosoma mansoni. Parasite Immunol., 22, 287-295. 
PIETERS, J. 2001. Evasion of host cell defense mechanisms by pathogenic bacteria. Current Opinion in 
Immunology, 13, 37-44. 
PITHUA, P., WELLS, S. J., SREEVATSAN, S. & GODDEN, S. M. 2010. Lack of evidence for fecal shedding 
of Mycobacterium avium subsp. paratuberculosis in calves born to fecal culture positive 
dams. Prev Vet Med, 93, 242-5. 
PLAYFAIR, J. & CHAIN, B. 2009. Immunology at a Glance. Ninth Edition, Wiley-Blackwell Publishing, 
West Sussex, UK. 
POLLOCK, J. M. & NEILL, S. D. 2002. Mycobacterium bovis infection and tuberculosis in cattle. Vet.J., 
163, 115-127. 
POULIN, R. 2006. Global warming and temperature-mediated increases in cercarial emergence in 
trematode parasites. Parasitology, 132, 143-51. 
PRITCHARD, G. C., BORLAND, E. D., WOOD, L. & PRITCHARD, D. G. 1989. Severe disease in a dairy 
herd associated with acute infection with bovine virus diarrhoea virus, Leptospira harjo and 
Coxiella burnetii. Vet Rec, 124, 625-9. 
PRITCHARD, G. C., FORBES, A. B., WILLIAMS, D. J., SALIMI-BEJESTANI, M. R. & DANIEL, R. G. 2005. 
Emergence of fasciolosis in cattle in East Anglia. Vet.Rec., 157, 578-582. 
PRITCHARD, G. C., KIRKWOOD, G. M. & SAYERS, A. R. 2002. Detecting antibodies to infectious bovine 
rhinotracheitis and BVD virus infections using milk samples from individual cows. Vet Rec, 
150, 182-3. 
RADOSTITS, O., GAY, C., HINCHCLIFF, K. & CONSTABLE, P. 2007. Veterinary Medicine: A textbook of 
the diseases of cattle, horses, sheep, pigs and goats. 10th Edition. Saunders Ltd, 
Philadelphia, USA. 
RAMIREZ-VILLAESCUSA, A. M., MEDLEY, G. F., MASON, S. & GREEN, L. E. 2010. Risk factors for herd 
breakdown with bovine tuberculosis in 148 cattle herds in the south west of England. Prev 
Vet Med, 95, 224-30. 
RAPSCH, C., DAHINDEN, T., HEINZMANN, D., TORGERSON, P. R., BRAUN, U., DEPLAZES, P., HURNI, L., 
BAR, H. & KNUBBEN-SCHWEIZER, G. 2008. An interactive map to assess the potential spread 
of Lymnaea truncatula and the free-living stages of Fasciola hepatica in Switzerland. 
Vet.Parasitol., 154, 242-249. 
RELF, V., GOOD, B., MCCARTHY, E. & DE WAAL, T. 2009. Evidence of Fasciola hepatica infection in 
Radix peregra and a mollusc of the family Succineidae in Ireland. Vet Parasitol, 163, 152-5. 
RIORDAN, P., DELAHAY, R. J., CHEESEMAN, C., JOHNSON, P. J. & MACDONALD, D. W. 2011. Culling-
Induced Changes in Badger (Meles meles) Behaviour, Social Organisation and the 
Epidemiology of Bovine Tuberculosis. PLoS One, 6, e28904. 
149 
 
ROACH, D. R., BEAN, A. G., DEMANGEL, C., FRANCE, M. P., BRISCOE, H. & BRITTON, W. J. 2002. TNF 
regulates chemokine induction essential for cell recruitment, granuloma formation, and 
clearance of mycobacterial infection. J Immunol, 168, 4620-7. 
ROBERTS, E. 1950. Studies on the life cycle of Fasciola hepatica (Linnaeus) and of its snail host, 
limnaea (Galba) truncatula (Muller), in the field and under controlled conditions in the 
laboratory. Annals of Tropical Medicine and Parasitology, 44, 187-206. 
ROSS, J. G. 1970. The epidemiology of fascioliasis in Northern Ireland. Vet Rec, 87, 370-2. 
ROSS, J. G., DOW, C. & TODD, J. R. 1967. A study of Fasciola hepatica infections in sheep. Vet Rec, 80, 
543-6. 
ROWCLIFFE, S. A. & OLLERENSHAW, C. B. 1960. Observations on the bionomics of the egg of Fasciola 
hepatica. Ann.Trop.Med.Parasitol., 54, 172-181. 
RUA-DOMENECH, R. 2006. Human Mycobacterium bovis infection in the United Kingdom: Incidence, 
risks, control measures and review of the zoonotic aspects of bovine tuberculosis. 
Tuberculosis.(Edinb.), 86, 77-109. 
SAIRA, K., ZHOU, Y. & JONES, C. 2007. The infected cell protein 0 encoded by bovine herpesvirus 1 
(bICP0) induces degradation of interferon response factor 3 and, consequently, inhibits beta 
interferon promoter activity. J Virol, 81, 3077-86. 
SALIMI-BEJESTANI, M. R., CRIPPS, P. & WILLIAMS, D. J. 2008. Evaluation of an ELISA to assess the 
intensity of Fasciola hepatica infection in cattle. Vet.Rec., 162, 109-111. 
SALIMI-BEJESTANI, M. R., DANIEL, R., CRIPPS, P., FELSTEAD, S. & WILLIAMS, D. J. 2007. Evaluation of 
an enzyme-linked immunosorbent assay for detection of antibodies to Fasciola hepatica in 
milk. Vet.Parasitol., 149, 290-293. 
SALIMI-BEJESTANI, M. R., DANIEL, R. G., FELSTEAD, S. M., CRIPPS, P. J., MAHMOODY, H. & WILLIAMS, 
D. J. 2005a. Prevalence of Fasciola hepatica in dairy herds in England and Wales measured 
with an ELISA applied to bulk-tank milk. Vet.Rec., 156, 729-731. 
SALIMI-BEJESTANI, M. R., MCGARRY, J. W., FELSTEAD, S., ORTIZ, P., AKCA, A. & WILLIAMS, D. J. 
2005b. Development of an antibody-detection ELISA for Fasciola hepatica and its evaluation 
against a commercially available test. Res.Vet.Sci., 78, 177-181. 
SCANTLEBURY, M., HUTCHINGS, M. R., ALLCROFT, D. J. & HARRIS, S. 2004. Risk of disease from 
wildlife reservoirs: badgers, cattle, and bovine tuberculosis. J Dairy Sci, 87, 330-9. 
SCHAIBLE, U., WINAU, F., SIELING, P., FISCHER, K., COLLINS, H. & HAGENS, K. 2003. Apoptosis 
facilitates antigen presentation to T lymphocytes through MHC-1 and CD1 in tuberculosis. 
Nature Medicine, 9, 1039-1046. 
SCHARLEMANN, J. P., BENZ, D., HAY, S. I., PURSE, B. V., TATEM, A. J., WINT, G. R. & ROGERS, D. J. 
2008. Global data for ecology and epidemiology: a novel algorithm for temporal Fourier 
processing MODIS data. PLoS One, 3, e1408. 
SCHLESINGER, L. 1993. Macrophage phagocytosis of virulent but not attenuated strains of 
Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement 
receptors. Journal of Immunology, 150, 2920-2930. 
SCHWEIZER, G., BRAUN, U., DEPLAZES, P. & TORGERSON, P. R. 2005. Estimating the financial losses 
due to bovine fasciolosis in Switzerland. Vet.Rec., 157, 188-193. 
SCHWEIZER, M. & PETERHANS, E. 2001. Noncytopathic bovine viral diarrhea virus inhibits double-
stranded RNA-induced apoptosis and interferon synthesis. J Virol, 75, 4692-8. 
SEKIYA, M., MULCAHY, G., IRWIN, J. A., STACK, C. M., DONNELLY, S. M., XU, W., COLLINS, P. & 
DALTON, J. P. 2006. Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) 
of the liver fluke, Fasciola hepatica. FEBS Lett, 580, 5016-22. 
SHARMA, S. K., MOHAN, A. & KADHIRAVAN, T. 2005. HIV-TB co-infection: epidemiology, diagnosis & 
management. Indian J Med Res, 121, 550-67. 
SHIVAPRASAD, H. L., ELY, R. & DUBEY, J. P. 1989. A Neospora-like protozoon found in an aborted 
bovine placenta. Vet Parasitol, 34, 145-8. 
150 
 
SHORT, E. C., JR., GEISERT, R. D., HELMER, S. D., ZAVY, M. T. & FULTON, R. W. 1991. Expression of 
antiviral activity and induction of 2',5'-oligoadenylate synthetase by conceptus secretory 
proteins enriched in bovine trophoblast protein-1. Biol Reprod, 44, 261-8. 
SINCLAIR, K. 1967. Pathogenesis of Fasciola and other liver-flukes. Helminthological Abstracts, 36, 
115-134. 
SMITH, R. L., STRAWDERMAN, R. L., SCHUKKEN, Y. H., WELLS, S. J., PRADHAN, A. K., ESPEJO, L. A., 
WHITLOCK, R. H., VAN KESSEL, J. S., SMITH, J. M., WOLFGANG, D. R. & GROHN, Y. T. 2010. 
Effect of Johne's disease status on reproduction and culling in dairy cattle. J Dairy Sci, 93, 
3513-24. 
SMYTH, J. & HALTON, D. 1983. The Physiology of Trematodes. Second Edition, Cambridge University 
Press, Cambridge, UK. 
SOHAL, J. S., SINGH, S. V., TYAGI, P., SUBHODH, S., SINGH, P. K., SINGH, A. V., NARAYANASAMY, K., 
SHEORAN, N. & SINGH SANDHU, K. 2008. Immunology of mycobacterial infections: with 
special reference to Mycobacterium avium subspecies paratuberculosis. Immunobiology, 
213, 585-98. 
SOULSBY, E. 1965. Textbook of Veterinary Clinical Parasitology. Volume 1: Helminths, Blackwell 
Scientific Publications, Oxford, UK, 529-576. 
STEINMAN, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol, 
9, 271-96. 
STRAUB, C. & AHL, R. 1976. [Local interferon production in cattle after intranasal infection with 
avirulent IBR/IPV virus and its effect on a subsequent infection with foot-and-mouth disease 
virus]. Zentralbl Veterinarmed B, 23, 470-82. 
SUKHDEO, M. V. & METTRICK, D. F. 1986. The behavior of juvenile Fasciola hepatica. J Parasitol, 72, 
492-7. 
SUNDER, S., LANOTTE, P., GODREUIL, S., MARTIN, C., BOSCHIROLI, M. L. & BESNIER, J. M. 2009. 
Human-to-human transmission of tuberculosis caused by Mycobacterium bovis in 
immunocompetent patients. J.Clin.Microbiol., 47, 1249-1251. 
SWEENEY, R. W., JONES, D. E., HABECKER, P. & SCOTT, P. 1998. Interferon-gamma and interleukin 4 
gene expression in cows infected with Mycobacterium paratuberculosis. Am J Vet Res, 59, 
842-7. 
TAILLEUX, L., NEYROLLES, O., HONORE-BOUAKLINE, S., PERRET, E., SANCHEZ, F., ABASTADO, J. P., 
LAGRANGE, P. H., GLUCKMAN, J. C., ROSENZWAJG, M. & HERRMANN, J. L. 2003a. 
Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells. J 
Immunol, 170, 1939-48. 
TAILLEUX, L., SCHWARTZ, O., HERRMANN, J. L., PIVERT, E., JACKSON, M., AMARA, A., LEGRES, L., 
DREHER, D., NICOD, L. P., GLUCKMAN, J. C., LAGRANGE, P. H., GICQUEL, B. & NEYROLLES, O. 
2003b. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. 
J Exp Med, 197, 121-7. 
TAYLOR, D. L., ZHONG, L., BEGG, D. J., DE SILVA, K. & WHITTINGTON, R. J. 2008. Toll-like receptor 
genes are differentially expressed at the sites of infection during the progression of Johne's 
disease in outbred sheep. Vet Immunol Immunopathol, 124, 132-51. 
TAYLOR, E. L. 1949. The epidemiology of fascioliasis in Britain. Report of the 14th international 
Veterinary Congress, London. 
TAYLOR, S. M. & KILPATRICK, D. 1975. The relationship between concurrent liver fluke infection and 
salmonellosis in cattle. Vet Rec, 96, 342-3. 
THOEN, C. O. & WAITE, K. J. 1990. Some immune responses in cattle exposed to Mycobacterium 
paratuberculosis after injection with modified-live bovine viral diarrhea virus vaccine. J Vet 
Diagn Invest, 2, 176-9. 
THOMAS, I., COLES, G. C. & DUFFUS, K. 2000. Triclabendazole-resistant Fasciola hepatica in 
southwest Wales. Vet Rec, 146, 200. 
151 
 
THRUSFIELD, M. 2005. Veterinary Epidemiology, 3rd Edition. Blackwell Science Ltd, Wiley Blackwell, 
Oxford, UK. 
THYE, T., BROWNE, E. N., CHINBUAH, M. A., GYAPONG, J., OSEI, I., OWUSU-DABO, E., BRATTIG, N. 
W., NIEMANN, S., RUSCH-GERDES, S., HORSTMANN, R. D. & MEYER, C. G. 2009. IL10 
haplotype associated with tuberculin skin test response but not with pulmonary TB. PLoS 
One, 4, e5420. 
TORGERSON, P. & TORGERSON, D. 2008. Does risk to humans justify high cost of fighting bovine TB? 
Nature, 455, 1029. 
TRINCHIERI, G. 1989. Biology of natural killer cells. Adv Immunol, 47, 187-376. 
TURNER, K., ARMOUR, J. & RICHARDS, R. J. 1984. Anthelmintic efficacy of triclabendazole against 
Fasciola hepatica in sheep. Vet Rec, 114, 41-2. 
URQUHART, G., ARMOUR, J., DUNCAN, J., DUNN, A. & JENNINGS, F. 1996. Veterinary Parasitology, 
2nd Edition. Blackwell Science Ltd, Oxford, UK. 
VAESSEN, M. A., VELING, J., FRANKENA, K., GRAAT, E. A. & KLUNDER, T. 1998. Risk factors for 
Salmonella dublin infection on dairy farms. Vet Q, 20, 97-9. 
VAN DRUNEN LITTEL-VAN DEN HURK, S. 2007. Cell-mediated immune responses induced by BHV-1: 
rational vaccine design. Expert Rev Vaccines, 6, 369-80. 
VAN DRUNEN LITTEL-VAN DEN HURK, S., TIKOO, S. K., LIANG, X. & BABIUK, L. A. 1993. Bovine 
herpesvirus-1 vaccines. Immunol Cell Biol, 71 ( Pt 5), 405-20. 
VARIN, A. & GORDON, S. 2009. Alternative activation of macrophages: immune function and cellular 
biology. Immunobiology, 214, 630-41. 
VASILEVA, I. 1960. A study of ontogenesis in the trematode Fasiola hepatica in the Moscow region. 
Zoologicheskii Zhurnal, 39, 1478-1484. 
VILLARREAL-RAMOS, B., MCAULAY, M., CHANCE, V., MARTIN, M., MORGAN, J. & HOWARD, C. J. 
2003. Investigation of the role of CD8+ T cells in bovine tuberculosis in vivo. Infect.Immun., 
71, 4297-4303. 
WAKEFIELD, J., KELSALL, J. & MORRIS, S. 2000. Clustering, cluster detection and spatial variation in 
risk. In: Elliot, P, Wakefield, JC, Best, NG, amd Briggs, DJ. (Eds) Spatial Epidemiology - 
Methods and Applications., Oxford University Press, Oxford, 128-152. 
WALRAVENS, K., WELLEMANS, V., WEYNANTS, V., BOELAERT, F., DEBERGEYCK, V., LETESSON, J. J., 
HUYGEN, K. & GODFROID, J. 2002. Analysis of the antigen-specific IFN-gamma producing T-
cell subsets in cattle experimentally infected with Mycobacterium bovis. Vet Immunol 
Immunopathol, 84, 29-41. 
WALSH, K. P., BRADY, M. T., FINLAY, C. M., BOON, L. & MILLS, K. H. 2009. Infection with a helminth 
parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 
responses. J.Immunol., 183, 1577-1586. 
WAMMES, L. J., HAMID, F., WIRIA, A. E., DE GIER, B., SARTONO, E., MAIZELS, R. M., LUTY, A. J., FILLIE, 
Y., BRICE, G. T., SUPALI, T., SMITS, H. H. & YAZDANBAKHSH, M. 2010. Regulatory T cells in 
human geohelminth infection suppress immune responses to BCG and Plasmodium 
falciparum. Eur J Immunol, 40, 437-42. 
WARBURG, O. & CHRISTIANSEN, W. 1941. Isolierung und Kristallisation des Garungsferments 
Enolase. Biochemische Zeitschrift, 310, 384-421. 
WARD, A. I., SMITH, G. C., ETHERINGTON, T. R. & DELAHAY, R. J. 2009. Estimating the risk of cattle 
exposure to tuberculosis posed by wild deer relative to badgers in England and Wales. 
J.Wildl.Dis., 45, 1104-1120. 
WATERS, W. R., MILLER, J. M., PALMER, M. V., STABEL, J. R., JONES, D. E., KOISTINEN, K. A., 
STEADHAM, E. M., HAMILTON, M. J., DAVIS, W. C. & BANNANTINE, J. P. 2003. Early Induction 
of Humoral and Cellular Immune Responses during Experimental Mycobacterium avium 
subsp. paratuberculosis Infection of Calves. Infect Immun, 71, 5130-8. 
WHITE, P. C. & BENHIN, J. K. 2004. Factors influencing the incidence and scale of bovine tuberculosis 
in cattle in southwest England. Prev Vet Med, 63, 1-7. 
152 
 
WILKINSON, D., BENNETT, R., MCFARLANE, I., RUSHTON, S., SHIRLEY, M. & SMITH, G. C. 2009. Cost-
benefit analysis model of badger (Meles meles) culling to reduce cattle herd tuberculosis 
breakdowns in Britain, with particular reference to badger perturbation. J Wildl Dis, 45, 
1062-88. 
WILLIAMS, D. J., GUY, C. S., SMITH, R. F., GUY, F., MCGARRY, J. W., MCKAY, J. S. & TREES, A. J. 2003. 
First demonstration of protective immunity against foetopathy in cattle with latent 
Neospora caninum infection. Int J Parasitol, 33, 1059-65. 
WILLIAMS, D. J., HARTLEY, C. S., BJORKMAN, C. & TREES, A. J. 2009. Endogenous and exogenous 
transplacental transmission of Neospora caninum - how the route of transmission impacts 
on epidemiology and control of disease. Parasitology, 136, 1895-900. 
WILLIAMS, D. J., MCGARRY, J., GUY, F., BARBER, J. & TREES, A. J. 1997. Novel ELISA for detection of 
Neospora-specific antibodies in cattle. Vet Rec, 140, 328-31. 
WILSON, R. A. & DENISON, J. 1970. Short-chain fatty acids as stimulants of turning activity by the 
miracidium of Fasciola hepatica. Comp Biochem Physiol, 32, 511-7. 
WINKLER, M. T., DOSTER, A. & JONES, C. 1999. Bovine herpesvirus 1 can infect CD4(+) T lymphocytes 
and induce programmed cell death during acute infection of cattle. J Virol, 73, 8657-68. 
WINT, G. R., ROBINSON, T. P., BOURN, D. M., DURR, P. A., HAY, S. I., RANDOLPH, S. E. & ROGERS, D. J. 
2002. Mapping bovine tuberculosis in Great Britain using environmental data. Trends 
Microbiol, 10, 441-4. 
WOODBINE, K. A., MEDLEY, G. F., MOORE, S. J., RAMIREZ-VILLAESCUSA, A. M., MASON, S. & GREEN, 
L. E. 2009. A four year longitudinal sero-epidemiological study of bovine herpesvirus type-1 
(BHV-1) in adult cattle in 107 unvaccinated herds in south west England. BMC Vet Res, 5, 5. 
WOUDA, W., MOEN, A. R., VISSER, I. J. & VAN KNAPEN, F. 1997. Bovine fetal neosporosis: a 
comparison of epizootic and sporadic abortion cases and different age classes with regard to 
lesion severity and immunohistochemical identification of organisms in brain, heart, and 
liver. J Vet Diagn Invest, 9, 180-5. 
WRAY, C. & ROEDER, P. L. 1987. Effect of bovine virus diarrhoea-mucosal disease virus infection on 
salmonella infection in calves. Res Vet Sci, 42, 213-8. 
WRIGHT, P. S. & SWIRE, P. W. 1984. Soil type and the distribution of Lymnaea truncatula. Vet.Rec., 
114, 294-295. 
WRIGHT, W. 1927. Studies on larval trematodes from North Wales. Part I: Observations on the redia, 
cercariae and cyst of Fasciola hepatica. Annals of Tropical Medicine and Parasitology, 21, 47-
56. 
WU, C. W., LIVESEY, M., SCHMOLLER, S. K., MANNING, E. J., STEINBERG, H., DAVIS, W. C., HAMILTON, 
M. J. & TALAAT, A. M. 2007. Invasion and persistence of Mycobacterium avium subsp. 
paratuberculosis during early stages of Johne's disease in calves. Infect Immun, 75, 2110-9. 
YILMA, J. M. & MALONE, J. B. 1998. A geographic information system forecast model for strategic 
control of fasciolosis in Ethiopia. Vet.Parasitol., 78, 103-127. 
ZEVALLOS, K., VERGARA, K. C., VERGARA, A., VIDAL, C., GARCIA, H. H. & EVANS, C. A. 2010. 
Tuberculin Skin-Test Reactions Are Unaffected by the Severity of Hyperendemic Intestinal 
Helminth Infections and Co-Infections. Am J Trop Med Hyg, 83, 319-25. 
ZIMMERLI, S., MAJEED, M., GUSTAVSSON, M., STENDAHL, O., SANAN, D. A. & ERNST, J. D. 1996. 
Phagosome-lysosome fusion is a calcium-independent event in macrophages. J.Cell Biol., 
132, 49-61. 
ZIMMERMAN, G. L., JEN, L. W., CERRO, J. E., FARNSWORTH, K. L. & WESCOTT, R. B. 1982. Diagnosis 
of Fasciola hepatica infections in sheep by an enzyme-linked immunosorbent assay. 
Am.J.Vet.Res., 43, 2097-2100. 
ZIMMERMAN, G. L., NELSON, M. J. & CLARK, C. R. 1985. Diagnosis of ovine fascioliasis by a dot 
enzyme-linked immunosorbent assay: a rapid microdiagnostic technique. Am.J.Vet.Res., 46, 
1513-1515. 
 
153 
 
 
  
I 
 
 
Appendices 
 
  
II 
 
Appendix A  
 
BBC News - Parasite may aid cattle TB spread 
BBC website 
SCIENCE & ENVIRONMENT 
22May 2012 Last uPdated at 16:00 
Parasite may aid cattle TB spread 
By Richard Black 
Environment correspondent, BBC News 
The spread of an animal parasite across the UK may be hampering 
moves to curb cattle tuberculosis, research suggests. 
Scientists have known for a few years that cows carrying both TB and the fluke 
Fasciola hepatica are less likely to show positive on the normal TB test. Now researchers 
have shown that this could lead to a reduction of one-third in the detection of infected cattle. 
Cases of bovine TB soared over the last decade, leading to tighter restrictions on farmers 
and a possible badger cull. 
The disease now costs the UK public purse more than £100m per year. Some of that is 
spent on regular testing of cattle herds for TB; but the new research, reported in Nature 
Communications iournal, suggests the testing is being compromised by presence of the liver 
fluke. 
It has been known since at least 2006 that under experimental conditions, infection with F. 
hepatica lowers a cow's reaction to the skin test. 
The 3cm long parasite fends off the cow's natural defence mechanisms by "turning down" its 
immune system. 
The TB skin test relies on detecting an immune response to a harmless part of the TB 
bacterium. With the cow's immune system suppressed, the response is not as strong. 
More is less: The new research takes this lab result into the real world of farming by looking 
at the relationship across the UK between levels of Iiver fluke infestation and rates of TB 
diagnosis. 
"We started this work thinking that infection with the liver fluke might make animals more 
susceptible to pathogens that are normally controlled by an inflammatory immune response, 
and TB is the obvious one to think about," said research leader Diana Williams from the 
University of Liverpool. 
"We were surprised, because we suspected there would be a TB increase in cattle infected 
with fluke; but what we found from the data was a negative association - more fluke, less 
apparent TB." 
Using a computer model relating disease incidence to environmental conditions such as 
temperature and rainfall, the researchers concluded that TB ought to be present in areas 
where it was not showing up. 
Their conclusion is that the sensitivity of the test in picking up TB infection is reduced in 
areas where lots of cows carry liver fluke. 
Prof Williams also said fluke had become more common in the UK over the last 15 years - 
the very period that has seen a tripling in the number of cattle herds where TB is present. 
Flukes may be thriving partly because of climate change, she suggested, but also because 
of agri-environment schemes that encourage farmers to maintain ponds, lakes and marshes 
to support wildlife. 
F. hepatica spends part of its life cycle in snails, which thrive in warm, wet 
conditions. 
Policy time? lf the chances of detecting TB through the skin test really do go down by a third, 
as the researchers conclude, that would mean infected cattle are not being detected during 
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routine testing - which in turn means they can infect other cows in the same herd and be 
eligible for transport from farm to farm. 
Carl Padgett, president of the British Veterinary Association, described the findings as 
"important research". 
"The skin test for TB has been proven to work well at eradicating infection in cattle 
throughout the world," he said. "lt is important to recognise its imperfections to maximise its 
value in the continued efforts to eradicate this disease." 
Epidemiologist Prof Christl Donnelly from lmperial College London, a former 
member of a government advisory panel on bovine TB, said that if confirmed, the findings 
could lead to useful policy changes. 
"!t's potentially really interesting - anything that can explain where test sensitivity is going 
wrong is potentially very useful in finding out where the cattle test might be doing less well," 
she told BBC News. 
"l think it would definitely be worth following up and asking whether there's any 
effect of liver fluke on gamma-interferon (another type of TB test) - and if the answer is 'no', 
maybe there should be more use of gamma interferon in those areas." 
But the Department for Environment, Food and Rural Affairs (Defra) played down the 
significance of the finding. A spokesman pointed to another line of research pursued by the 
Liverpool-led team, in which cattle had been infected in experimental conditions with both 
liver fluke and the TB-causing agent Mycobacterium bovis. All cows showed a depressed 
response to the skin test - but not so much that the test would not have picked them up. 
"This research shows that cattle who have both liver fluke and bovine TB still test positive for 
bovine TB, and would be culled to control the disease," he said. 
"The absence of positive cases of bovine TB in some areas co-inciding with large amounts 
of liver fluke cannot be used to claim liver fluke is hiding cases, as cattle carcasses are 
inspected in abattoirs and we would see evidence of TB in the slaughtered animals if this 
was the case." 
However in farm conditions, where cows may carry a heavier load of fluke, it is possible that 
the skin test would fail to produce a response, the researchers say. 
Everybody agrees that the case is not proven by this one piece of research, and 
Prof Williams said more needed to be done to understand the real situation on farms and 
also look for ways to respond. 
"Fluke infestation is quite seasonal - we tend to see it occurring towards the end of the 
summer, and so by controlling access to marshy pastures or fencing off marshy areas, 
farmers could reduce the risk of infection," she said. 
The picture is somewhat clouded by the fact that resistance is emerging to triclabendazole, a 
commonly used drug against fluke. 
In addition, the European Medicines Agency recently restricted use of ivermectin, a drug 
often used in combination with anti-fluke agents in broad parasite formulations after the UK 
raised concerns that its presence in cow's milk could pose a threat to human health. 
The research will inevitably raise anew the question of whether badger culling, which Defra 
wants to see started later this year, is really needed. 
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Research reveals new clue in fight against TB in cattle 
 
The failure of the current bovine tuberculosis (TB) eradication programme could be partly 
due to a parasitic worm that hinders the tests used to diagnose TB in cows, according to 
new research published this week. 
Scientists at The Universities of Nottingham and Liverpool have discovered that a parasitic 
flatworm often found in cattle reduces the sensitivity of skin tests used to diagnose TB in the 
animals. The flatworm is called Fasciola hepatica, otherwise known as the common liver 
fluke. 
Bovine TB is a bacterial disease that in 2011 resulted in the slaughter of approximately 
25,000 cattle in England, at a cost to the country of more than £90 million. Solutions for 
eradicating the infection have included badger culling, but new research, published in Nature 
Communications, now suggests that the spread of the disease may also be due to problems 
in diagnosing it in cattle infected with the common livestock disease. 
In a study of more than 3,000 dairy herds in England and Wales, scientists at Liverpool and 
in collaboration with Nottingham, the Agri-food and Biosciences Institute, Stormont, and 
University College Dublin, found that liver fluke infection reduces the effectiveness of skin 
tests used to diagnose bovine TB, effectively creating false negatives for TB in some. 
Co-author of the research, Dr Robin Flynn, from The University of Nottingham's School of 
Veterinary Medicine and Science said: "We have been very interested in the ability of 
Fasciola hepatica to modulate host immunity for some time and this study is a worrying 
example of when this occurs in nature given an estimated 70-80 per cent of dairy herds 
show signs of liver fluke infection demonstrates the scale of this problem." 
Professor Diana Williams, from the University of Liverpool's Institute of Infection and Global 
Health, said: "Tests to diagnose bovine TB rely on inflammation of the skin in response to 
injected TB proteins, but if the animal also has liver fluke infection, this inflammation is 
suppressed, reducing the detection of bovine TB. This means that cattle infected with both 
liver fluke and bovine TB may not be identified by the current bovine TB surveillance scheme 
in operation in the UK." 
Professor Matthew Baylis, co-author of the research from the Liverpool Institute of Infection 
and Global Health, said: "The potential consequences of these findings are that infected 
cattle can continue transmitting BTB to other cattle, to wildlife reservoirs and, if they are 
moved from their farm of origin, to other areas of the country. This may in part explain the 
continuing spread of bovine TB and the failure of the current eradication programme in the 
UK." 
The research team suggests that this finding will help improve the future diagnosis of bovine 
TB and speed up eradication of the disease from the UK. 
 
A,MS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by 
contributing institutions or for the use of any information through the EurekAlert! system. 
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Analysis: Badgers and bovine TB. (Or, 
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Everything eventually comes back to 
parasites) 
 
Posted on May 28, 2012 
 
I've been interested in the ongoing debate around the culling of badgers in the UK as a 
control method for bovine tuberculosis (Mycobacterium bovis). European badgers (Meles 
meles) have been known to be infected with bovine TB since the 1970s, and other British 
wildlife have also been identified as carriers, e.9., deer, foxes and rats (Gallagher & Clifton-
Hadley 2000). Close proximity of badgers and cattle can result in bovine TB being spread 
back and forth, usually via eating contaminated grass, or inhaling bacteria released via 
aerosol (e.g. sneezing). Bovine TB is an important disease of livestock, with around 4o/o of 
the national cattle herd infected. lt has cost the UK around 500 million pounds to control 
bovine TB over the past 10 years (stats from www.defra.gov.uk). 
 
Now, that ongoing debate about culling: The UK government wanted to conduct a pilot study 
to see how culling of badgers would reduce rates of bovine TB, but the plan is currently 
being reviewed by the High Court. Wales has already decided against culling, instead opting 
for vaccination of badgers to reduce the spread of the disease. Vaccinating would take 
longer and involve higher costs for materials and manpower than culling, which would be 
faster and cheaper. So why not just cull? Because badgers are territorial, and have varying 
sized home ranges. ln areas where badgers are not culled, they move around less, whereas 
badgers who have fewer neighbours are more likely to move around. So, if an infected 
badger is not culled, but its neighbours are, it may end up with a larger home range and still 
be busily infecting any cattle that also exist in its range. Modifications to badger home 
ranges caused by culling strategies that remove small proportions of badger populations 
means that it is less likely that long-term benefits on cattle health will be observed 
(Woodroffe et al. 2006). 
 
A key aspect of control is understanding the movement of the pathogens of the disease 
through a population. Cows can infect badgers TB, and the badgers can return the favour to 
other, uninfected cattle. Testing cattle herds for the presence of bovine TB is one measure 
that can be used to monitor the spread and prevalence of the infection, in order to manage it. 
ldentification of carriers of TB is conducted by the single Intradermal comparative cervical 
tuberculin (SICCT) test (Claridge et al. 2012) where a small amount of tuberculin (= M. bovis 
bacteria) is injected under the skin of the neck of a cow (or person). The immune systems of 
infected cattle (or people) will mount a response in the region of the injection, causing 
swelling. 
 
Now comes the part about the parasites. One pathogen that has been implicated in 
compromising the sensitivity of the SICCT test is the cattle liver fluke, Fasciola hepatica. 
This fluke is common in the UK, and has had quite a spectacular increase in distribution over 
the past 10-20 years (due, in part to climatic changes) (Kenyon et al. 2009). lnfection with F. 
hepatica causes an anti-inflammatory response in the host, which not only increases host 
susceptibility to infection with other pathogens, but would also interfere with tests that involve 
the immune system function as an indicator. New research published in Nature 
Communications indicates that cattle infected with F. hepatica are less likely to produce the 
typical immune system response to the SICCT test, thus producing a false negative result 
(Claridge et al. 2012). 
 
What on earth does this all mean? 
This means that, when considering appropriate control of a disease such as bovine TB, it is 
important to understand as much of the problem as possible. lt is well-known that badgers 
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can transmit TB to cattle, yet a straight-out cull may not be the answer as this may actually 
compound the problem via the changes to the movements of the un-culled badgers. Further, 
understanding the infection rate and prevalence of cattle infected with TB is also integral to 
controlling the spread of the disease. Cattle that are falsely negative for TB because their co-
infection with F. hepatica masks the immune response of the SICCT test may be moved 
around and potentially infect new herds, and badgers. Culling wildlife is always controversial. 
This is an example of how important it is to understand all the interacting factors of a 
particular problem before making a decision. 
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Bovine TB test undermined: infected cows escape detection  
 
Bovine TB test undermined: infected cows escape 
detection 
 
by Jo on May 25 2012 in Press Releases 
23rd May 2012 
 
Up to a third of infected cattle could be missed by the standard test for bovine tuberculosis 
(bTB) because a liver parasite may be hampering eradication of the disease, research 
suggests. 
Dairy cattle carrying both TB and the 3-cm fluke Fasciola hepatica were less likely to reveal 
the infection, but the fluke has been increasing in the UK. 
Prof Diana Williams of Liverpool University said the research team had been surprised to 
find that where there was more fluke there was less evidence of disease. Prof Williams also 
said fluke had become more common in the UK over the last 15 years - the very period that 
has seen a threefold increase in the number of cattle herds where bTB was present. She 
added that flukes could be thriving partly because of climate change and because of on-farm 
schemes that encouraged farmers to maintain ponds, lakes and marshes to support wildlife. 
This carries forward work published in May last year by the Veterinary Sciences Division of 
the Agri-Food and Biosciences Institute of Northern Ireland. One of their conclusions was 
that "co-infection with parasites, most notably liver fluke, and also the mycobacterial Johne's 
disease, influenced the diagnostic sensitivity of both the comparative skin test and the 
gamma interferon test". 
David Williams, Chairman of the Badger Trust, said: "The cattle industry should not only 
welcome these findings but actively follow them up, particularly on behalf of farm businesses 
that endure persistent bTB breakdowns. For decades badgers have been blamed, now this 
research clearly shows how infection stay undetected in a herd. Instead of spending its 
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money trying to kill badgers the industry should be pressing for all efforts to be to improve 
testing and remove the danger of leaving up to one third of a still infected. 
"Until the science is clear, we should not be making the badger a scapegoat. Remember 
DDT, myxomatosis and Thalidomide. We thought we knew that these were scientific 
certainties but they were disastrous. We should be wary for the future". 
 
Badger Trust 
We are group members of the Badger Trust, the UK's national Badger charity and voice for badgers. 
http://www.lancashirebadgergroup.org.uk/20l2105l25lbovine-tb-test-undermined-infe... 
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Myth bust: Observer and BBC report claims on badger culling << Defra News  
Defra 
Myth bust: Observer and BBC report 
claims on badger culling 
 
The myth: The Observer and BBC have reported claims that Ministers have ignored 
scientists' advice that a cull of badgers will have a marginal effect on bovine TB and that the 
cull could spread TB in cattle if farmers fail to oversee it effectively. 
The truth: Natural England's advice has been in the public domain for over six months. We 
took on board all comments received in response to the consultation on licensing and they 
contributed to the final policy. 
Culling will only take place in the localised areas where it will make a difference, the number 
of licences to cull badgers will be limited, the licence will specifu the maximum number of 
badgers that can be controlled, and the number of animals controlled will be monitored to 
guard against local disappearance. 
Nobody wants to cull badgers. But no country in the world where wildlife carries TB has 
eradicated this devastating disease, which forced the slaughter of 25,000 cattle in 2010 
alone, without tackling it in wildlife too. 
 
http://www.defra.gov.uk/newsl20l2l03l11/observer-and-bbc-claims-on-badger-culling/ 
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Bovine TB disguised by liver fluke 
Cattle infected with a common parasite could be spreading TB across Britain undetected. 
 
Alice Lighton 
22 May 2012 
 
Bovine tuberculosis (bTB) could be spreading across Britain because the most widely used 
test for the disease is ineffective when cattle are infected with a common liver parasite. The 
liver fluke Fasciola hepatica was already known to affect the standard skin test for bTB, but it 
was unclear whether the fluke stopped the disease developing or merely hid the symptoms. 
A study published today in Nature Communications suggests that the latter is more likely, 
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and that the effect is significant. lt estimates that around a third of bTB cases in England and 
Wales are undiagnosed because the test is less sensitive in cattle infected with the fluke. 
Cows infected with both bovine tuberculosis and a common liver fluke may not test positive 
on standard TB tests. 
 
Researchers tested milk from dairy herds across England and Wales for antibodies against 
F. hepatica, an indication of infection, and added the data to an existing model of bTB 
transmission. lf they assumed that a fluke infection inhibited bTB detection, they achieved a 
closer match between the model and actual bTB detection rates. The authors suggest that 
the fluke may alter the production by T lymphocytes - key cells in the immune system - of the 
protein interferon-y, which is crucial to a genuine result in both the skin test and the second 
most common test for bTB, the interferon-y release assay (IGRA) blood test. 
 
Diana Williams, an infectious disease specialist at the University of Liverpool, UK, and an 
author of the paper, says the result helps explain why bTB is still endemic across England 
and Wales. "Everyone is aware that current methods aren't detecting early enough or with 
enough sensitivity," she says. "We need to look at better control of fluke." 
 
But the Department for Environment, Food and Rural Affairs, which is responsible for bTB 
control in Britain, questions whether the liver fluke hides infections. "Cattle carcasses are 
inspected in abattoirs and we would see evidence of TB in the slaughtered animals if this 
was the case," a spokesperson said in a statement. The authors of the Nature 
Communications study hypothesize that cows display fewer symptoms because the fluke 
alters their immune response. A2OO7 study supports this interpretation, showing that 
animals with pre-existing tuberculosis had reduced sensitivity to the skin test when they were 
infected with liver fluke. 
 
Deworming difficulties:  The United States, Canada and Australia have eradicated bTB, but 
Britain and Ireland have struggled to control it. The disease costs the UK government around 
8100 million (US$158 million) a year. Control relies on testing cattle for bTB before they are 
moved between farms; animals that test positive are destroyed and the herd is retested. But 
the strategy isn't working. Cases have increased over the past 25 years and new infection 
sites crop up long distances from existing hotspots. 
 
Eradicating liver fluke could increase the sensitivity of the skin test and allow better control of 
infected cattle, but this poses its own difficulties. Farmers can keep cattle away from damp 
fields that are home to the fluke's snail host, but treating infected dairy cattle is complicated. 
ln 2010 the European Union (EU) banned most flukicide drugs because they leave toxic 
residues in milk. The milk from cows that receive the remaining two allowed drugs is 
undrinkable for three days after treatment. 
 
Badgers have been blamed for spreading bTB between farms, and after a fraught debate the 
UK government last year announced a badger cull in England. (The welsh government 
backed out of the trial last month.) David Williams, chairman of the UK charity, the Badger 
Trust, believes the decision to cull should be reassessed in light of the new research. The 
unreliability allows disease to remain undetected, and badgers are blamed when [infected 
cows] are found later," he says. "We have frequently queried the accuracy of testing, only to 
be told it is acceptable by EU standards and is the best test available." 
 
Beyond badgers 
Although more experiments are needed to confirm the precise interaction between flukes 
and the skin test, Dirk Werling, an immunologist at the Royal Veterinary College in Hatfield 
says there could be implications beyond cattle. Human liver flukes are rife in tropical and 
sub-tropical regions, and bTB causes 10% of human tuberculosis deaths in Africa. 
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"We know that a similar immune mechanism exists in humans," he says. "The potential 
consequences of these observations could potentially be quite severe, not only for the farm 
animals, but also for people in third-world countries." 
 
Liver fluke could also explain epidemiological mysteries, such as why bTB has never gained 
a foothold in northwest England. "Our knowledge has holes in it," says William Wint, an 
ecologist at the University of Oxford, UK, who has become frustrated by the badger-centric 
debate. "lf this can make people look more at epidemiology than politics, that would be 
marvellous." 
 
Nature doi:1 0.1038/nature.2012.'t 0685 
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Appendix B: Questionnaire for collecting Chapter 5 farm variables 
 
The University of Liverpool 
Veterinary Parasitology Group, Crown Street, Liverpool, L69 7ZJ 
 
Introduction 
Study Aim: Does infection with liver fluke increase the susceptibility of dairy cows to other 
infectious diseases? 
This questionnaire has been designed to give complete and up-to-date information on the 
management and the disease status of cattle on the farms participating in this study. The 
study will determine whether fluke infection in dairy cows alters their susceptibility to other 
infectious diseases present on the farm. We use the term ‘co-infection’ in this study to 
mean infection of a cow with fluke and another infectious disease. 
We will test milk samples to measure the level of exposure to fluke in your herd. We will 
test a sample of milk from the bulk tank to give an estimation of exposure for the whole 
herd and we will also test 10 individual cows. These results will be paired with the 
information obtained from the questionnaire, to indicate if other diseases are present on 
the farm and whether cows are ‘co-infected’.  For the 10 individual animals tested, specific 
information about those cows will be correlated with their fluke status. 
We would like to contact your veterinary surgeon to confirm some of the information you 
have given in this questionnaire. A list of the questions for your vet is enclosed at the end of 
this questionnaire copy. Signing the consent form included in these documents means that 
we can contact your vet. 
For this study to be effective, it is very important that the sampling protocol outlined in the 
enclosed instructions is strictly adhered to. 
A report summarising the results of the study will be sent to all participants at the end of 
the study (autumn 2011). 
Confidentiality 
 All information given will be treated as absolutely confidential 
 The names and locations of farms and farmers will be kept strictly confidential.  
 All data will be handled confidentially according to the Participant Information 
Sheet, provided. 
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Questionnaire 
Farm information: 
What was/is the approximate number of cows in milk in: 2008:  2009:        2010: 
What is the average milk yield per cow over the last 12 months? ................................................... 
 
What is the main breed of dairy cow on this farm? (Please tick) 
Holstein-
Friesian 
Jersey Aryshire Holstein Guernsey Friesian Other 
       
 
What percentage of the animals on your farm are home-bred? ..........................................................% 
 
Buying animals in: 
Number of dairy cows on the farm:   Number of dairy cows bought last yr: 
Number of dairy calves on the farm:   Number of dairy calves bought last yr: 
Number of dairy heifers on the farm:   Number of dairy heifers bought last yr: 
 
Number of beef cows on farm:    Number of beef cows bought in last yr: 
Number of beef calves on farm:    Number kept: 
       Destination of calves sold:  
Are any other species kept on the farm? 
Sheep  ... Horses ..... Donkeys ..... Goats ..... Alpacas/Llamas ..... Other ..... 
 
From where do you purchase your cows? 
 Dairy 
cows/heifers 
Dairy calves Beef cows Beef calves Bulls 
Another farm      
Dealer      
Market      
Farm 
dispersals 
     
Other      
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Feeding your animals 
How are your cows fed? (Please tick) 
Dairy Cows/Heifers Dairy calves Beef cows Beef calves 
TMR 
Grazing 
     Spring 
     Summer 
     Autumn 
     Winter 
Zero-Grazing 
Silage 
TMR 
Grazing 
     Spring 
     Summer 
     Autumn 
     Winter 
Zero-Grazing 
Silage 
TMR 
Grazing 
     Spring 
     Summer 
     Autumn 
     Winter 
Zero-Grazing 
Silage 
TMR 
Grazing 
     Spring 
     Summer 
     Autumn 
     Winter 
Zero-Grazing 
Silage 
 
Fertility and Calvings 
Please give the number of cows and heifers calving down during each month: 
2009 
J F M A M J J A S O N D 
            
2010 
J F M A M J J A S O N D 
            
 
Using your fertility records (NMR or other) please complete the following:  
 Rolling 12 month Rolling 3 month 
What is the calving to 
conception interval? 
                                                 days                                                  Days 
What is the calving to 1st 
service index? 
                                                   %                                                   % 
What is the number of services 
per conception? 
  
 
What proportion of the herd have a calving interval of: 
a) <344 days  % 
b) 344-385 days  % 
c) 386-425 days  % 
d) >425 days  % 
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Where do calvings occur? Please indicate all applicable. 
 
During: 
Cubicles Straw Yard Individual 
Pens 
Separate 
Pastures 
Pasture not 
separated 
Housing 
period 
     
Grazing time      
 
Acreage and Housing 
Acreage of farm:   
Organic: Yes/No 
Diseases and Vaccinations 
Have any of the following diseases been diagnosed in cattle on this farm in the last 2 years, and if so 
are they vaccinated against now? 
Disease Has this infection 
been diagnosed? 
Is vaccination 
used? 
Frequency of 
vaccination? 
How long have 
you been 
vaccinating for? 
BVDv     
IBR     
Leptospirosis     
Salmonella species     
RSV     
PI3     
E. coli     
Rotavirus     
Pasteurella multocida     
Other:     
 
Salmonella Dublin: 
Suspect numbers of cases: 
Confirmed cases on farm and dates in last 24 months: 
Method of diagnosis: 
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Johnes: 
Has a case of Johnes been suspected on the farm in the last 24 months?  
How many cases: 
Has a case of Johnes been confirmed on the farm in the last 24 months? 
How many cases: 
Method of diagnosis: 
 
Neospora caninum: 
Has a case of Neospora caninum been suspected on the farm in the last 24 months?  
How many cases: 
Has a case of Neospora caninum been confirmed on the farm in the last 24 months? 
How many cases: 
Method of diagnosis: 
 
Abortion rate on this farm last year: ...............................................% 
Main cause of abortion if known: ................................................... 
 
What is your TB status at present?  
How often do you test your herd?   1 2 3 4years 
     Other ......................................................................................  
XV 
 
Information about the cows you have sampled: 
Cow ID (tag 
or brand) 
Age in 
years and 
months 
Stage of 
current 
lactation 
(days post 
calving) 
Has this cow suffered 
mastitis since the start of 
the previous lactation? 
Any other diseases 
diagnosed in this 
animal: 
1.     
 
2.     
 
3.     
 
4.     
 
5.     
 
6.     
 
7.     
 
8.     
 
9.     
 
10.     
 
 
Somatic Cell Count data: 
Please fax or email the SCC data you hold for the 10 sampled animals (all data sent will be handled 
completely confidentially and documents will be destroyed once individual cow data has been used). 
Our fax number is: 0151 794 1519 
Jen Claridge’s Email: j.a.claridge@liv.ac.uk 
 
Sheep production 
What is the purpose of your sheep enterprise? 
(Lambs/fattening/showing/etc) 
Number of sheep on the farm:    Number of sheep bought in last year: 
Number of sheep culled last year: 
 
XVI 
 
From where do you purchase sheep? 
 Ewes Lambs Rams 
Another farm    
Dealer    
Market    
Farm 
dispersals 
   
 
When and how do your sheep have access to grass? (Please tick) 
Ewes Lambs Rams 
Grazing 
    Spring 
    Summer 
    Autumn 
    Winter 
Zero-Grazing 
    Spring 
    Summer 
    Autumn 
    Winter 
TMR 
    Spring 
    Summer 
    Autumn 
    Winter 
Silage 
    Spring 
    Summer 
    Autumn 
    Winter 
Grazing 
    Spring 
    Summer 
    Autumn 
    Winter 
Zero-Grazing 
    Spring 
    Summer 
    Autumn 
    Winter 
TMR 
    Spring 
    Summer 
    Autumn 
    Winter 
Silage 
    Spring 
    Summer 
    Autumn 
    Winter 
Grazing 
    Spring 
    Summer 
    Autumn 
    Winter 
Zero-Grazing 
    Spring 
    Summer 
    Autumn 
    Winter 
TMR 
    Spring 
    Summer 
    Autumn 
    Winter 
Silage 
    Spring 
    Summer 
    Autumn 
    Winter 
 
Have you had any deaths due to fluke infection in your sheep?      Y /N  Approx no. 
How were the deaths diagnosed?............................................................................................................ 
 
Flukicide use on farm: 
Are flukicidal drugs used on this farm? 
 Dairy cows  Yes/No 
 Beef cows Yes/No 
 Sheep  Yes/No 
 
XVII 
 
Did the cows you have sampled receive a flukicidal drug dose in the last 12 months? Yes/No 
If yes, which drug...................................................................................................................................... 
What regime is used for flukicide treatment? 
Dairy cattle 
 
Beef cattle 
 
Sheep 
 
 
Are anthelmintics (wormers) used on this farm? 
 Dairy cows  Yes/No 
 Beef cows Yes/No 
 Sheep  Yes/No 
 
If yes, which drugs were used? 
.................................................................................................................................................................. 
 
Did the cows you have sampled receive an anthelmintic (wormer) drug dose in the last 12 months?
 Yes/No 
If yes, which drug...................................................................................................................................... 
 
At what ages are animals routinely wormed?   
Dairy Animals  Beef animals?  Sheep? 
 1st yr of life only  ................  .....................  ..................... 
 Up to 2nd yr of life ................  .....................  ..................... 
 Up to 3rd yr of life ...............  .....................  ..................... 
 Every yr of life  ...............  .....................  ..................... 
XVIII 
 
 Never   ...............  .....................  ..................... 
 Other (pls specify) ...............  .....................  ..................... 
 
Has there ever been a positive diagnosis of anthelmintic/flukicidal drug resistance made on your 
farm?    Yes/No 
 
 
Thank you for your time 
 
 
XIX 
 
Verification of information by farm veterinary surgeons 
Diseases and Vaccinations 
Have any of the following diseases been diagnosed on this farm in the last 2 years, and if so are they 
vaccinated against now? 
Disease Problems on farm Vaccination used? Frequency of 
vaccination? 
BVDv    
IBR    
Leptospirosis    
Salmonella species    
RSV    
PI3    
E. coli    
Rotavirus    
Pasteurella multocida    
Other:    
 
Salmonella Dublin: 
Suspect numbers of cases: 
Confirmed cases on farm and dates in last 24 months: 
Method of diagnosis: 
 
Johnes: 
Has a case of Johnes been suspected on the farm in the last 24 months?  
How many cases: 
Has a case of Johnes been confirmed on the farm in the last 24 months? 
How many cases: 
Method of diagnosis: 
 
Neospora caninum: 
Has a case of Neospora caninum been suspected on the farm in the last 24 months?  
How many cases: 
Has a case of Neospora caninum been confirmed on the farm in the last 24 months? 
XX 
 
How many cases: 
Method of diagnosis: 
 
Abortion rate on this farm last year: ...............................................% 
Main cause of abortion if known: ................................................... 
 
What is this farm’s TB status at present?  
How often do you test this herd?   1 2 3 4years 
     Other ...................................................................................... 
 
Thank you 
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